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RESUMO 
 
O principal objectivo desta dissertação foi o desenvolvimento de um método baseado em 
nanopartículas de ouro para detecção de aductos de DNA como biomarcadores, para 
complementar as desvantagens existentes nos métodos actualmente utilizados. O trabalho 
experimental foi dividido em 3 componentes: preparação da amostra, detecção e avaliação de um 
modelo biológico de exposição. 
Foram implementadas e combinadas diferentes técnicas de purificação de amostras de DNA 
(incluindo ultra-sons, endonucleases e cromatografia) num protocolo completo para preparação 
da amostra de DNA, antes da detecção.  
A detecção de nucleótidos alquilados utilizando nanopartículas de ouro foi realizada por dois 
métodos distintos: espectrometria de massa e colorimétrico. No primeiro, as nanopartículas de 
ouro foram utilizadas para ionização por laser em vez da matriz orgânica normalmente utilizada. 
Foi possível a identificação de nucleótidos através de sinais de massa específicos no espectro. No 
entanto, não foram observados sinais correspondentes aquando da análise de amostras biológicas. 
Um método alternativo baseado nas propriedades colorimétricas das nanopartículas de ouro foi 
também utilizado para detecção. Este método inspirado pelo método de non-cross-linking 
permitiu a identificação de guaninas alquiladas e aductos do DNA produzidos numa reacção in 
vitro.  
Para avaliação de um modelo de exposição à acrilamida foram testados dois organismos: o 
peixe-dourado e o mexilhão. Os organismos foram expostos à acrilamida na água, a mortalidade 
foi avaliada e foram estimadas as concentrações letais. No caso do peixe-dourado, a 
genotoxicidade e alterações metabólicas mostraram relações entre concentração de exposição e 
resposta dos biomarcadores. Alterações histopatológicas foram verificadas principalmente nas 
células pancreáticas, mas também ao nível dos hepatócitos. Nos mexilhões foram observadas 
concentrações letais maiores que as estimadas para os peixes-dourados. A análise de 
biomarcadores de stress oxidativo após exposição prolongada mostrou que a acrilamida causa 
alterações no estado oxidativo da célula e induz actividade de enzimas envolvidas na 
destoxificação de radicais. Uma análise histopatológica qualitativa revelou gonadotoxicidade 
acentuada em mexilhões fêmea, o que pode constituir um risco para a dinâmica populacional. 
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ABSTRACT 
 
The main objective of this thesis was the development of a gold nanoparticle-based 
methodology for detection of DNA adducts as biomarkers, to try and overcome existing 
drawbacks in currently employed techniques. For this objective to be achieved, the experimental 
work was divided in three components: sample preparation, method of detection and development 
of a model for exposure to acrylamide. 
Different techniques were employed and combined for de-complexation and purification of 
DNA samples (including ultrasonic energy, nuclease digestion and chromatography), resulting in 
a complete protocol for sample treatment, prior to detection. 
The detection of alkylated nucleotides using gold nanoparticles was performed by two distinct 
methodologies: mass spectrometry and colorimetric detection. In mass spectrometry, gold 
nanoparticles were employed for laser desorption/ionisation instead of the organic matrix. 
Identification of nucleotides was possible by fingerprint, however no specific mass signals were 
denoted when using gold nanoparticles to analyse biological samples. An alternate method using 
the colorimetric properties of gold nanoparticles was employed for detection. This method 
inspired in the non-cross-linking assay allowed the identification of glycidamide-guanine adducts 
and DNA adducts generated in vitro. 
For the development of a model of exposure, two different aquatic organisms were studies: a 
goldfish and a mussel. Organisms were exposed to waterborne acrylamide, after which mortality 
was recorded and effect concentrations were estimated. In goldfish, both genotoxicity and 
metabolic alterations were assessed and revealed dose-effect relationships of acrylamide. 
Histopathological alterations were verified primarily in pancreatic cells, but also in hepatocytes. 
Mussels showed higher effect concentrations than goldfish. Biomarkers of oxidative stress, 
biotransformation and neurotoxicity were analysed after prolonged exposure, showing mild 
oxidative stress in mussel cells, and induction of enzymes involved in detoxification of oxygen 
radicals. A qualitative histopathological screening revealed gonadotoxicity in female mussels, 
which may present some risk to population equilibrium.  
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CHAPTER 1. GENERAL INTRODUCTION 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Experience is not what happens to you; it's what you do with what happens to you. 
Aldous Huxley 
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The work presented in this dissertation was accomplished at the interface of nanotechnology, 
mass spectrometry and toxicology. Most concepts and state-of-the art on these research areas are 
presented in the introduction section. However, besides these subjects, it integrates other concepts 
such as ultrasonic energy, chromatography and molecular biology techniques. With this in mind, 
the subsequent chapters may present a less extensive introduction which is included as to explain 
the particular concepts and subjects concerning that chapter alone. The following introduction 
will address nanotechnology, mass spectrometry, and toxicology directed to DNA lesions, 
presented in this specific order of contents merely to facilitate comprehension for the reader. It is 
more favourable to perceive the application of nanoparticles to mass spectrometry, if both 
concepts have previously been introduced in separate. As such, and despite this being a 
dissertation in Biology, focused in the biological subject of DNA adducts, I will firstly introduce 
concepts of nanotechnology and applications to biomolecular detection. Afterwards, the 
principles of mass spectrometry and applications of nanoparticles to mass spectrometry detection 
will be discussed, and only the last part will address notions about toxicology, with an emphasis 
on chemical carcinogenesis and the biological problem of DNA adduct formation and detection. 
Throughout this dissertation, some concepts may be regarded as ambiguous, such as adducts 
(DNA adducts or cation/mass adducts) or matrix (biological matrix or organic matrix). Whenever 
they appear, an adequate explanation will be provided as well as a proper context, in order to 
avoid confusion. 
 
1.1 Nanotechnology  
 
Nanotechnology involves the creation and manipulation of materials and structures on a 
nanometer (10-9 meter) scale. Several authors describe nanotechnology as the control and 
manipulation of materials at an atomic and molecular level, as most macromolecules present sizes 
comprised between 1 and 100 nm (Vo-Dinh 2005). The concept of nanotechnology was firstly 
introduced by Richard Feynman in 1959, in a lecture named “There’s plenty of room at the 
bottom” presented at CalTech (Feynman 1960). Ever since, different nanotechnology-based 
approaches have been developed towards an unlimited number of applications, e.g. electronics, 
mechanics, medicine, pharmacology, etc. 
The study of nanotechnology has prompt the synthesis of novel materials and structures, and 
has also allowed for a more detailed comprehension of already existing materials. In terms of 
synthesis of nanomaterials, there are essentially two different approaches to be considered: top-
down or bottom-up (Miller et al. 2005). Top-down approaches involves eroding nanomaterials 
from the bulk material and are mainly accomplished by diverse forms of lithography techniques, 
such as electron-beam lithography or soft lithography (Zhao et al. 1997, Watt et al 2005). 
Conversely, bottom-up approaches rely on conjugation of several molecular components, to build 
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nanostructures. Different techniques are utilised for bottom-up synthesis and characterisation of 
nanomaterials, with the most common being chemical synthesis or chemical self-assembly, where 
different molecules or atoms are mixed together and spontaneously organise into well-defined 
and stable nanostructures, due to their spatial and electronic properties (Lazzari et al. 2006). A 
common example of this organisation is the chemical synthesis of metallic nanoparticles, e.g. 
noble metal nanoparticles, from precursor salts, described in more detail in the following sections. 
The field of nanotechnology draws and integrates knowledge from diverse research areas, such 
as physics, chemistry and material science, to develop novel applications or improve existing 
ones. This way, more specialised research areas have been created based in the synergy between 
nanotechnology and other areas, e.g. nanoelectronics, nanofluidics, nanotoxicology, 
nanobiotechnology. The latter, for instance is a term that defines the creation of nanostructures or 
nanoconjugates by using biological molecules, such as DNA or proteins as raw materials 
(Niemeyer and Mirkin 2004). In the last decades, there has been a massive increase in the number 
of nanobiotechnology-oriented platforms, namely towards biomolecular detection, with a direct 
application in diagnostics (Doria et al. 2007, Doria 2010, Conde et al. 2010). The following 
sections will address some of these systems, based on noble metal nanoparticles, for biomolecular 
detection of nucleic acids or biomarkers, considering a more clinical point of view. 
 
1.1.1 Noble metal nanoparticles  
The emergence of nanotechnology has prompted an intense research effort on the nanoscale 
properties of several materials, such as noble metal nanoparticles (NPs). These nanoparticles are 
usually constituted by clustered metal atoms (3 to 107 atoms) protected by a capping agent, and 
exhibit remarkable properties, such as highly tuneable spectral behaviour and an elevated surface-
to-volume ratio (Liz-Marzán 2006). Other than this, noble metal NPs possess amazing optical 
properties, due to the localised surface plasmon resonance (LSPR), i.e. the collective oscillations 
of free electrons at a metal-dielectric interface when the frequency of incident light coincides with 
the frequency of electron oscillation (see Figure 1.1). These oscillations are influenced by the 
NPs’ size, dispersion, shape and composition and originate the intense colours and/or very intense 
scattering of the colloidal dispersions of NPs (Jain et al. 2006, Liz-Marzán 2006). Particularly, 
gold nanoparticles (AuNPs), also referred to as colloidal gold, exhibit astounding optical, physical 
and catalytic properties which favour its utilisation in promising tools for biosensing, imaging or 
therapy applications (Boisselier and Astruc 2009, Conde 2013), such as more sensitive, faster, 
and simpler assays, which may also be cost-effective. Noble metal NPs have, thus, been the 
subject of intense research for use in biosensing, namely for low-cost high-sensitivity approaches 
for molecular recognition assays. Special attention has been paid to the development of systems 
capable of nucleic acid detection, or protein biomarker identification. These nano-based platforms 
may present a noteworthy alternative to already established multiplex technologies based on 
5 
 
fluorescence or chemiluminescence (Cai et al. 2010, Leroy and Raoult 2010), towards genome 
screening strategies, identification of mutations/polymorphisms associated to relevant phenotypes 
or characterisation of specific protein disease profiles.  
  
 
Figure 1.1. Schematic representation of the SPR phenomenon. The incident electromagnetic wave interacts 
with the electrons at the surface of the metal nanoparticle, generating a surface plasmon resonance. 
 
1.1.1.2 Synthesis and derivatisation 
Gold nanoparticles with sizes between 2 and 40 nm, which exhibit a typical LSPR band centred 
at around 520 nm, can be easily synthesised in aqueous medium via reduction of a gold salt 
(Baptista et al. 2008). The size dispersity of AuNPs may be tailored by altering the reduction 
agent (e.g. citrate, borohydride), the gold-reduction agent ratio, or temperature. These AuNPs can 
then be directly functionalised with thiol-containing molecules, such as antibodies or thiol-
modified oligonucleotides (Mirkin et al. 1996). An oligonucleotide-gold nanoparticle conjugate 
is more commonly designated as a gold-nanoprobe (Au-nanoprobe) and was firstly synthesised 
in 1996 by Mirkin and co-workers. This remarkable contribution to the field of 
nanobiotechnology inspired many subsequent applications that can be used in a multitude of 
detection strategies for recognition of specific DNA/RNA sequences (Thaxton et al. 2006, 
Baptista et al. 2008) or discrimination of single-base alterations (Sato et al. 2003, Doria et al. 
2007). Aside from gold-biomolecule nanoconjugates, AuNPs have also been used for several 
applications such as electrochemistry (Kerman et al. 2004) or mass spectrometry (Chiang et al. 
2010).  
There are considerably fewer reports on the use of silver NPs (AgNPs) functionalised with 
oligonucleotides for nucleic acid sequence detection in comparison to AuNPs. Firstly, the 
synthesis of AgNPs with homogeneous (normal) size distribution is considerably more difficult 
than that of AuNPs, and secondly, the affinity of sulphur towards silver is considerably lower, 
rendering functionalisation with thiolated molecules less efficient. Functionalisation with amine-
modified biomolecules (Steinbrück et al. 2008) or cyclic disulphide groups (Lee et al. 2007) has 
been explored as an alternative to thiol-modified biomolecules. Despite exhibiting higher 
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scattering properties than their gold counterparts, AgNPs do not exhibit the same intense colours 
when in solution, and therefore their application in colorimetric assays has been residual. AgNPs 
have been more explored for the development of protocols involving fluorescence detection - 
silver enhancement (Malicka et al. 2003, Li et al. 2010), surface-enhanced Raman scattering - 
SERS (Moody and McCarthy 2009, Lowe et al. 2010) and in combination with gold to form 
bimetallic NPs, with distinct assembly concepts - core/shell and alloy (Wilcoxon 2009, Shore et 
al. 2011).  
 
1.1.2 Noble metal nanoparticles for colorimetric detection of nucleic acids 
1.1.2.1 Assays based on unmodified noble metal nanoparticles 
As mentioned earlier, a colloidal solution of dispersed AuNPs shows an intense red colour due 
to the LSPR band in the visible region. Changes to the medium dielectric (such as an increase in 
ionic strength) cause the AuNPs to aggregate, with concomitant red-shift of the LSPR band and 
the solution turns blue (Baptista et al. 2008). This phenomenon has been explored for the 
development of detection schemes where the presence/absence of a given analyte (e.g. nucleic 
acid sequence) prevents or causes aggregation, thus yielding the result. The repulsion between 
negative charges of capping agents (e.g. citrate) at the surface of AuNPs prevents aggregation. 
Based on the difference in electrostatic properties from single-strand DNA (ssDNA) to double-
strand DNA (dsDNA), Li and Rothberg (2004) proposed a colorimetric detection scheme where 
ssDNA easily adsorbs to the AuNPs’ surface and stabilises them against increasing ionic strength; 
conversely, dsDNA does not adsorb to the surface due to electrostatic repulsion and aggregation 
of AuNPs occurs. Detection of single-base mismatches was possible by de-hybridisation of 
previously formed dsDNA structures (perfectly matched versus single-base-mismatched) and 
observation of its influence on an AuNPs solution facing increasing ionic strength. A similar 
approach was used by Lee and co-workers for genotyping, where oligonucleotide probes that 
were perfectly complementary to the target allele sequence were hybridised to PCR products, 
amplified from human DNA samples, and then duplexes were denatured and mixed with AuNPs 
for SNP discrimination (Lee et al. 2010). A similar strategy using peptide nucleic acid (PNA) 
probes to control AuNPs’ aggregation was proposed by Kanjanawarut and Su (2009) whereby 
PNA serves both as hybridisation probe and aggregating agent of citrate-capped AuNPs and 
AgNPs, in the absence of complementary DNA. Conversely, the presence of complementary 
DNA induces PNA-DNA complex formation and prevents NP aggregation. More recently, Liu 
and co-workers proposed an approach for discrimination of single-base mismatches localised at 
various positions within the target nucleotide sequence involving a probe-target hybridisation 
followed by a treatment with structure-selective nucleases (Liu et al. 2011). If S1 nuclease is used, 
when a perfect matched target hybridises with the probe, the resulting duplex will be protected 
from degradation; whereas a non-complementary/mismatched target will be digested to 
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deoxynucleotides monophosphate (dNMPs) that stabilise AuNPs against salt induced 
aggregation. A main drawback of this system is limited sensitivity, requiring a PCR amplification 
step prior to detection. 
 
1.1.2.2 Assays based on functionalised noble metal nanoparticles 
In 1996, Mirkin and co-workers described the use of oligonucleotide functionalised AuNPs for 
specific DNA sequence analysis, based on the change of colour of Au-nanoprobe-containing 
solutions, upon hybridisation to a complementary target (Mirkin et al. 1996, Elghanian et al. 1997, 
Storhoff et al. 1998). Upon hybridisation, the target sequences and the nanoprobes form a 
network, the AuNPs are brought into close vicinity and aggregation is induced, resulting in a 
change of colour from red to blue. The scheme in Figure 1.2 demonstrates the referred cross-
linking hybridisation approach. This system has also been used in a microarray format, where a 
capture probe is functionalised to the surface of the array and the second probe (functionalised 
with an AuNP) hybridises to the captured target. Following capture and hybridisation, the Au-
nanoprobe is coated with silver via a localised reduction of silver, thus amplifying detection 
through coupled evanescent wave-induced light scattering. This very system was used for SNP 
genotyping associated with thrombotic disorders on unamplified human genomic DNA (Bao et 
al. 2005). 
 
Figure 1.2. The detection principle and colorimetric result behind the cross-linking assay developed by 
Mirkin and co-workers for identification of nucleotide sequences. From Thaxton et al. (2006), with 
permission. 
 
Using only one Au-nanoprobe in a non-cross-linking approach, Baptista and co-workers 
developed a sensitive method for specific identification of nucleic acids sequences (Baptista et al. 
2005a,b, Conde et al. 2010). Upon mixing of the Au-nanoprobe with DNA, an increase in ionic 
strength will cause extensive aggregation and concomitant change of the solution from red to 
blue; this aggregation is prevented in case the Au-nanoprobe hybridises specifically to the 
complementary target (Figure 1.3). This method is capable of detecting single base mismatches 
(mutations or single nucleotide polymorphism, SNP) at room temperature (Doria et al. 2007), 
provided the following minimal conditions are met i) better discrimination is attained when the 
mismatch is localised at the 3’end of the nanoprobe sequence; ii) probe oligonucleotides on the 
AuNPs’ surface strongly influences hybridisation, thus Au-nanoprobe density should not be 
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higher than 24 pmol/cm2 so as not to induce repulsion of the target sequence due to the phosphate 
backbone (Doria et al. 2010). An overview of AuNP-based biomolecular assays for detection of 
single base mismatches is presented in Table 1.1. 
 
 
Figure 1.3. The detection principle behind the non-cross-linking colorimetric assay developed by Baptista 
et al. for identification of nucleotide sequences. The letters identify the possible cases and depict the 
mechanism, spectrum and colorimetric result for a) hybridisation with a complementary target, and b) 
presence of a non-complementary target. 
 
Conversely to what has been described for AuNPs, there are only a few reports on the use of 
silver nanoparticles for colorimetric detection of nucleic acids, probably due to the lower 
efficiency of surface functionalisation provided by silver (Steinbrück 2008). AgNPs have been 
functionalised with oligonucleotides (Ag-nanoprobes) in an attempt to increase sensitivity due to 
the favourable optical properties of silver (Wilcoxon 2009). Mirkin and co-workers presented a 
cross-linking hybridisation colorimetric assay using AgNPs derivatised with terminal cyclic 
disulphide group-modified oligonucleotide probes (Lee et al. 2007). Similarly to the proposed 
cross-linking methods involving Au-nanoprobes, two Ag-nanoprobes, each complementary to 
half of the target sequence were used (Thompson et al. 2008). An interesting approach using 
naked AgNPs for detection of specific sequences through non-covalent interactions between 
oligonucleotides and AgNPs surface has been reported by Xu et al. (2009). In the presence of 
high ionic strength, AgNPs aggregation (and concomitant colour change of solution) can be 
9 
 
prevented by the unspecific adsorption of free oligonucleotides. This approach was designed 
mainly for poly(A) sequence analysis, benefiting from its affinity towards the coralyne ligand that 
binds strongly to adenine-rich regions. Recent reports have highlighted poly(A) sequences as 
putative new therapeutic targets for RNA-based drug design (Giri and Kumar 2009). In the 
absence of coralyne, poly(A) targets adsorb non-specifically to the AgNPs’ surface, stabilising 
them against an increase in ionic strength. When coralyne is present in solution, it binds the 
poly(A) targets forming a duplex that prevents the oligonucleotides from interacting and 
stabilising the AgNPs, and aggregation occurs. Also, a colorimetric assay for characterisation of 
DNA:protein interactions based on DNA-AgNPs conjugates has been proposed for assessing the 
function of oestrogen receptor alpha (ERα), a nuclear receptor which modulates oestrogen 
production through regulation of transcription. Increasing ERα concentration helped stabilisation 
of Ag-nanoprobe against high ionic strength (Tan et al. 2010). In this study, Ag-nanoprobes were 
shown to be more sensitive than their gold counterparts.  
 
1.1.3 Noble metal nanoparticles for signal enhancement 
1.1.3.1 Fluorescence assays 
Applications of AgNPs to metal-enhanced fluorescence (MEF) for DNA hybridisation 
assays have also been reported, profiting from the enhancement of fluorescence when 
fluorophores are in the vicinity of noble metal nanostructures (Malicka et al. 2003) - see Figure 
1.4 for schematic representation. AgNPs have been successfully utilised in a MEF-based system 
in a microarray platform to improve sensitivity (Sabanayagam and Lakowicz 2007). Li and co-
workers, using a flat silicon surface (p-Chips) functionalised with AgNP-films, tested the 
fluorescence enhancement on four different fluorophores, demonstrating the potential of MEF-
based detection for multiplex sequence analysis (Li et al. 2010). MEF-based RNA sensing has 
also been described using AgNP-films on glass surfaces and immobilised thiolated-
oligonucleotide probes (Aslan et al. 2006a). First, a fluorophore-labelled oligonucleotide was 
hybridised to the RNA, and this conjugate was then hybridised to the immobilised probe on the 
surface, thus bringing the fluorophore and the AgNPs close together. This method presented a 
100-fold improvement on RNA quantification sensitivity, in comparison to previously developed 
assays. Another approach has been to use microwave-accelerated metal-enhanced fluorescence 
(MAMEF) in DNA hybridisation assays, with high detection limits (Aslan et al. 2006b). This 
procedure involves the use of a MEF scheme in which low-power microwave heating is used in 
order to promote biomolecular recognition events.  
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Figure 1.4. Schematic representation for a detection system based in metal-enhanced fluorescence (MEF). 
Fluorescence signal enhancement may be achieved by coating a surface with AgNPs prior to probe 
immobilisation. After hybridisation with a fluorophore labelled probe and excitation at the adequate 
wavelength, fluorescence intensity is potentiated by the AgNPs (MEF).  
 
1.1.3.2 Luminescence assays 
Approaches for AuNP-based labelling and chemiluminescence-based detection exhibiting good 
sensitivity, sequence specific discrimination and DNA target quantification have also been 
reported, in particular microarray platforms coupled to AuNP-catalysed silver enhancement (Li 
et al. 2007, Girigoswami et al. 2009). A successful genotyping approach targeting the BRCA1 
gene was reported by Girigoswami and co-workers (2009), which includes two primers (primer1 
and primer2), each complementary to half of the target sequence. Primer1 bears a 5’ zip 
complementarity, necessary for analysis to be carried on a zip-code microarray platform. Primer2 
is 3’ thiol-modified, required to bind an AuNP for silver enhancement-based detection. Upon 
successful hybridisation, a ligase reaction is carried out, to seal the nick between the two primers. 
When the allele-specific probe is 100% complementary to the target, ligation occurs and, upon 
assembly on the microarray platform, the sequence binds an AuNP through 3’-thiol modification. 
Afterwards, the AuNP is silver-coated, for enhanced detection. 
A chemiluminescent approach for DNA detection was described, whereby the Ag+ ions arising 
from AgNPs dissolution act as indicators for detection (Liu et al. 2006). In this system, two 
different probes are used, complementary to different halves of the target, similarly to the cross-
linking method previously described (see above). Following successful probe-target 
hybridisation, the AgNPs are dissolved using HNO3 and Ag+ ions determined via a coupling 
chemiluminescence reaction. SNPs were analysed by comparison of thermal dissociation curves 
for perfect complementary targets and mismatched targets, hybridised with the referred probes 
with very low limits-of-detection. Guo and co-workers (2010) proposed another approach for 
discrimination of single base alterations based on oligonucleotide probes with a cytosine loop 
(C6) and AgNPs’ photoluminescence detection, and used this method to discriminate a single-
base mutation associated to sickle-cell anaemia. Upon probe hybridisation to a perfect 
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complementary target, an efficient scaffold of Ag+ ions originates a photoluminescent AgNP, 
whose emissive properties potentiate the detection. Mismatched targets yielded residual 
luminescence emission.  
 
1.1.3.3 Spectral labels 
Noble metal NPs have also been used as signal enhancers for Raman scattering-based detection 
of biomolecules. AuNPs for Raman spectroscopy-based detection have also been used in 
combination with i) methylene blue for target labelling (Harpster et al. 2009), ii) magnetic 
nanoparticles for effective target capture (Zhang et al. 2011a), and iii) assembled on a multi-metal 
nanojunction structure for identification of single-base mismatches in an HIV-1-derived DNA 
sequence (Hu et al. 2010). In an effort to improve existing platforms for nucleotide sequence 
analysis and mismatch discrimination, Moody and McCarty (2009) proposed a proof-of-concept 
involving AuNPs for signal amplification of Surface-enhanced Raman Scattering (SERS). SERS 
detection potentiated by AuNPs was also used on cancer gene expression studies aiming at 
detection of multiple splice variants of human BRCA1 gene analysis (Sun and Irudayaraj 2009). 
AgNPs have also been used as Raman scattering enhancers for nucleotide sequence analysis. 
Zhang et al. (2011b) presented an approach, using a combination of mixed Ag-nanoprobes and 
Raman reporter molecules, for multiplex detection of specific nucleotide sequences, through a 
sandwich hybridisation assay for recognition and signal amplification. Lo and co-workers (2011) 
used AgNPs for enhancement of the Raman scattering signal, using an Au-nanotip covered with 
oligonucleotide molecules and the subsequent deposition of sub~10 nm AgNPs to coat the Au-
nanotip. A distinct method for SNP genotyping based on a ligation reaction coupled to Raman 
scattering detection and including two probes (each complementary to different halves of a target 
sequence) was presented by Lowe et al. (2010). A first oligonucleotide probe hybridises with the 
target strand downstream of a SNP and is later conjugated to an AgNP for signal amplification. 
The second probe, containing a Raman active fluorophore and a discriminating base at the 3′ end, 
binds upstream of the SNP and adjacent to the first probe allowing maximum specificity. In 
presence of a perfect match, ligation between the two oligonucleotides is attained, bringing the 
fluorophore and the AgNP closer. This enhances the signal, and particular Raman signatures may 
be observed as different fluorophores are placed on the SNP allelic specific probes. This approach 
allows for flawless discrimination of SNPs occurring in the KRAS oncogene at picomolar 
detection levels. 
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Table 1.1. Overview of AuNP-based colorimetric systems for nucleic acid detection. 
Detection 
method 
Category Principle for detection Application Refs 
Naked 
AuNPs 
Colorimetric A specific probe is hybridised to a 
target sequence. Afterwards, AuNPs 
and salt are added; ssDNA stabilises 
AuNPs against aggregation, whilst 
dsDNA does not. 
Detection of 
single-base 
mismatches 
Li and 
Rothberg 
2004. 
Probes 100% complementary to the 
target allele were hybridised to PCR 
products; duplexes were denatured 
and mixed with AuNPs; ssDNA 
strands resulting from dehybridisation 
stabilised AuNPs.  
SNP genotyping of 
human DNA 
samples 
Lee et al. 
2010 
PNA probes are used both as 
hybrisidation probes and as an 
aggregating agent for AuNPs. Probe 
hybridisation to a complementary 
target prevents PNA-induced AuNPs 
aggregation. 
Single-base 
mismatch 
discrimination on 
DNA targets with 
different lengths 
Kanjanawarut 
and Su 2009 
S1 nuclease is used to degrade 
probe:mismatch target duplexes to 
dNMPs, and AuNPs are added to the 
solution; dNMPs stabilise AuNPs 
against salt-induced aggregation. 
Detection of point 
mutations in viral 
genomic DNA 
Liu et al. 
2011 
Au-
nanoprobes 
Colorimetric 
Scanometric 
Two Au-nanoprobes, each 
complementary to different halves of 
the sequence, are hybridised to a 
target; the presence of a 
complementary sequence induces 
nanoprobe aggregation. 
Detection of one-
base mismatch, 
insertion and 
deletion; SNP 
genotyping on 
human genomic 
DNA 
Mirkin et al. 
1996; 
Storhoff et al. 
1998; Bao et 
al. 2005 
Colorimetric Au-nanoprobe hybridisation to a 
complementary target results in the 
formation of duplexes at the 
nanoprobes' surface, which stabilise it 
against salt-induced aggregation. 
Detection of 
single-base 
mutation on the β-
globin gene; SNP 
discrimination on 
the DOR gene. 
Baptista et al. 
2005a,b; 
Doria et al. 
2007 
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1.1.4. Noble metal nanoparticles for biomarker analysis 
Most clinical diagnostics applications strongly rely on the identification of biomarker proteins 
for disease characterisation, and an enormous effort has been put into developing novel 
nanotechnology-based approaches for this effect (Perfézou et al. 2012, Ray et al. 2011). Several 
platforms specifically designed for protein biosensing often include standard assembly concepts 
using antigens and antibodies for molecular recognition (e.g. sandwich immunoassay), coupled 
to distinct detection strategies, such as spectroscopy (Cai et al. 2009, Neely et al. 2009), 
electrochemistry (Mani et al. 2009, De la Escosura-Muñiz and Merkoçi 2011) or imaging (Kah et 
al. 2007, Lee et al. 2009). Noble metal nanoparticles have brought a new dimension to such 
bioassays by increasing the sensitivity at lower costs (Perfézou et al. 2012). Because most of these 
assays rely on previously studied and widely used biomarkers, integration into nanoparticle-based 
sensing platforms has been rather straightforward - Table 1.2. 
Most AuNPs applications have been directed towards signal enhancement of standard protein 
detection assays, ranging from enzyme-linked immunosorbent assays (ELISAs) to immunoassay 
platforms coupled to electrochemical or SERS-based detection. Examples include increase in 
Rayleigh scattering intensity for Alzheimer disease diagnostics (Neely et al. 2009), nanochannel-
based filtering and sensing platform for cancer biomarkers (De la Escosura-Muñiz and Merkoçi 
2011) and enhancement for immunochromatographic test strips (Tanaka et al. 2006). Resonance 
Rayleigh scattering was used in conjunction with antibody-coated AuNPs for transferrin 
biosensing (Cai et al. 2009) for transferrin quantification in human serum samples with a detection 
limit two orders of magnitude lower than ELISA. A similar concept was shown for two-photon 
Rayleigh spectroscopy detection of tau protein in cerebrospinal fluid (Neely et al. 2009). By using 
monoclonal anti-tau antibodies functionalised to AuNPs’ surface, it was possible to improve 
scattering intensity by 16-fold, which reflects a significant increase in sensitivity (by two orders 
of magnitude). Femtomolar levels of prostate-specific antigen (PSA) in serum were detected 
using an immunoassay coupled to SERS-based detection. This was achieved by using monoclonal 
antibodies, with the secondary antibody being directly attached to a multifunctionalised AuNP 
(Grubisha et al. 2003).  
A different platform using a naked-eye detection method and consisting of a AuNPs-based 
enhancement for immunochromatographic test strips showed promising results for clinical 
diagnostics purposes (Tanaka et al. 2006). In this sandwich-like assay, both the primary and the 
secondary antibodies are conjugated with AuNPs, increasing the limit of detection of the 
chorionic gonadotropin hormone (HCG) in human serum by 1 order of magnitude, to reach 10 
pg/mL and of the total PSA to reach 200 pg/mL. Besides the advantage in sensitivity, this is a 
simple and fast method which provides results in less than 20 minutes. Self-assembled gold 
colloids functionalised with extractable nuclear antigens (ENAs) have also been used in 
combination with an optical fibre evanescent-wave sensor, for anti-nuclear antibodies (ANAs) 
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detection in human serum (Lai et al. 2007). This system does not require a secondary antibody 
and presents increased sensitivity (by an order of magnitude) when compared to traditional 
ELISA. 
AuNPs have also been utilised as optical signal enhancers when used in conjunction with the 
traditional ELISA test (Ambrosi et al. 2010). The signalling antibody (secondary antibody 
conjugated to a reporter molecule) was attached to the surface of AuNPs and the optical signal 
resulting from molecular recognition was then compared in the presence and absence of the 
AuNP-antibody conjugates - see schematics in Figure 1.5. Besides a 2-fold increase in sensitivity, 
the use of AuNPs resulted in shorter incubation times when attaining a colorimetric result applied 
to detection of the breast tumour biomarker CA15-3 at clinically relevant levels. 
 
Table 1.2. Protein bioassays based on noble metal NPs - a clinical perspective. 
Category Detection technique Target / Clincal Application Ref. 
Scanometric Light scattering 
measurement 
Human chorionic gonadotropin 
(HGC), Prostate-specific antigen 
(PSA) and α-fetoprotein (AFP) 
as cancer biomarkers 
Kim et al. 2009; 
Thaxton et al. 
2009 
Spectroscopy Rayleigh scattering Tau protein and human 
holotransferrin; PSA as cancer 
biomarker 
Grubisha et al. 
2003; Cai et al. 
2009; Cao and 
Sim 2009 
SERS Thrombin and carcinoembryonic 
antigen (CEA) as cancer 
biomarkers; prion protein PrPc  
Bizzarri and 
Cannistraro 
2009; Chon et 
al. 2009; Serra 
et al. 2011 
UV-Vis spectroscopy 
(naked-eye detection) 
Cyclic A2 as a cancer 
biomarker; Glycated 
haemoglobin (HbA1c) as a 
diabetic marker 
Wangoo et al. 
2010; Wang et 
al. 2011 
Immunoassay Dynamic light 
scattering 
CA152, CEA, CA19-9 and PAP 
(prostatic acid phosphatase) as 
cancer biomarkers 
Huo 2010 
ELISA CA15-3 cancer biomarker Ambrosi et al. 
2010 
Immunocromatography 
(naked-eye detection) 
HCG and PSA as cancer 
biomarkers 
Tanaka et al. 
2006 
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Immunoassay 
(cont.). 
Gold-modified optic 
fiber 
Anti-nuclear antibodies (ANAs) Lai et al. 2007 
UV-Vis spectroscopy PSA and CEA as cancer 
biomarkers 
Cao et al. 2009, 
Liu et al. 2010 
Electrochemical 
immunoassay 
Amperometry Interleukin-6 (IL-6) and PSA as 
cancer biomarkers 
Mani et al. 
2009; 
Chikkaveeraiah 
et al. 2011 
Differential pulse 
voltammetry 
CA15-3, tumour necrosis factor 
alpha (TNF-α) and Hepatitis B 
surface antigen 
De la Escosura-
Muñiz et al. 
2011; Liang et 
al. 2011; Yin et 
al. 2011 
Square wave 
voltammetry 
Human serum albumin and 
cardiac myoglobin as 
biomarkers; HIV-1 reverse 
transcriptase level in human 
serum 
Omidfar et al. 
2011; Suprun et 
al. 2011; Labib 
et al. 2011 
Cyclic voltammetry CEA and human cardiac 
troponin I as cancer biomarkers 
Ou et al. 2007; 
Ahammad et al. 
2011 
Imaging Surface plasmon 
resonance imaging 
Epidermal growth factor 
receptor (EGFR) as cancer 
biomarker 
Kah et al. 2007 
SERS imaging Human epidermal growth factor 
2 (HER2) as cancer biomarker 
Lee et al. 2009 
Reflectance imaging Prostate-specific membrane 
antigen (PMSA) as a cancer 
biomarker 
Javier et al. 
2008 
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Figure 1.5. Schematic representation for an ELISA system with AuNPs. AuNPs conjugated with secondary 
labelled-antibodies are used for a sandwich assay. The antidoby-AuNP conjugates provide an amplified 
response, increasing sensitivity without compromising selectivity. Adapted from Ambrosi et al (2010), with 
permission. 
 
This section of the introduction addressed several concepts which are important to understand 
the applications of noble metal NPs. The enormous, and still growing number of systems 
including noble metal NPs for biomolecular detection reflects the high versatility of these 
nanostructures. In addition, noble metal NPs have been widely used in mass spectrometry 
applications, in particular for laser desorption/ionisation of small molecules. This subject however 
will be discussed in the mass spectrometry section, after a general introduction on mass 
spectrometry concepts.  
 
1.2 Mass Spectrometry 
 
The foundations of mass spectrometry (MS) go back to the beginning of the 20th century and 
the necessity to measure the mass of recently discovered charged particles. In 1897, J.J. 
Thompson (Nobel Prize of Physics in 1906) discovered the electron and measured its mass-to-
charge ratio (Griffiths 2008). Later, in 1912, he developed the first mass spectrometer (called a 
parabola spectrograph) and observed the formation of positive and negative ions by 
experimenting on O2, N2, CO, CO2 and CoCl2. The next year he discovered the isotopes 20 and 
22 of neon (De Hoffman and Stroobant 2007). The following decades during the first half of the 
20th century were extremely fruitful for the mass spectrometry field, with new ionisation sources 
and isotopes being discovered. However, it was World War II and the “Manhattan Project” that 
greatly boosted the field of mass spectrometry, with the isolation of uranium-235 by A.O. Nier 
(1940). From here on, mass spectrometers became commercially available and throughout the 
17 
 
second half of the 20th century novel ionisation methods and different analysers continued to be 
developed (Griffiths 2008). 
MS techniques present a high versatility as they can be applied to analysis of all elements and a 
wide range of analytes with very good sensitivities, some techniques reaching sub-attomolar 
detection (Dass 2007). Moreover, most MS techniques provide valuable information about 
structure and fragmentation of chemical compounds or biological molecules. It is therefore not 
surprising that MS techniques are currently being more and more employed in diverse areas of 
scientific research, to provide answers to problems related to physics, chemistry, biology and 
genetics (Baker 2010). The following sections describe the basic concepts of MS, an introduction 
to Matrix-Assisted Laser Desorption/Ionisation (MALDI) and the creation of Surface-Assisted 
Laser Desorption/Ionisation (SALDI), the incorporation of nanoparticles into mass spectrometry 
and applications to biomolecular detection.   
 
1.2.1 General concepts 
Mass spectrometry techniques are essentially composed by three integrated sequential events: 
ionisation, analysis and detection. The first phase of a MS technique consists of generating gas-
phase ions from a sample of interest. Afterwards, the ionised molecules are separated according 
to their mass-to-charge ratio (m/z) in an analyser. Finally, the separated ions are measured in the 
detector and the generated signal is amplified and acquired as a mass spectrum, where information 
about the relative intensity (abundance) of ionised species is plotted against their m/z. The 
detected ions provide valuable information about the nature and structure of their precursor 
molecule (Dass 2007, De Hoffman and Stroobant 2007).  
As previously mentioned, in MS techniques the events are sequential, despite occurring in 
different components of the mass spectrometer (see Figure 1.6 for a diagram of a mass 
spectrometer). Firstly, the sample is inserted into the ionisation source through the sample inlet. 
The mechanism by which the sample is introduced into the ionisation chamber varies according 
to the ionisation method, for example in MALDI the sample is directly introduced in the chamber, 
whereas other methods may include a chromatographic interface. Afterwards, the sample is 
ionised, either by electron ejection or capture, protonation or deprotonation, or via mass adduct 
formation (De Hoffman and Stroobant 2007). The first ionisation methods were electron 
ionisation (EI), developed in 1902 and chemical ionisation (CI), developed later in 1969. These 
methods were designed mainly for analysis of volatile organic compounds and were extremely 
energetic, causing extensive fragmentation of the analytes (Fernandes 2004). The need for new 
techniques suitable for analysis of liquid or solid non-volatile samples has prompt the 
development of more contemporary ionisation strategies, such as the soft ionisation method of 
MALDI, described in section 1.2.2. 
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After sample ionisation, the ions are accelerated into the mass analyser, where a separation 
occurs according to their m/z, using electric, magnetic fields or a combination of both. The choice 
of a given mass analyser depends on the nature of the sample, the type of analysis and the 
characteristics of the analyser: i) mass resolving power, i.e. how well can the analyser separate 
and measure ions; ii) mass accuracy, which refers to errors when measuring the m/z ratio; iii) 
mass range, which is the m/z range over which a mass analyser can operate; iv) ion transmission, 
i.e. the ratio between the number of ions that reach the detector and the number of ions that entered 
the analyser; v) scanning speed, which is the required period of time to produce a full mass 
spectrum (De Hoffman and Stroobant 2007, Carreira 2011, Hart-Smith and Blanksby 2012). For 
a detailed analysis and discussion on the characteristics of several mass analysers, please refer to 
Carreira (2011), and references therein. 
 
 
 
Figure 1.6. Diagram of a mass spectrometer, including an ion source, one mass analyser, a detector and an 
output system for generating data (computer and printer). Adapted from De Hoffman and Stroobant (2007), 
with permission. 
 
The final part of a mass spectrometer is the detector, which records, amplifies and converts the 
ion current into an electrical signal that can readily be displayed as a count of ion pulses per time. 
The most important characteristics of an ion detector are sensitivity, accuracy, resolution, 
response time, stability, a wide dynamic range and a low noise (Dass 2007). The majority of 
detectors falls under two categories: i) focal-point detectors, which detects ions of a single mass 
at a time, and ii) focal plane detectors, that monitor ions all the time, immediately after their 
arrival, resulting in increased sensitivity and mass accuracy. The simplest design for a detector is 
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the Faraday cup, consisting in a metal box (Faraday cage) with a collector electrode to measure 
ion current (Koppenaal et al. 2005, Dass 2007). Nowadays, the most common ion detector is the 
electron multiplier (EM), or secondary ion multiplier (SEM), which can amplify the ion signal by 
106 or more, by production of secondary electrons when the ion beam reaches an ion-sensitive 
dynode. The produced secondary electrons are detected by dynodes, generating a cascade signal. 
Other examples of detectors include photomultipliers or photographic plates, explained 
thoroughly by Koppenaal and co-workers (2005). The following section will introduce the basic 
principles of MALDI and its advantages, the relation to the creation of SALDI and applications 
to biomolecular detection. 
 
1.2.2 Matrix-assisted laser desorption/ionisation time-of-flight (MALDI-TOF) 
One of the most utilised and advantageous soft ionisation approaches is the MALDI technique. 
This term firstly appeared as “Matrix-Assisted Laser Desorption” in 1985, when Karas and co-
workers published a paper about the influence of the irradiation wavelength in desorption of 
amino acids, and observed differences in fragmentation between amino acids alone or in a mixture 
(Karas et al. 1985). Some years later, in 1988, came the first application of a laser 
desorption/ionisation (LDI) to protein analysis, performed by Tanaka and co-workers, which 
dissolved the proteins in a suspension of ultra-fine cobalt powder and glycerol, for an effective 
ionisation. This was actually the first application of SALDI towards biomolecular analysis. At 
around the same time, Karas and Hillenkamp (1988) reported a method for laser desorption 
analysis of proteins in which the sample was mixed with a UV-absorbing organic compound in 
excess, acting as a matrix for ionisation. The organic matrix-based method gained momentum in 
the scientific community due to its advantages and is nowadays used in widespread applications 
(Hillenkamp and Peter-Katalinić 2007, Kafka et al. 2011, Croxatto et al. 2012). 
MALDI exhibits several important characteristics that make it suitable for analysis of virtually 
all types of analytes: i) it is rather tolerant to buffers, salts, surfactants or chelating agents; ii) 
exhibits high sensitivity, usually reaching the picomolar range; iii) allows for analysis of 
molecules with elevated molecular weigths (> 100,000 Da); iv) can generate whole molecule 
monovalent ions; v) has the capability of performing molecular imaging in complex samples 
(McDonnell and Heeren 2007, Reyzer and Caprioli 2007). MALDI is a discontinued ionisation 
technique, for ions are produced by laser pulses. In MALDI, a chemical compound known as “the 
matrix” is mixed in excess with the sample and the mixture is allowed to dry on an appropriate 
plate. During this, a “co-crystallisation” of matrix and analyte molecules occurs, i.e. the matrix 
forms crystals, where the sample becomes embedded and (most likely) heterogeneously 
distributed. After crystallisation, the plate containing the mixture is introduced into the ionisation 
chamber and irradiated with a pulsed laser beam (commonly used lasers are nitrogen lasers with 
a wavelength of 337 nm). After irradiation, the matrix absorbs the laser energy and transfers it to 
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the analyte, promoting a “soft ionisation” (see schematics in Figure 1.7). The ions thus formed 
are transported to the analyser where they are separated and then reach the detector. MALDI is 
regarded as a “soft ionisation” method, in contrast to other methods such as EI or CI as the 
inclusion of an organic matrix in excess allows for a more controlled energy transfer to the analyte 
and prevents extensive fragmentation, upon laser irradiation. Therefore, MALDI is of great 
importance when generating molecular ions with minimum fragmentation. 
 
 
Figure 1.7. Schematic representation of the MALDI process. Adapted from De Hoffman and Stroobant 
(2007), with permission.  
 
MALDI is often coupled to time-of-flight (TOF) analysers, providing a MALDI-TOF 
combination, suitable and most used for analysing biomolecules, such as peptides or proteins 
(Hillenkamp and Peter-Katalinić 2007). TOF analysers possess great mass accuracy, resolution 
and sensitivity and are suitable for analysis of any kind of analyte, in theory. This makes TOF 
mass analysers the perfect candidates to couple to a MALDI ionisation source, for analysis of 
singly charged, high molecular weight ions. These analysers consist of a long field-free flight 
tube, where ions are separated according to their velocities, i.e. the m/z is determined by 
measuring the time needed for the ions to travel from the source to the detector (Dass 2007). This 
way, smaller ions travel faster than larger ones and need less time to travel distance, from the 
source to the detector, however the difference in kinetic energy of ions with the same mass may 
affect their initial velocity and the time at which they are detected (Lane 2005). This drawback 
was overcome by introducing delayed-ion extraction (Brown and Lennon 1995) and reflector 
mode. Delayed extraction mode is achieved by introducing a time delay (in the nanosecond range) 
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between ionisation and acceleration into the TOF analyser. This nullifies differences in kinetic 
energy between ions with a same mass (although not completely), accounting for increased mass 
accuracy. The TOF reflector mode consists in adding a new detector and reflecting the ions to 
that second detector. This way, the time-of-flight path is increased without physically increasing 
the flight tube length, which accounts for increased resolution, through ion focusing. However, 
as the path length is increased, sometimes ion loss occurs mainly with high molecular weight ions, 
and sensitivity may be slightly compromised. This way, two distinct modes of analysis exist: 
linear mode and reflector mode, both depicted in Figure 1.8. 
 
Figure 1.8. Schematic representation of A) linear and B) reflector mode of analysis. A) Linear TOF: ions 
are separated in a field-free drift tube, according to its velocity; smaller ions reach the detector faster than 
heavier ions. B) Reflector TOF: Ions are reflected by a reflectron at the end of the analyser, increasing the 
path length, and improving separation and resolution. Adapted from Lane (2006). 
 
1.2.3 Surface-assisted laser desorption/ionisation time-of-flight (SALDI-TOF) 
As previously mentioned, little before Karas and Hillenkamp analysed proteins via MALDI, 
Tanaka and co-workers (1988) developed the first application for LDI analysis of high molecular 
weight proteins and polymers, by using 30 nm-cobalt nanoparticles (CoNPs) dispersed in glycerol 
to assist in the ionisation process, instead of an organic matrix. This was the first report on LDI 
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using an inorganic surface other than an organic matrix to absorb and transfer energy to the analyte 
(see Table 1.3). Later, Sunner et al. (1995) followed a similar idea and coined the term surface-
assisted laser desorption/ionisation (SALDI) for the first time applied to graphite, to distinguish 
desorption/ionisation performed on an inorganic surface from the organic matrix used in MALDI. 
Four years later, Wei et al. (1999) developed desorption/ionisation on silicon (DIOS), where the 
inorganic surface is composed by an array of silicon. Since then, many different nanoparticles 
have been employed as an inorganic surface to facilitate ionisation, instead of the traditional 
organic matrix (Schurenberg et al. 1999, McLean et al. 2005, Yonezawa et al. 2009). A more 
detailed discussion on application of nanoparticles to mass spectrometry will be presented in 
section 1.2.5. Different names have been used to define this approach, SALDI, nanoparticle-
assisted laser desorption/ionisation (nano-PALDI), etc., but all with the common purpose of 
finding an organic matrix-free alternative optimal for soft ionisation of biomolecules with better 
sensitivity, lower background noise and reduced costs. Throughout this thesis the term SALDI 
will be the only one used when referring to inorganic NPs for ionisation, although it may actually 
comprehend other inorganic surfaces. The following sections deal with the introduction of NPs, 
mainly noble metal NPs, into protocols for MS biomolecular analysis. As MS techniques are 
composed of integrated events of ionisation, analysis and detection, with precedent protocols for 
sample preparation, inorganic NPs may be introduced somewhere into the system as to improve 
sensitivity or analytical capabilities, as discussed in the following section.  
 
Table 1.3. The first reported applications of inorganic surfaces for mass spectrometry 
Surface Application Analytes Reference 
30 nm cobalt NPs LDI-TOF Proteins, polymers Tanaka et al. 1988 
2–150 µm graphite 
particles 
SALDI-TOF Peptides, proteins, 
organic compounds 
Sunner et al. 1995 
Porous silicon DIOS Peptides, small drug 
molecules,   
glycolipids, 
carbohydrates 
Wei et al. 1999 
Several different 
nanoparticles 
SALDI-TOF Peptides, proteins Schurenberg et al. 1999 
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1.2.4 Advantages of nanoparticles for SALDI-TOF-MS  
Since the first application in 1988, NPs have been used as inorganic surfaces to overcome the 
main limitations of MALDI-MS, namely due to three main aspects: homogeneity in crystallisation 
preventing the formation of sweet spots, absence of matrix interference due to ionisation of 
matrix-derived molecular ions and efficiency of energy transfer to the analyte. 
Crystal orientation heterogeneity verified during crystallisation of the matrix:analyte mixture 
will often originate sweet spots on the MALDI plate, which renders the analysis more complicated 
and makes quantification difficult to accomplish. The high surface area of NPs allows better 
sample deposition and absorption, and homogeneity in the mixture, preventing formation of sweet 
spots upon application (Black et al. 2006, Guo et al. 2006, Budimir et al. 2006). What is more, 
spot-to-spot and shot-to-shot variability is considerably diminished for more accurate 
quantification approaches (Chiang et al. 2009, Kuo et al. 2011). In contrast to what happens in 
commonly used organic matrices, NPs in general are not so easily ionisable upon laser irradiation 
(Kong et al. 2005, Vanderpuije et al. 2006, Shibamoto et al. 2009). Laser incidence may cause 
fragmentation and desorption of matrix-derived molecular ions producing spectra with high 
background signal, thus rendering analysis of low molecular weight compounds rather ineffective 
(Cohen and Gusev 2002, Peterson 2007). Depending on the NP composition and properties, the 
mass spectrum may present some signals corresponding to ionisation of metal clusters, e.g. gold 
nanoparticles (McLean et al. 2005). Considering that the size influences the NPs ionisation and 
mass signals, interference is greatly reduced when compared to conventional organic matrices. 
Due to their minimum size (1~100 nm), NPs possess excellent optical properties deriving from 
phenomena such as surface plasmon resonance (Liz-Marzan 2006), addressed beforehand. Noble 
metal NPs, such as gold or silver, possess an enhanced absorptivity in the ultraviolet-visible 
region, which favours transformation of photothermal energy during laser irradiation and provides 
a more effective ionisation of analytes (Wei et al. 1999, Finkel et al. 2005). Photothermal 
properties and heat generation at the NP surface are directly dependent of NP volume, size and 
incident energy, and heat generation at a given point is related to the distance to the centre of the 
NP (Govorov and Richardson 2007, Maity et al. 2012). This way, ligands covalently bound to the 
NP surface will ionise easily as distance to the NP is minimal, but the desorption process is more 
difficult due to higher bond-dissociation energy. Analytes interacting weakly with NP surface 
will ionise differently than those covalently bound, and so NPs ought to be tailored to optimise 
interaction to maximise ionisation and desorption efficiency.  
Most reports of nanoparticles for SALDI-MS focus on spherical nanoparticles regardless of 
composition. Spherical NPs seem to be the most effective for SALDI due to their high surface 
area and homogeneity of functionalisation with ligands. Besides this, surface heating and energy 
transfer from nanospheres to the vicinity occurs evenly. Of extreme relevance is the fact that the 
most commonly used laser for ionisation in SALDI (and MALDI) is the nitrogen laser with a 
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fixed wavelength at 337 nm, and nanospheres often possess high absorption values in this region 
of the spectrum. Other shapes, usually exhibit high absorptions in other regions of the spectrum 
(e.g. nanorods, 650-800 nm), which would require change of laser for optimal analysis. 
Despite the advantages, a major limitation observed so far is the optimisation of the adequate 
NP surface according to the analyte of interest, rendering some NPs very inefficient as surface 
for LDI of determined analytes (Huang and Chang 2007), whereas commonly used organic 
matrices are often directed to a particular class or type of molecules e.g. 3-hydroxipicolinic acid 
(3-HPA) for long polymers and oligonucleotides, CHCA for peptides. The following section will 
focus on the use of noble metal NPs for laser desorption/ionisation (SALDI) analysis of a wide 
number of analytes. 
 
1.2.5 Noble metal nanoparticles for SALDI-TOF-MS analysis  
Noble metal NPs, functionalised or not, have been extensively used for SALDI-MS analysis of 
a multitude of biomolecules and elements. Besides its use as affinity probes/pre-concentrating 
agents, noble metal NPs have also been employed as surface for LDI (see Table 1.4). The 
following section considers gold, silver and platinum NPs for SALDI-MS of different analytes, 
with an emphasis on gold (AuNPs). 
For AuNP-based SALDI-MS analysis, the most utilised AuNPs are citrate-capped 14 nm ones, 
most favourable for ionisation of biomolecules when compared other with smaller and larger 
diameter (Huang and Chang 2006). These AuNPs can be easily synthesised with a relatively fair 
control of size dispersion and reproducibility via the citrate reduction method developed by 
Turkevich (Turkevich 1985). Moreover, citrate-capped AuNPs are rather simple to derivatise with 
molecules containing thiol- or amino-functional groups (Mirkin et al. 1996, Duan et al. 2009). 
Citrate-capped AuNPs have been reported for LDI detection of melamine, ammeline and 
ammelide in infant formula and grain powder with detection limits in the nanomolar range (Hsieh 
et al. 2012). These compounds interact weakly with AuNPs, through Au-N bonds and allow easy 
and rapid separation through centrifugation, prior to analysis. On a different study, AuNP-based 
SALDI was employed towards quantification of four urinary biomarkers for carcinoid tumours in 
human urine samples (Kuo et al. 2011), by using an internal standard.  
Aptamer-AuNP conjugates have also been used as capturing probes for ATP and glutathione 
molecules for SALDI analysis (Huang and Chang 2007) but unmodified 14 nm AuNPs were used 
as surface for LDI because the aptamer-AuNP conjugates were not effective for biomolecular 
ionisation. Another consideration on efficiency of AuNPs towards ionisation was recently 
presented by Kim and Lee (2012), where a time-of-flight secondary ion mass spectrometry (TOF-
SIMS) signal amplification is promoted by enlarging AuNPs through the NH2OH/Au3+ seeding 
method. Due to an increased surface area and spherical structure, the mass signal intensity of the 
peptides became higher on the enlarged-AuNPs surface, when compared to bare gold surface or 
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submonolayer of AuNPs.  AuNPs functionalised with a thrombin-binding aptamer were employed 
for thrombin binding and deposition on a nitrocellulose membrane (Liu et al. 2012). Upon pulsed-
laser irradiation, Au cluster signals decreased proportionally to the amount of bound thrombin, 
and by measuring the intensity of these decreasing mass signals, very sensitive (fM) quantification 
of thrombin was achieved.  
Antibody-modified AuNPs were used to actively interact with bacterial components, allowing 
for a rapid separation by centrifugation and subsequent deposition on a nitrocellulose membrane 
for SALDI-MS identification of bacteria (Tseng et al. 2012). Upon deposition, samples were 
irradiated with a pulsed-laser (LDI) and the Au cluster signals were analysed. This method was 
validated by analysing different samples (tap water, juice, milk, and urine) and, if the surface 
modification is altered it may be employed for several other analytes, such as biomarkers and 
viral epitopes.  
Gold–silica core–shell nanoparticles (Au@SiO2 CSNPs) for LDI-TOF-MS (Zhu et al. 2012) 
with different core sizes and shell thickness have been combined to attain optimal enhanced 
ionisation. The system was applied to a polymer (dPEG6) and results suggest that NPs with 
smaller core and ultrathin SiO2 shell (2-4 nm) exhibited the best efficiency, both in signal intensity 
and S/N ratio. Comparing to common MALDI-TOF-MS, this approach show improved sensitivity 
for small molecules, but are not capable to match common organic matrices. AuNPs 
functionalised with dopamine dithiocarbamate were also used as a surface for SALDI-TOF-MS 
quantification of small molecules (Kailasa and Wu 2012), allowing cleaner mass spectra than 
conventional MALDI-TOF using CHCA as a matrix, and better sensitivity when analysing and 
quantifying small molecules such as glutathione or the drugs desipramine and enrofloxacin. 
Besides this, dopamine dithiocarbamate-modified AuNPs served as efficient affinity probes and 
ionisation surface for rapid and straightforward determination of phosphopeptides from casein 
proteins.   
Silver nanoparticles (AgNPs) have also been employed in LDI processes. AgNPs exhibit higher 
scattering than AuNPs, which may be valuable when transferring absorbed energy to an analyte 
in the vicinity (Hua et al. 2007). For example, unmodified AgNPs were used both as affinity 
probes and as a surface for SALDI for determination and quantification of three different 
oestrogen derived molecules (Chiu et al. 2008) in the low micromolar range. Oestrogens in the 
urine were capable of establishing weak interactions with the AgNPs’ surface, allowing for 
separation and pre-concentration but without notable sensitivity (0.2 μM). Recently, Niziol et al. 
(2013) applied monoisotopic cationic 109AgNPs as a surface for LDI analysis of different low 
molecular weight organic compounds, including alkaloids, saccharides, amino acids, nucleosides 
and nucleic bases. These 109AgNPs were further characterised on cationisation adducts for higher 
sensitivity, mass accuracy, and resolution.  
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SALDI-TOF using AgNPs has also been employed towards bacterial analysis of dairy products 
(Lee et al. 2012). By using AgNPs, bacterial identification was improved by 6-fold in yogurt 
samples preventing interference from milk complex proteins. In the same study, an ionic solution 
of CrO42- was also used for SALDI-MS analysis and proved to be more effective than AgNPs as 
it improved bacteria determination by 40-fold. 
AgNPs functionalised with different functional groups were employed as both affinity probes 
and SALDI surface for analysis of biothiol molecules such as glutathione, cysteine and 
homocysteine (Shrivas and Wu 2008). A comparison between 10 and 20 nm AgNPs for LDI 
revealed that smaller diameters correspond to better efficiency, possibly due to a higher surface 
area. Unmodified AgNPs were also used as a surface for direct SALDI-MS analysis of sulphur 
drugs. 
Platinum nanoparticles (PtNPs) have been characterised in terms of SALDI efficiency, where 
the elevated melting point and low heat capacity of the platinum contributed to a more effective 
ionisation than the one obtained with silver and copper NPs (Yonezawa et al. 2009). The use of 
PtNPs for SALDI analysis of amino acids, peptides, proteins and microwave digested proteins 
has also been reported (Shrivas et al. 2011). PtNPs played three main roles in this approach: 
affinity probe, surface for LDI and acceleration of protein digestion by absorbing the microwave 
irradiation. Higher numbers of peptide sequences were obtained for PtNP-accelerated microwave 
digestion of the lysozyme protein, when compared to standard digestion of proteins for MALDI-
MS.  
Besides being used as surface for SALDI, PtNPs with sizes between 2-10 nm (mainly 4 nm) 
were used as additives with a SA matrix to enhance sensitivity when analysing cell populations 
of Saccharomyces cerevisiae and Chlamydomonas reinhardtii (an improvement of 125- and 5-
fold, respectively) (Manikandan et al. 2012). An approach using modified PtNPs for both pre-
concentration and as matrix additives for signal enhancement was described for bacterial 
proteomic analysis (Ahmad et al. 2012). Adding immunoglobulin G-functionalised PtNP probes 
to samples from rhizospheric soil and carrot plant roots proved to be an effective enrichment 
strategy, as the PtNP probes interact and adsorb to the bacteria surface. Together with a signal 
enhancement from the combination of SA with the PtNP probes, Bacillus thuringiensis and B. 
subtilis isolates were directly detected with low concentrations. 
This section of the introduction addressed mass spectrometry and the relevance of NPs for novel 
MS applications for biomolecular detection. The following section will address toxicology, with 
an emphasis on formation, MS detection and biological relevance of DNA adducts. 
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Table 1.4. Noble metal nanoparticles for SALDI-MS 
Nanoparticle for 
ionisation 
Size (nm) Detected analyte Detection Limit Ref 
AuNPs 2-10 Peptides 100 fmol McLean et al. 2005 
14 Melamine, ammeline, 
ammelide 
5, 10 and 300 nM Hsieh et al. 2012 
13 Tumour biomarkers 
(TRP, 5-HTP, 5-HT 
and 5-HIAA) 
1.5 and 1.8 μM  Kuo et al. 2011 
3.5 and 14 Glutathione, cysteine, 
homocysteine 
2-44 nM Chiang et al. 2009 
14 Captopropil 1 μM Chen et al. 2010 
9-14 Carbohydrates 82-151 nM Su and Tseng 2007 
13.2 Carbohydrates, 
indolamines, peptides 
46.5-5115 nM Wu et al. 2009a 
Aptamer-modified 
AuNPs 
14 ATP, glutathione 0.48 μM Huang and Chang 
2007 
13.3 Thrombin 50 fM Liu et al. 2012 
Antibody-
modified AuNPs 
5.5 Escherichia coli 1000 CFU/mL Tseng et al. 2012 
Au@SiO2 NPs 20-38 Polymers 10 fmol Zhu et al. 2012 
CHCA-modified 
AuNPs 
14 Peptides 20 pmol Duan et al. 2009 
Dopamine 
dithiocarbamate-
modified AuNPs 
5-12 Phosphopeptides 0.01-1.6 nM Kailasa and Wu 2012 
Nile-red adsorbed 
AuNPs 
14, 32, 56 Glutathione, cysteine, 
homocysteine 
1-2 μM and 25-54 
nM 
Huang and Chang 
2006 
AuNPs, AgNPs, 
PtNPs 
20; 10-30; 
20 
Surfactant, peptides N.A.a Yonezawa et al. 2009 
AuNPs, PtNPs 14; 37 Biomolecules, 
peptides, proteins 
140 fmol; 23pmol Chiang et al. 2010 
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1.3 Toxicology 
 
Ever since the pre-historic times, mankind has always been aware of substances that induce 
adverse effects on an organism, i.e. poisons. In ancient times, i.e. Greek and Roman civilizations, 
countless references have been found that describe the use of poisons for hunting or assassination 
purposes (Gallo 2008). The study of poisons evolved throughout times, and reached its apogee 
during the Renaissance period in Italy. Phillip von Hohenheim, better known as Paracelsus (1493-
1541) was perhaps the most significant figure in the history of toxicology (Borzelleca 2000). He 
was the first one to focus on the primary toxic agent, instead of the mixture or concoxion at it had 
been so far. He stated that “all substances are poisons: there is none which is not a poison. The 
right dose differentiates poison from a remedy”. This statement revolutionised the modern 
toxicological and pharmacological sciences, which continued to evolve constantly from the 
Middle Ages, until the 19th century. At this time, with the beginning of organic synthesis, new 
chemicals started to be developed, namely phosgene and mustard gas, which would later be used 
for warfare in World War I. Some decades later, during the World War II era, toxicology evolved 
rapidly, similarly to what happened with mass spectrometry. After World War II, began a fruitful 
period for regulatory toxicologists, marked by creation of safety programs and legislations for 
experimental procedures. Historical milestones of toxicological sciences are described in detail 
by Gallo (2008), and Hayes and Gilbert (2009).   
 
1.3.1 General concepts 
Toxicology is the study of adverse effects of a chemical or physical agent on living organisms. 
In order for this to be possible, toxicology is a field that integrates notions from cellular and 
molecular biology, biochemistry and mathematics. Toxicological research assesses the cellular, 
biochemical and molecular mechanisms of action as well as functional effects and their 
probability of occurrence. As Paracelsus defined, the study of toxicology is extremely concerned 
about the dose, e.g. the total amount of a certain chemical agent to which the organism has been 
exposed, in relation to its weight (James et al. 2000, Eaton and Gilbert 2008). Dose-response 
relationships allow obtaining information about potential adverse effects of a given chemical 
agent, lethality thresholds and simulating these effects in a population. Dose-response 
relationships are the domain of specialisation of descriptive toxicologists, and ultimately provide 
information for safety evaluation and regulatory requirements.  
Other than descriptive toxicology, other sub-fields exist, such as mechanistic toxicology, 
regulatory toxicology, or risk assessment (James et al. 2000, Eaton and Gilbert 2008). Mechanistic 
toxicology, for instance, tries to understand cellular biochemical and molecular mechanisms by 
which chemicals exert toxic effects on living organisms. These studies are of high importance in 
many areas of toxicology and also pharmacology, when developing novel therapeutic agents. 
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Regulatory toxicologists decide if a chemical compound is safe enough to be marketed, and 
establish threshold levels for that chemical in society. Risk assessment draws information from 
all other areas of toxicology and estimates potential effects of a given chemical agent in human 
health or environmental, e.g. mycotoxins in food, sewage effluents in waterbodies, etc. 
Toxicological sciences are of extreme relevance, for human beings and animals are constantly 
being exposed to external agents, capable to induce damage at a tissue, and even cellular level. 
In superior eukaryotic organisms, when a xenobiotic agent (i.e. a compound that is not naturally 
produced in the body) enters an organism it undergoes several phases: absorption, distribution, 
metabolism, elimination. The combination of all these phases constitutes the disposition of a 
chemical (Lehman-McKeeman 2008). Because the term absorption may be confounded with 
cellular absorption, I will refer to absorption by the organism as uptake. Uptake refers to the 
process by which a chemical passes the biological barriers (external tissues, body membranes) 
and reaches the bloodstream. There are various ways of uptake, depending on the organism, 
toxicant and route of exposure. In most metazoans, the liver or an analogue organ is the major 
organ involved in xenobiotic metabolism. Detoxification comprises two different phases: phase I 
and phase II. The metabolism of a xenobiotic begins with its bioactivation during phase I, which 
is a very important step. Phase I metabolism of organic xenobiotics (e.g. dioxins, mycotoxins) 
includes enzymatic complexes usually belonging to the CYP family (cytochrome P450 
monoxygenases), that perform hydrolysis, reduction and oxidation reactions, which render the 
xenobiotic more polar and often more reactive, depending on the parent compound. Phase II 
enzymes perform conjugation reactions of biotransformed species with intracellular nucleophiles, 
e.g. glutathione. For chemicals which are mainly metabolised in the liver, the main route of 
excretion (i.e. elimination) is through bile (O’Flaherty 2000, Rozman and Klaasen 2003, Lehman-
McKeeman 2008). 
Edmond Locard (1877-1966), considered the father of forensic sciences, postulated that “every 
contact leaves a trace” and this became known as Locard’s Exchange Principle. In toxicological 
sciences, this principle also applies when the xenobiotic agent establishes contact with tissues, 
cells or cellular components, hence the notion of biomarker. A biomarker is a reaction, behaviour 
or chemical compound which may indicate the interaction between a toxicant and the organism 
(Silins and Högberg 2011). Generally, three types of biomarkers are considered: susceptibility, 
exposure and effect. However, these notions are dynamic, depend on how the data is interpreted 
and towards what endpoint. Biomarkers of susceptibility are indicators of native (i.e. prior to 
exposure) characteristics of an organism/individual that render it more susceptible to the effects 
of certain agents, e.g. polymorphisms in DNA repair systems have been linked to increased 
probability of chemically-induced cancer (Goode et al. 2002). Biomarkers of exposure can be, for 
instance, metabolites resulting from interaction of xenobiotics with intracellular components, e.g. 
DNA and haemoglobin adducts as biomarkers of exposure to acrylamide (Pérez et al. 1999, 
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Ogawa et al. 2006, Chevolleau et al. 2007), or a broader example, the increase in activity in 
oxidative stress-related enzymes. Lastly, biomarkers of effect can be defined as biological 
consequences that constitute alterations to the basal metabolism, or structure, and may reflect 
adverse effects, e.g. the formation of lipid peroxides (Schrenk 1998, Sato et al. 2008). Some 
biomarkers, such as DNA adducts may be considered of both exposure and effect, because 
formation of a DNA adduct may imply a genotoxic effect, if left unrepaired (Silins and Högberg 
2011). The following sections will discuss the formation and detection of DNA adducts, their 
biological relevance and significance as biomarkers of exposure. 
     
1.3.2 Formation of DNA adducts and chemical carcinogenesis 
The DNA molecule is susceptible to various types of damage, either physically or chemically-
induced lesions. The sub-field of toxicology that studies the effects of chemical and physical 
agents on the DNA molecule and genetic processes of living beings is genetic toxicology (Preston 
and Hoffmann 2008). This field of study was pioneered in 1927 by H.J. Muller that observed 
mutations in Drosophila resulting from exposure to X-rays, constituting the first report of a DNA 
lesion induced by a physical agent. However, the first report of a chemically-induced DNA lesion 
came only in 1946, when Auerbach and Robson showed that mustard gas could induce mutations 
in Drosophila similar to those induced by X-rays. The major breakthrough on DNA adducts was 
presented in 1977 by Miller and Miller, who showed that chemical carcinogens could form stable, 
covalent bonds with macromolecules. 
As previously defined, a DNA adduct results from a covalent reaction between an alkylating 
agent and the DNA molecule. Alkylating agents exhibit electrophilic properties, which means 
they are attracted to an electron-rich centre, i.e. a nucleophilic centre. Nucleotides in the DNA 
molecule possess several nucleophilic centres that are targeted by the alkylating agents - depicted 
in Figure 1.9. Specific functional groups are particularly reactive towards different nucleophilic 
centres, e.g. epoxide groups tend to bind positions N3 or N7 in the purine ring. In general, most 
abundant DNA adduct species result from alkylation of the guanine nucleobase at position N7, 
revealing pertinent information as biomarkers of exposure (Boysen et al. 2009). 
 
 
Figure 1.9. Some examples of sites for possible adduct formation in DNA bases. Purines are more targeted 
than pyrimidines. 
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Figure 1.10. Some examples of possible guanine DNA adducts with different toxicants (PAHs, 
mycotoxins, etc.).   
 
There is a wide range of substances that present the potential to alkylate nucleophilic centres in 
DNA, e.g. PAHs, mycotoxins, etc. (Kriek et al. 1998, Wang and Groopman 1998, Carbajal 2008) 
– see some examples of DNA adducts in Figure 1.10. This alkylation of the DNA molecule by 
exogenous agents frequently originates mutations, if not correctly repaired. These agents are 
called genotoxic carcinogens and play a key role in the initiation stage in the chemical 
carcinogenesis process (Klaunig and Kamendulis 2008). Whereas some genotoxicants are 
naturally reactive towards the DNA molecule (direct-acting), most agents require bioactivation 
beforehand (indirect-acting), which usually occurs by oxidation during phase I metabolism 
(Parkinson and Ogilvie 2008). The risk to the cell concerning a specific DNA adduct depends 
essentially of its reactivity, structure and persistence. More reactive molecules tend to overcome 
the competition between DNA and detoxification systems, and form an elevated number of DNA 
adducts, which may lead to accumulation of lesions or errors. Regarding structure, alkylating 
agents with a larger, less polar structure, such as PAHs, tend to originate bulky DNA adducts, 
which constitute a higher risk to the cell (Kriek et al. 1998, Godschalk et al. 2003, Klaunig and 
Kamendulis 2008). The structure also determines the main targeted sites, and consequently, the 
biological relevance of the DNA adduct. For instance, it has been described that smaller and more 
polar electrophiles binding guanine at position N7 cause instability in the purine-pentose bond, 
and the DNA adduct tends to be released from the DNA chain, originating an apurinic site. This 
lesion may be efficiently repaired by the cell, meaning this particular DNA adduct poses little 
carcinogenic risk, however it is extremely valuable as a biomarker of exposure (Boysen et al. 
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2009). Lastly, a DNA adduct persistence depends on the ability of the cell to repair the targeted 
site. So, for different agents, the competition between the target cellular nucleophiles (DNA, 
proteins) and detoxification systems comes into play, with distinct outcomes. Either way, whether 
as a biomarker of exposure of as a potential carcinogen, the detection of DNA adducts has 
provided remarkable information for mechanistic, descriptive and regulatory toxicologists.   
 
1.3.3 Methods for detection of DNA adducts 
Detection and quantification of DNA adducts in biological samples is a rather complex issue 
that has gained attention amongst genetic toxicologists. Different techniques have been developed 
and employed for identification and characterisation of DNA adducts as biomarkers of exposure 
to chemical agents, or cancer biomarkers (Phillips et al. 2000, Farmer et al. 2005, Brown 2012). 
However, there exists no perfect methodology as every described technique presents a major 
limitation. This way, the choice of the most adequate method for detection of a DNA adduct is 
closely related to the molecular structure of that DNA adduct, its abundance, and the quantity of 
available sample for testing. Table 1.5 depicts the different techniques employed for detection 
and characterisation of DNA adducts. 
   
Table 1.5. Different techniques employed for DNA adduct detection (Farmer 2005, Brown 2012) 
Method Max. sensitivity 
(adducts/nucleotide) 
Required DNA 
sample (µg) 
References 
(examples) 
HPLC/ECD or 
HPLC/FD 
~1/108 < 100 Park et al. 1989, 
Helbock et al. 
1998 
Immunoassay ~1/108 < 200 Santella 1999, 
Divi et al. 2002 
32P-post-labelling ~1/1010 < 10 Reddy et al. 1989, 
Kotova et al. 2011 
Mass spectrometry ~1/108 10-100 Brown et al. 
2003, Gamboa da 
Costa et al. 2003, 
Barnes and Chiu 
2009 
AMS ~1/1012 < 2,000 Turteltaub and 
Dingley 1998 
ECD: electrochemical detection; FD: fluorescence detection; AMS: accelerator mass spectrometry. 
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Amongst all the methods employed for detection of DNA adducts, electrochemical and 
fluorescence detection methods are by far the simplest and exhibit reasonable sensitivity. These 
methods are usually used in conjunction with HPLC or capillary electrophoresis (CE) for 
separation (Brown 2012). Despite these advantages, such methods are only suitable to analyse 
fluorescent or electrochemically active adducts. Whenever the DNA adduct does not present a 
sufficient electrochemical or fluorescent signal, it must be derivatised to a different, more active 
compound, if possible (Sharma 2000). 
Immunoassays may be a powerful tool in DNA adduct detection as well. These techniques rely 
in the use of antibodies which grants them elevated specificity, but also the risk of cross-reactivity. 
One other great advantage of these methods is they allow for localization of adducts in tissue, and 
the detection of DNA adducts in fixed preparations, by immunohistochemistry. Despite this, 
obtaining suitable and specific antibodies is not always simple, so immunological methods are 
highly dependent on the success of antibody synthesis.    
32P-post-labelling is perhaps considered as the election technique for detection of DNA adducts. 
This technique is of extreme versatility and sensitivity, and requires only a small sample for 
analysis (1-10 µg of DNA). However, it involves intensive labour and cumbersome protocols. 
The use of a radiolabeled compound is crucial for this technique to work and it may be seen as 
both an advantage and a drawback. The elevated levels of radioactivity require specialised 
personnel and pose a risk of exposure, but it also allows the possibility to screen a sample for 
DNA adduct formation without previous knowledge on the mechanisms and structures (Brown 
2012). This kind of analysis is optimal for large, bulky DNA adducts, such as PAHs or mycotoxin-
derived adducts, but it presents some limitations when analysing DNA adducts of low molecular 
weight.  
From all methodologies employed for DNA adduct detection, mass spectrometry methods are 
those that have been more frequently used, due to its elevated specificity and the capability to 
provide information about the molecular structure. This is a major advantage over other 
techniques as it allows completely unknown DNA adducts to be analysed and characterised. 
Detection of DNA adducts benefits from the vast number of available instuments and the 
continuous evolution of mass spectrometers, with increased sensitivity (Brown 2012). For 
instance, liquid chromatography coupled to MS, e.g. electrospray ionisation, has been employed 
for DNA adduct characterisation. MS/MS data are simple to attain and provide valuable 
information on structure, with good sensitivity (Gamboa da Costa et al. 2003, Singh and Farmer 
2006, Gaskell et al. 2007). Inductively coupled plasma mass spectrometry (ICP-MS) has also 
been used to analyse DNA adducts resulting from chemotherapeutic agents, such as cisplatin (Sar 
et al. 2008) or from toxicants, such as styrene oxide (Siethoff et al. 1999). MALDI-TOF has also 
been employed for characterisation of carcinogenic DNA adducts (Qiao et al. 2006, Barnes and 
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Chiu 2009). The major limitation of MS analysis it that it requires DNA adduct standards in order 
to provide an actual quantification. 
Accelerator mass spectrometry (AMS) has been used since the 1980s for toxicokinetic and 
pharmacokinetic research (Brown et al. 2006). This technique possesses the highest sensitivity (1 
adduct per 1012 nucleotides) and elevated specificity for DNA adduct detection. These features 
are closely related to the use of radiolabeled compounds (14C or 3H), an absolute requirement for 
the analysis (Vogel et al. 1995). Nevertheless, the most significant disadvantages are the cost of 
analysis and the lack of available instrumentation. 
Overall, there is a need for novel methodologies for DNA adduct detection and characterisation 
that overcome major limitations of currently employed techniques, without compromising 
sensitivity and specificity. The recent advances in nanotechnology and mass spectrometry may 
contribute greatly for this purpose. Other than this, it is important to define procedures for sample 
preparation, DNA adduct enrichment or isolation, preferably simple, fast and inexpensive, to try 
and counter sensitivity issues during detection. The following sections focus the target molecule 
of study, acrylamide, its known mechanisms of toxicity and environmental risk.    
  
1.3.4 The case of acrylamide 
Acrylamide (C3H5NO) is an industrially-produced unsaturated amide with a multitude of 
applications in various fields. This molecule possesses extreme versatility, presenting a high 
solubility in water and in organic solvents (IARC 1994), which render it adequate for many 
different industrial applications. Its primary use is the production of polyacrylamide (co)polymers 
to be used as flocculants in water treatment processes (Bajdur 2008). Another relevant application 
is the use of acrylamide or N-methylacrylamide-based grouts in the construction of tunnels. 
Additional applications include agricultural processes, textile manufacturing (Myagchenkov and 
Kurenkov 1991) and life science research. 
In 2002, acrylamide has been classified a “probable carcinogen for humans” by IARC 
(International Agency for Research on Cancer), following reports that showed formation of 
acrylamide during food processing, through the Maillard reaction (Stadler et al. 2002, Tareke et 
al. 2002). Until then, the main concerns were related to the ecotoxicological risk and 
environmental fate of acrylamide, but it readily began to turn towards human health, mostly 
related to the presence of acrylamide in foodstuff (Vikström et al. 2011, Watzek et al. 2012, 
Dobrowolski et al. 2012). Actually, ever since it was classified as a “probable carcinogen for 
humans”, there has been a decrease in environment-related studies of acrylamide monomers and 
derivatives, with most studies focusing formation of acrylamide and its metabolites in vivo, and 
corresponding dose-response effects. 
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1.3.4.1 Environmental risk 
Employing acrylamide derivatives in water treatment processes, tunnel construction or 
agriculture inevitably raises the question of the environmental risk it poses. With this in mind, 
there has been some work about the environmental fate of acrylamide monomers after degradation 
of polyacrylamide (co)polymers and subsequent consequences to the biota (e.g. Brown et al. 
1980a, 1980b, Friedman 2003). There are essentially two sources of acrylamide monomers which 
may end up in waterbodies: the contamination of polyacrylamide (co)polymer solutions with 
residual monomers and the eventual degradation of polymers to acrylamide molecules. Since 
these monomers may partition to aquatic niches, mainly freshwater systems, water contamination 
with acrylamide and its effects to aquatic wildlife remain a critical concern (NICNAS 2002, 
Badjur 2008, Weston 2009). In fact, waterbodies are acknowledged to be the main reservoirs of 
the substance, (Mackay model calculates that >99.9% of total acrylamide in the environment will 
end up in water systems) in large part owing to its high solubility in water, low vapour pressure 
and ability to become adsorbed to particulates (NICNAS 2002).  
Acrylamide in water may suffer degradation, causing an increase in the ammonia concentration. 
The absence of degradation in sterilised waters suggests that the removal of acrylamide occurs 
via a biotic route, with abiotic removal mechanisms such as hydrolysis and photolysis being 
negligible (Brown et al. 1980b). Regarding biotic degradation of acrylamide at low concentrations 
(1 and 2 mg/L), a complete degradation by microorganisms was observed past 15 and 28 days, 
respectively (United States Testing Company Inc. 1991). At a concentration of 5 mg/L, approx. 
50 % degradation was observed after 15 and 28 days, suggesting that, at this concentration, 
bacteria can no longer efficiently degrade acrylamide after 15 days of exposure. Higher 
acrylamide concentration denoted fewer degradation rates. Together with data from 5 mg/L, this 
could mean possible toxic effects to the bacteria in water.   
The concerns of acrylamide monomers to aquatic wildlife led mainly to studies focusing acute 
toxicity to fish and crustaceans, revealing moderate to low effects (Bridié et al. 1979, Krautter et 
al. 1986). The effects of chronic exposure to acrylamide monomers to aquatic organisms have 
rarely been addressed, possibly as a consequence of reduced acute toxicity. Nonetheless, there is 
evidence in freshwater fish (Edwards 1975, Haasch et al. 1992) that may account for potential 
chronic toxicity associated to acrylamide. These findings, together with the studies in vivo or in 
vitro with model subjects, indicate that acrylamide monomers may indeed cause multi-level 
adverse effects to wildlife that require more prolonged and ecologically-realistic exposures to the 
xenobiotic in order to be fully comprehended. Most studies concerning acrylamide toxicity to 
aquatic biota targeted fish models (Woodiwiss and Fretwell 1974, Bridié et al. 1979, Krautter et 
al. 1986, Waddell et al. 1990) and only a few studies have focused on invertebrates, mostly model 
organisms like Daphnia magna (ABC Labs 1983a); the midge Parathanyarsus parthenogenetica 
(ABC Labs 1983b); the rotifer Adineta vaga (Örstan 1992), and the saltwater mysid shrimp 
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Mysidopsis bahia (Springborn Bionomics 1985, EG&G Bionomics 1986). Overall, invertebrates 
show very different sensitivities to acrylamide, as opposed to what happens in fish models, where 
effect concentrations typically yield little interspecific variation (see for instance Krautter et al. 
1986, Walker 1991, Weston et al. 2009).  
  
1.3.4.2 Known mechanisms of toxicity 
Ever since the 80s, several studies focusing on acrylamide exposure were carried out on human 
and animal models (Green and Egle 1983, Howland 1985, He et al. 1989), indicating that 
acrylamide is metabolised in hepatocytes into a reactive epoxide by the cytochrome P450 
monoxygenases (CYP2E1 in mammals), during phase I metabolism (see Figure 1.11). This 
bioactivation is achieved by oxidation of the double bond between α and β carbons (Carere 2006, 
Lineback et al. 2012). The resulting epoxide, glycidamide, is highly reactive towards nucleophilic 
centres in the DNA molecule, originating DNA adducts mainly at N3 and N7 in the purine ring, 
when in contact with DNA (Martins et al. 2007, Watzek et al. 2012). Formation of glycidamide 
from acrylamide during phase I metabolism is the main concern of acrylamide-induced 
carcinogenicity. The production of glycidamide-DNA adducts may lead to transitions, and strand 
breakage that, if not correctly repaired, may progress on to cancer.  
Reactivity of acrylamide to cellular components is directly linked to the double bond between 
α and β carbons. Besides an epoxidation to glycidamide, this functional group may undergo a 
Michael’s addition and alkylate nucleophilic centres in proteins (Mather et al. 2006, Zamora et 
al. 2010). For instance, acrylamide has been described to bind to neurofilaments and cytoskeletal 
proteins, preventing microtubule disassembly (Lapadula et al. 1989, Sickles et al. 1995). 
However, the major biomarkers of exposure to acrylamide found in superior organisms are 
haemoglobin-adducts derived from reaction of cysteine or amine groups with acrylamide or 
glycidamide (Pérez et al. 1999, Ogawa et al. 2006, Chevolleau et al. 2007). However it has been 
shown that acrylamide itself presents low reactivity towards DNA and most DNA adducts formed 
are a consequence of alkylation by glycidamide. The schematics in Figure 1.11 illustrates the 
known interactions of acrylamide and glycidamide with cellular components. 
Exposure to acrylamide has been related to alterations in gene expression and oxidative stress 
in human cell lines and rats (Yousef and El-Demerdash 2006, Camacho et al. 2012, Sen et al. 
2012), reproductive impairment (Sakamoto and Hashimoto 1986, Zenick et al. 1986, Chapin et 
al. 1995, Tyl and Friedman 2003, Wang et al. 2010, Camacho et al. 2012), increased formation 
of benign tumours in mammals and neurotoxicological effects in different organisms such as 
goldfish, frogs, rats and flies (Edwards 1975, Seale et al. 2012, Prasad and Muralidhara 2012), 
being a proven carcinogen to rodent models (see Besaratinia and Pfeifer 2007, for a review). The 
proposed molecular models for acrylamide toxicity have recently been reviewed by LoPachin and 
Gavin (2012). Acrylamide and its metabolite glycidamide are known to interact with a wide range 
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of biomolecules, at the cellular level, which aids in explaining the potential broad scope of its 
toxicological effects. For instance, evidence that acrylamide may indeed be mutagenic and 
clastogenic is directly linked to the binding of cytoskeletal proteins, leading to irregularities 
during the mytotic cycle and increased nuclear abnormalities. Chromatid gaps and breaks have 
also been observed in mammalian cells, previously exposed to acrylamide (Martins et al. 2007). 
All in all, it is believed that acrylamide and glycidamide exhibit distinct mechanisms of toxicity 
and different preferential targets within the cell, and to better understand the pathways adopted 
by each of these chemicals, their exact consequences should be analysed separately. In terms of 
genetic toxicology, there has been some research towards that objective, establishing comparisons 
between acrylamide and glycidamide (Barber et al. 2001, Doerge et al. 2005, Puppel et al. 2005, 
Martins et al. 2007).  
 
 
Figure 1.11. Epoxidation of acrylamide to glycidamide and possible interactions of these compounds 
with cellular components. 
 
1.4 Scope of thesis and main objectives 
 
This dissertation is centred in the biological question of DNA adducts as biomarkers of exposure 
to carcinogen agents, namely acrylamide. Despite being sensitive, currently employed procedures 
are cumbersome, time-consuming, require specialised personnel and are not risk absent for the 
user (the case of radiolabeled isotopes). One of the main objectives of this work is the 
development of an easy-to-perform gold nanoparticle-based technique suitable for identification 
of DNA adducts in biological samples from individuals previously exposed to a carcinogen agent. 
To accomplish this objective, several intermediate objectives will have to be addressed, namely 
at the sample preparation and the detection steps. 
Regarding the sample preparation procedure, all protocols included in this section will be broken 
down and analysed for its utility, advantages and disadvantages. This way, a decision will be 
made on which protocols are the most valuable for the desired outcome and the sample 
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preparation procedure will be tailored according to the necessities. In particular, ultrasonic 
fragmentation of DNA, enzymatic hydrolysis of DNA and chromatography protocols will be 
addressed.  
Concerning the detection step, gold nanoparticles will be employed for two distinct approaches 
towards DNA adduct identification: i) as an inorganic surface for laser desorption/ionisation 
(SALDI), to potentiate mass spectrometry detection. Gold nanoparticles will be evaluated as an 
inorganic surface towards nucleotide profiling, and compared to the more traditional organic 
matrix for laser desorption/ionisation (MALDI). After a careful analysis of SALDI vs. MALDI, 
and optimisation of the detection conditions, this system will ultimately be employed for 
identification of DNA adducts generated by exposure to acrylamide; ii) conjugated with aptamer 
molecules, constituting gold-aptamer nanoprobes, capable of a colorimetric identification. The 
stability of nanoprobes will be assessed, as well as its spectral behaviour in the presence of 
different nucleotides. The assay conditions will be optimised before detection of DNA adducts 
generated in vitro in different substrates (free nucleotides vs. DNA chain). 
The development of a promising approach for identification of DNA adducts as exposure 
biomarkers would strengthen the versatility of gold nanoparticles for bioanalytical purposes, and 
might provide a future alternative to currently employed protocols for DNA adduct detection. 
A second main objective of this work is the development of a biological model for exposure to 
acrylamide. This will be accomplished by a rigorous and thorough assessment of acrylamide 
toxicity and biomarker response in two different aquatic organisms: the goldfish and the 
Mediterranean mussel. Particularly, effects both at the cellular and tissue-level will be evaluated 
and a general overview of acrylamide mechanisms of toxicity will be explained, including 
genotoxicity and oxidative stress. Both acute and prolonged exposures will be assayed for a more 
broad comprehension of acrylamide consequences to the target organisms. To complete the 
toxicological study, qualitative histopathological screening will be performed and relations will 
be established amongst all considered biomarkers. Once the mechanisms of acrylamide toxicity 
in these organisms have been assessed, as well as their value as biological model for exposure, 
collected samples will be treated according to the developed sample preparation protocol analysed 
using the proposed AuNP-based approach for DNA adduct detection, as mentioned beforehand.     
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CHAPTER 2. MATERIALS AND METHODS 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Tell me and I forget. Teach me and I remember. Involve me and I learn. 
Benjamin Franklin 
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2.1 Materials 
  
2.1.1 Chemical reagents 
Reagents CAS number Distributor 
1-chloro-2,4-dinitrobenzene (CDNB) 97-00-7 Sigma-Aldrich 
2,4,6-trihydroxyacetophenone (THAP) 480-66-0 Sigma-Aldrich 
3-(4-chloro-phenyl)-2-cyano-acrylic acid - Sigma-Aldrich 
3-hydroxypicolinic acid (3-HPA) 874-24-8 Sigma-Aldrich 
7-ethoxyresorufin 5725-91-7 Santa Cruz Biotech. 
α-cyano-4-hydroxycinnamic acid (CHCA) 28166-41-8 Sigma-Aldrich 
ABTS diammonium salt 30931-67-0 Alfa-Aesar 
Acetonitrile 75-05-8 Carlo-Erba 
Acetylcholine iodide (ACTI) 2260-50-6 Sigma-Aldrich 
Acetylcholinesterase (AChE) from electric eel 9000-81-1 Sigma-Aldrich 
Acridine orange 10127-02-3 Sigma-Aldrich 
Acrylamide 79-06-1 Sigma-Aldrich 
Albumin, from bovine serum (BSA) 9048-46-8 Sigma-Aldrich 
Agarose 9012-36-6 Invitrogen 
Ammonium chloride 12125-02-9 Merck 
Ampicillin 69-53-4 Sigma-Aldrich 
Bacteriological agar 9002-18-0 Difco 
Boric acid 10043-35-3 Fluka 
Bradford reagent - Sigma-Aldrich 
Bromophenol blue 115-39-9 Merck 
Catalase, from bovine liver 9001-05-2 Sigma-Aldrich 
Chloroform 67-66-3 Merck 
Dimethyl sulfoxide (DMSO) 67-68-5 Sigma-Aldrich 
DL-Dithiothreitol (DTT) solution, 1 M 3483-12-3 Fluka 
DPX mounting medium - BDH 
Dulbecco phosphate buffered saline - Sigma-Aldrich 
Eosin Y 15086-94-9 Sigma-Aldrich 
Ethanol 64-17-5 Panreac 
Ethidium bromide (EtBr) 1239-45-8 Sigma-Aldrich 
Ethylenediamine tetracetic acid (EDTA) 60-00-4 Merck 
Ferulic acid 537-98-4 Sigma-Aldrich 
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Reagents (cont.) CAS number Distributor 
Ficoll 26873-85-8 Sigma-Aldrich 
Glacial acetic acid 64-19-7 Sigma-Aldrich 
Glucose 50-99-7 Sigma-Aldrich 
Glycerol 56-81-5 Sigma-Aldrich 
Glycine 56-40-6 Sigma-Aldrich 
Glycidamide 5694-00-8 Sigma-Aldrich 
Gold(III) chloride trihydrate 16961-25-4 Sigma-Aldrich 
Haematoxylin 517-28-2 Sigma-Aldrich 
Hydrochloric acid 7647-01-0 Sigma-Aldrich 
Hydrogen peroxide 7722-84-1 Sigma-Aldrich 
Low-melting point GtG agarose 39346-81-1 NuSieve 
Magnesium chloride 7786-30-3 Merck 
Malondialdehyde (MDA) 100683-54-3 Sigma-Aldrich 
Methanol 67-56-1 Merck 
Myoblobin from horse heart 100684-32-0 Sigma-Aldrich 
Nicotinamide adenine dinucleotide phosphate 
(NADPH) 
100929-71-3 Sigma-Aldrich 
Nitric acid 7697-37-2 Sigma-Aldrich 
Paraffin pellets, histology grade 8002-74-2 Panreac 
p-nitrophenylphosphate (pNPP) developing 
solution 
333338-18-4 Sigma-Aldrich 
Potassium chloride 7447-40-7 Merck 
Potassium hydroxide 1310-58-3 Merck 
Potassium periodate 7790-21-8 Alfa Aesar 
Potassium phosphate dibasic 7758-11-4 Sigma-Aldrich 
Potassium phosphate monobasic 7778-77-0 Sigma-Aldrich 
Proteinase K 39450-01-6 Roche 
Purpald® 1750-12-5 Sigma-Aldrich 
Reduced glutathione (GSH) 70-18-8 Sigma-Aldrich 
Resorufin 635-78-9 Sigma-Aldrich 
Sinapinic acid 530-59-6 Fluka 
Sodium chloride 7647-14-5 Sigma-Aldrich 
Sodium citrate tribasic hydrate 6132-04-3 Sigma-Aldrich 
Sodium dodecyl sulfate (SDS) 151-21-3 Sigma-Aldrich 
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Reagents (cont.) CAS number Distributor 
Sodium hydroxide 1310-73-2 Sigma-Aldrich 
Sodium phosphate dibasic dihydrate 10028-24-7 Merck 
Sodium phosphate monobasic monohydrate 10049-21-5 Merck 
Sucrose 57-50-1 Sigma-Aldrich 
Super DHB 63542-76-7 Sigma-Aldrich 
TE-buffered phenol 108-95-2 Sigma-Aldrich 
Thiobarbituric acid (TBA) 504-17-6 Sigma-Aldrich 
\Trichloroacetic acid (TCA) 76-03-9 Merck 
Trizma® base 77-86-1 Sigma-Aldrich 
Triton-X 100 9002-93-1 Sigma-Aldrich 
Trolox® 53188-07-1 Sigma-Aldrich 
Tryptone 91079-40-2 Difco 
Tween® 20 9005-64-5 Sigma-Aldrich 
Xylene 1330-20-7 Sigma-Aldrich 
Yeast extract 8013-01-2 USB 
 
2.1.2 Solutions and buffers 
All necessary solutions and dilutions were prepared using ultrapure (> 16.2 MΩ.cm) sterile 
water from a Merck Millipore Milli-Q system. 
 
Phosphate buffer (sodium/potassium) 
According to the desired pH and concentration (from Sambrook and Russel 2001) 
pH 
Na2HPO4 
10 mM 
(mL) 
NaH2PO4 
10 mM 
(mL) 
 pH 
K2HPO4 
50 mM 
(mL) 
KH2PO4 
50 mM 
(mL) 
7.0 57.7 42.3  7.0 61.5 38.5 
7.4 77.4 22.6  7.4 80.2 19.8 
7.6 84.5 15.5  7.6 86.6 13.4 
8.0 93.2 6.8  8.0 94.0 6.0 
 
AL1  
10 mM Tris-HCl (pH 8.0)  
1 mM EDTA (pH 8.0) 
50 mM glucose (Added after sterilisation in autoclave) 
Store at 4 ºC. 
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AL2 
0.2 M NaOH  
1 % SDS (m/v) 
Prepare fresh before use. 
 
AL3 
3 M Sodium acetate (adjust pH to 4.8 with glacial acetic acid).  
Store at 4 ºC. 
 
Bouin-Hollande´s solution  
10 % (v/v) formalin  
7 % (v/v) acetic acid 
Picric acid added to saturation 
Store at RT. 
 
Blocking solution 
1 % BSA in 1xPBS 
 
BM mixture 
125 mM NaCl 
60 mM KCl 
35 mM NaH2PO4 
50 mg/L BSA 
If necessary, adjust pH to 7.0. Store at 4 ºC. 
 
Carnoy’s solution  
60 % (v/v) ethanol 
30 % (v/v) chloroform 
10 % (v/v) glacial acetic acid 
Store at 4 ºC. 
 
Coating buffer 
50 mM Na2CO3/NaHCO3 (pH 9.6) 
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CS1 
450 mM NaCl 
3.72 % (m/v) EDTA 
5 mM Tris 
Sterilise by autoclaving and store at 4 ºC. 
Before using, add DMSO to a final concentration of 10 % (v/v) and Triton-X 100 to a final 
concentration of 1 % (v/v). Use within 2 hours afterwards.  
 
CS2 
1 mM EDTA 
300 mM NaOH (pH 13) 
Sterilise by autoclaving and store at 4 ºC. 
 
CS3 
0.1 M Tris-HCl buffer (pH 7.5) 
Sterilise by autoclaving and store at 4 ºC. 
 
Eluent 1 
25 mM Tris-HCl (pH 8.0) 
0.5 % acetonitrile 
 
Eluent 2 
25 mM Tris-HCl (pH 8.0) 
800 mM NH4Cl 
0.5 % acetonitrile 
 
ENA washing solution  
Ethanol with 0.1 % (v/v) acetic acid 
 
GST mix 
100 µL of GSH 200 mM in water 
100 µL of CDNB 0.1 mM in 96 % ethanol 
9.8 mL of Dulbecco phosphate buffered saline 
Prepare fresh before use. 
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LB medium (Luria-Bertani medium) 
1 % (m/v) yeast extract  
2 % (m/v) tryptone  
2 % (m/v) NaCl 
Adjust pH to 7.0 with NaOH. Sterilise by autoclaving and store at 4 ºC.  
 
LS1  
0.32 M sucrose 
5 mM MgCl2 
TrisHCl 10 mM (pH 7.5) 
Triton-X 1 % (v/v); added after sterilization in autoclave 
Store at 4 ºC. 
 
LS2 
100 mM NaCl 
5 mM EDTA (Na2) 
Store at RT. 
 
MIC buffer 
100 mM NaH2PO4 (pH 7.4) 
150 mM KCl 
1 mM EDTA 
1 mM DTT 
87 % (v/v) glycerol 
Store at 4 ºC. 
 
PBS (phosphate buffered saline, pH 7.4) 
8.3 mM Na2HPO4 
1.5 mM KH2PO4  
136 mM NaCl  
2.7 mM KCl 
Sterilise by autoclaving and store at 4 ºC. 
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PMS buffer  
100 mM NaH2PO4 (pH 7.4) 
150 mM KCl 
1 mM EDTA 
1 mM DTT 
Store at 4 ºC. 
 
TBE (5x) 
446 mM Tris base 
445 mM boric Acid 
10 mM EDTA (pH 8.0) 
Sterilise by autoclaving and store at RT. Dilute to 1xTBE working solution. 
 
TPBS  
0.05 % (v/v) Tween-20 in 1xPBS 
 
2.1.3 Biological material 
2.1.3.1 Antibodies 
- Polyclonal rabbit anti-fish CYP1A antibody (Biosense Labs, Norway) 
- Alkaline phosphatase-labeled anti-rabbit antibody, produced in goat (Sigma, USA) 
 
2.1.3.2 Enzymes 
- Ribonuclease A (RNase A), DNase and protease-free (Thermo, USA) 
- Eco47I restriction enzyme (Thermo, USA) 
- MvaI restriction enzyme (Thermo, USA) 
- DNase I, RNase-free (Thermo, USA) 
 
2.1.3.3 Nucleotides 
- dTTP solution (Thermo, USA) 
- dCTP solution (Thermo, USA) 
- dATP solution (Thermo, USA) 
- dGTP solution (Thermo, USA) 
 
2.1.3.4 DNA size markers 
- GeneRuler DNA Ladder Mix, ready-to-use (Thermo, USA) 
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2.1.3.5 Plasmid DNA 
- pUC19 vector (Thermo, USA) - see appendix I for additional information 
- p158 plasmid (kindly provided by G. Doria) - see appendix I for additional information 
 
2.1.3.6 Oligonucleotides 
All modified-oligonucleotide were purchased from STABVida (Portugal). Sequences and 
specifications are displayed below. 
 
Aptamer Sequence 
(5’  3’) 
Probability at 
20° C (kJ/mol) 
XBA-DNA Thiol-C6-AGG GCA CGT GTA TTA CCC TAG 
TGG TCG ACG TCG 
-19.34 
His-945 Thiol-C6-TTA GGC ATC GGA AAG TGG GTT 
GAT GTA AGT AAC AGG CGA TGC 
-33.20 
 
2.1.4 Equipment 
- Ultrasonic bath Transsonic TI-H-5 (Elma, Germany) 
- Ultrasonic probe UP100H, 1 mm tip diameter (Heilscher, Germany) 
- Sonoreactor UTR200 (Heilscher, Germany) 
- VialTweeter (Heilscher, Germany)  
- Ultrasonic bath Elmasonic S10H (Elma, Germany) 
- Wide Mini-Sub Cell GT electrophoresis cell with PowerPac Basic power supply (Bio-Rad, 
USA) 
- Sub-Cell model 96 electrophoresis cell (Bio-Rad, USA) 
- Gel Doc XR+ Molecular Imager system (Bio-Rad, USA) 
- HPLC pump P680 and ASI-100 autosampler, coupled to a DAD-3000RS (Dionex, USA) 
- Savant SpeedVac concentrator SVC-100 (Thermo, USA) 
- Thermal Cycler DNA Engine (Bio-Rad, USA) 
- Thermal Cycler MyCycler (Bio-Rad, USA) 
- pH 21 pH/mV meter with glass electrode (Hanna, USA) 
- Orbital incubator OrbiSafe TS Netwise (Sanyo, Japan) 
- Sigma 3-16K refrigerated centrifuge (Sartorius, Germany) 
- Sigma 1-14 microcentrifuge (Sartorius, Germany) 
- UV-Vis Spectrophotometer UV Mini-1240 (Shimadzu, Germany) 
- UV-Vis Spectrophotometer Nanodrop ND-1000 (Nanodrop Technologies, USA) 
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- Microplate reader Infinite M200 with Absorbance module (Tecan, Switzerland)  
- SZ-100 Nanoparticle Analyzer (Horiba, Japan) 
- Ultraflex TOF/TOF mass spectrometer, equipped with a reflectron (Bruker, Germany) 
- DMLB microscope, coupled with a DFC480 digital camera (Leica, Germany) 
- EL6000 light source for DMLB microscope ((Leica, Germany) 
- I3 and N2.1 filters for DMLB microscope ((Leica, Germany) 
 
2.1.5 Specialised materials 
- Quartz absorption cells (Hellma, Germany) 
- 384-well small volume, microplates, black (Greiner Bio-One, Germany) 
- 96-well microplates, transparent (Greiner Bio-One, Germany) 
- 96-well ELISA microplates, transparent (Greiner Bio-One, Germany) 
- NAP-5 columns (GE Healthcare, Sweden) 
- Zeta-potential cells (Hellma, Germany) 
- Glass microscope slides with ground edges (Normax, Portugal) 
- Glass coverslips for microscope slides, 24x50 mm (Normax, Portugal) 
 
2.4 Methods 
  
2.4.1 Molecular biology 
2.4.1.1 Plasmid DNA isolation 
Plasmid DNA isolation was performed according to the alkaline lysis protocol described in 
Baptista (2000). 
 
1. 100 mL of LB medium supplemented with 100 µg/mL ampicilin were inoculated with 100 µL 
of a glycerol stock, previously prepared from an isolated E.coli colony. The culture was grown 
for 14 hours, at 37 ºC with constant agitation (200 rpm).  
2. a) From the grown culture, a volume of 700 µL was pipetted to an eppendorf tube and 300 µL 
of glycerol were added. The culture stock was mixed by inversion and stored at -80ºC. 
 
b) The remaining culture was used for plasmid extraction via alkaline lysis protocol. Culture 
was transferred to 1.5 mL Eppendorf tubes and centrifuged 8 000xg and the supernatant was 
discarded. Two consecutive centrifugations were performed per tube, in order to maximize the 
number of pelleted cells. Pelleted celles were resuspended in 150 µL of AL1 solution. 
3. Tubes were placed in ice for 5 min. 
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4. 300 µL of AL2 solution were added and the tube was gently inverted to mix and placed in ice 
for 5 min. 
5. 225 µL of AL3 solution were added and solution was mixed by inverting the tube. Tubes were 
left on ice for 30 min. 
6. The tubes were centrifuged for 15 min, at 15 000xg, at 4 ºC. 
7. After centrifugation, 630 µL (c.a. 1 vol.) from the supernatant were transferred to a clean 2 
mL tube. 1 260 µL of ice-cold absolute ethanol (ca. 2 vol.) were added to each tube, and tubes 
were left for 2 hours in the freezer, at -20 ºC. 
8. Samples were centrifuged for 10 min, at 15 000xg, at 4 ºC. Afterwards the supernatants were 
discarded, whereas the pellets were washed 2 times with ice-cold 70% ethanol and dried. 
9. Pellets were resuspended in 200 µL of sterile water per tube. At this step, the number of tubes 
was reduced by one third, by pooling together samples from 3 tubes. 
10. Afterwards, RNase A was added to a final concentration of 200 µg/mL, and digestion was 
carried at 37 ºC for 2 hours. 
11. A microextraction step followed. Firstly, 600 µL (ca. 1 vol.) of TE-buffered phenol were 
added, the solution was mixed by inversion for 1 min and centrifuged for 5 min, at 15 000xg, RT.  
12. The aqueous (upper) phase was removed to a new tube and 600 µL of a chlorophorm:isoamyl 
alcohol (24:1) solution were added. The solution was mixed by inversion for 1 min and 
centrifuged for 5 min, at 15 000xg, RT.  
13. The aqueous (upper) phase was removed to a new tube. To this solution, 2 volumes of ice-cold 
absolute ethanol (c.a. 1 100 µL) and 1/10 volumes of 3 M sodium acetate (pH 7.5) were added. 
The tubes were left for 2 hours in the freezer, at -20 ºC. 
14. The tubes were centrifuged for 15 min, at 15 000xg, at 4 ºC. The supernatants were discarded 
and pellets were washed 3 times with ice-cold 70 % ethanol, dried and resuspended in 40 µL of 
sterile water. 
 
2.4.1.2 Genomic DNA isolation from total blood  
The genomic DNA isolation protocol was employed in different samples: chicken blood and 
goldfish hepatopancreas. The presented volumes were optimised for chicken total blood. Protocol 
was scaled-down when employed to DNA isolation from goldfish hepatopancreas. For blood, 
samples were thawed and transferred to an Eppendorf or falcon tube (depending on the volume), 
whereas for hepatopancreas, samples were weighted and crushed beforehand in a small volume 
of PBS buffer.   
1. After thawing/crushing, samples were transferred to new tubes and 10 volumes of cold LS1 
were added. The solution was gently mixed on ice for 10 min.  
2. Tubes were centrifuged at 9 170xg, at 4° C for 10 min and the supernatant was discarded. 
3. The pellet was carefully resuspended in 2 mL of LS2. 
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4. Afterwards, 250 µL of SDS 10 % and 50 µL of proteinase K were added. The mixture was 
incubated at 55° C for a minimum of 3 h with agitation.  
5. A salting-out step followed, by adding 1 mL of saturated sodium chloride and mixing carefully 
by inverting the tube. 
6. Tubes were centrifuged at 5 000xg, for 15’ at 15° C and supernatant was carefully removed to 
a new tube.  
7. Precipitation was achieved by adding 2 volumes of ice-cold absolute ethanol, mixing and 
leaving the tubes for 2 h in the freezer (-20° C).  
8. Tubes were centrifuged at 15 000xg, for 10’ at 4° C, the supernatant was discarded and the 
pellet was washed with 70 % cold ethanol. 
9. The pellet was resuspended in 500 µL of sterile water and 10 µL of RNase (DNase free) were 
added to the DNA. Solution was incubated at 37 ºC with agitation for 2 h. 
10. After incubation, 500 µL phenol were added and mixed by inverting the tube. Solution was 
centrifuge at 15 000 xg, for 20 min. 
11. The aqueous phase was removed and 500 µL of chloroform were added. The tube was mixed 
by inversion and centrifuged at 15 000xg, for 10 min. 
12. The aqueous phase was removed to a new tube. 2 volumes of absolute ethanol (-20ºC) and 1/5 
volumes of saturated sodium chloride were added to the solution, and left for 2 h in the freezer (-
20° C).   
13. Genomic DNA was precipitated by centrifugation at 15 000xg, for 10 min at 4° C and the 
pellet washed 2 times with 70 % ethanol (-20ºC) and subsequently dried. 
14. Ready-to-use genomic DNA was resuspended in 100 µL sterile water. 
 
2.4.1.3 In vitro alkylation of nucleotides 
1. Glycidamide-guanine (GA-Gua) adducts were produced by reacting 5 mM glycidamide (GA) 
with 1 mM dGTP at 37° C, for 72 h (pH between 7.0 and 7.5). The final volume used was 100 
µL. 
2. DNA adducts were produced by reacting 5 mM of GA with 500 µg/mL of genomic DNA at 
37° C, for 72 h (pH between 7.0 and 7.5). The final volume used was 100 µL. 
3. After alkylation, the mixtures were heated up to 100° C for 15 min to release the alkylated 
guanines (Martins et al. 2007). 
 
2.4.2 Sample preparation 
2.4.2.1 Ultrasonic procedure and agarose gel electrophoresis 
1. Standard ultrasonication was performed in 1.5 mL tubes with a total volume of 100 µL and 
final DNA concentration of 100 µg/mL, using sterile (bidistilled) water as a solvent. 
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2. An initial assay was performed to compare DNA fragmentation through several ultrasonic 
systems: probe, sonoreactor, VialTweeter and ultrasonic bath (Figure 2.1). For more information 
on conditions, please refer to Table 3.1 in chapter 3. 
3. In parallel, an assay was performed to evaluate the temperature variation with sonication time 
in the sonoreactor, probe and ultrasonic bath, using bidistilled water as a solvent, with a total 
volume of 1 mL. For the sonoreactor and probe, temperature was measured at least once each 10 
seconds, for 1.5 min. For the ultrasonic bath, temperature was measured every 10 min, for 2 hours.  
4. The following assay focused the sonoreactor apparatus, at different sonication conditions 
(described in chapter 3 - Table 3.2).  
5. After sonication, all samples were stored at 4 ºC and for subsequent analysis by agarose gel 
electrophoresis.  
6. Agarose gel electrophoresis was carried out for 300 min, at 2 V/cm, with a 1 % agarose gel in 
1xTBE, using 0.1 µg/mL of GeneRuler DNA Mix Ladder (Fermentas) as a molecular weight 
reference. 
7. Following electrophoresis, agarose gels were post-stained for 20 min in an ethidium bromide 
(EtBr) bath (0.5 µg/mL of EtBr in bidistilled water). A subsequent washing step with bidistilled 
water was used to remove excess EtBr. 
8. Acquisition was carried out using a GelDoc system (hood and transilluminator) with UV 
excitation and the Quantity One software from Bio-Rad. 
 
 
Figure 2.1. Image of the four ultrasonic devices utilised in the study. 
 
2.4.2.2 Restriction enzyme digestion  
Eco47I and MvaI were carefully chosen from a vast number of restriction enzymes, to produce 
a considerable amount of DNA fragments ranging from 100 to 1 000 bp. 
 
1. Enzymatic digestion was carried out at 37 ºC for 2 hours, in 1.5 mL tubes, with a final 
concentration of 1 enzyme unit/μg of DNA. Reaction buffers and mixtures were made according 
to the manufacturer. 
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2. Inactivation was performed at 65 ºC, for 20 min. The digestion products were left at room 
temperature, to cool down, and stored at 4 ºC for subsequent analysis. 
3. Digestion products were analysed by agarose gel electrophoresis, following the previously 
mentioned experimental conditions. 
 
2.4.2.3 Acceleration of nuclease digestion via ultrasonic energy 
An unmodified pUC19 plasmid was used for this study. 
  
1. Reaction mixtures were made in 150 µL tubes with a final volume of 20 µL, for 1 µg of 
plasmid DNA. DNaseI reaction buffer as present at 1x, according to the manufacturer. 
2. For the first experiment, non-sonicated reactions were carried out at 37 ºC, for 10 min. 
Sonicated reactions were treated for 10 min in a sonoreactor, with an amplitude of 50 %. 
3. Afterwards, all reactions were inactivated by adding EDTA (1 mol EDTA for each mol of 
Mg2+) and incubating 15 min, at 70 ºC. 
4. Digestion products were analysed by agarose gel electrophoresis, following the previously 
mentioned experimental conditions. 
5. For the second experiment, the same reaction conditions were used. The chosen final 
concentration of DNase I was 0.01 units, whereas the amplitude of sonication varied. Inactivation 
was performed as described, followed by agarose gel electrophoresis. 
 
2.4.2.4 Sample treatment prior to HPLC analysis 
1. BM mixture was divided into several 25 mL aliquots. 
2. Aliquots were spiked with 100 µM of GA, dGTP or GA-Gua adducts (final concentrations), 
previously formed by in vitro alkylation. An additional aliquot spiked with bidistilled water was 
used as control. 
3. Samples were concentrated to 1 mL by evaporation. Each sample was divided to 2 new tubes 
(2x500 µL). 
4. A phenol:chlorophorm extraction was performed, according to the previously described 
procedure in section 2.4.1.2. 
5. A desalting step with a NAP-5 column followed. Column was previously equilibrated with 3 
volumes of bidistilled water. Afterwards, 500 µL of the sample were loaded in to the column. 
After adsorption was complete, the purified nucleotides were eluted with 1 mL of bidistilled 
water. 
6. Samples were concentrated by evaporation for subsequent analysis by HPLC. 
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2.4.2.5 HPLC conditions 
HPLC analysis of nucleotides was carried out using a DNAPac PA-100 column (4 x 250 mm), 
using a 4 x 50 mm guard column.  
1. The whole system was washed O/N with filtered bidistilled water, at a flow of 0.1 mL/min. 
2. Afterwards, mobile phase was set to a combination of Eluent 1 and Eluent 2 (90:10).  
3. The entire system was washed and purged with the mobile phase. 
4. Following the purge, the column was equilibrated with the mobile phase (90:10, Eluent 
1:Eluent 2) for a minimum of 2 hours, at 0.2 mL/min. The backpressure was carefully monitored. 
5. Afterwards, the flow was slowly increased to 1 mL/min, over 30 min. Once 1 mL/min reached, 
mobile phase was passed through the column for 30 min more. 
6. After all preparations were made, acquisition was set to a wavelength of 254 nm. Nucleotides 
were analysed with a flow of 1.0 mL/min, applying the solvent gradient in Figure 2.2, with water 
injections between samples. 
 
 
Figure 2.2. Solvent gradient utilised for HPLC nucleotide analysis. 
 
2.4.2.6 Sample preparation for MS-detection: complete protocol 
The complete protocol for sample preparation included DNA isolation, treatment with ultrasonic 
energy and nucleases, purification and concentration. A schematic representation of this protocol 
can be seen in Figure 3.11 (Chapter 3). 
1. Genomic DNA isolation from goldfish hepatopancreas was performed as described in section 
2.4.1.2. 
2. Samples with a final volume of 100 µL and a final DNA concentration of 100-200 µg/mL 
were sonicated in a sonoreactor for 6 min, at maximum amplitude. 
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3. Afterwards, DNase reaction buffer and DNase I were added to final concentrations of 1x and 
0.1 units per µg DNA, respectively. Reaction was carried at 37 ºC, for 1 hour to ensure complete 
breakdown. 
4. A phenol:chlorophorm microextraction followed, according to the conditions described in 
section 2.4.1.2. 
7. The final purification step involved a NAP-5 column. Please refer to section 2.4.2.4 for the 
complete desalting protocol.  
8. Samples were concentrated by evaporation, and quantified in a NanoDrop spectrophotometer, 
for subsequent MS-detection. 
  
2.4.3 Nanotechnology 
2.4.3.1 Gold nanoparticle synthesis by citrate reduction 
Synthesis of gold nanoparticles via citrate reduction was performed as firstly described by 
Turkevich (1985) and extensively used within the Nanomedicine@FCT Research Group. 
 
1. All glassware was previously immersed in Acqua Regia (3:1 HCl:HNO3) overnight. 
2. Glassware was washed with bidistilled water at least 5 times, and the pH inside the glassware 
confirmed to match the pH of the bidistilled water. 
3. Using a 500 mL round bottom flask with a condenser, 250 mL of a 1 mM HAuCl4 solution 
were boiled, with constant agitation. 
4. While in reflux 25 mL of 38.8 mM trissodium citrate were quickly added and, upon verifying 
the subsequent colour change, both heat and stirring were maintained for 15 minutes. 
5. After 15 minutes, the heat was turned off and stirring kept for an additional 20 minutes.  
6. The solution was cooled down to room temperature and filtered using a 0.2 µm membrane 
filter.  
 
2.4.3.2 Gold nanoparticle characterisation 
1. An aliquot of the synthesised colloidal gold solution was diluted to reach a final concentration 
of ≈ 1.5 nM and UV-Vis behaviour was followed from 400 to 800 nm, on a 1240 UV-Mini 
spectrophotometer from Shimadzu (Japan). 
2. A different aliquot was placed diluted to the same concentration in 0.1 M NaCl and UV-Vis 
behaviour was followed from 400 to 800 nm. 
3. An aliquot of colloidal gold solution was diluted to reach a final concentration of ≈ 2.5 nM 
and divided into three parts. 
4. The first part of this aliquot was analysed by transmission electron microscopy (TEM), as an 
external service, at the Microlab, Instituto Superior Técnico facilities in Lisbon, Portugal. 
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5. The second part was analysed by dynamic light scattering (DLS), at REQUIMTE, Faculdade 
de Ciências e Tecnologia, UNL. Analysis was carried out on a SZ-100 Nanoparticle Analyzer 
from Horiba Scientific (Japan), at a temperature of 20 °C, dispersion medium viscosity of 1 009 
mPa.s and a scattering angle of 90 °C. 
6. The remaining part was used for measurement of zeta-potential (ζ-potential), at REQUIMTE, 
Faculdade de Ciências e Tecnologia, UNL. Analysis was carried out on a SZ-100 Nanoparticle 
Analyzer from Horiba Scientific (Japan), at a temperature of 20 °C, dispersion medium viscosity 
of 1 009 mPa.s and an electrode voltage of 3.3 V. 
 
2.4.3.3 Aptamer-gold nanoprobe synthesis  
Synthesis of aptamer-gold nanoprobes was performed essentially as described by Baptista et al. 
(2005a) and extensively used within the Nanomedicine@FCT Research Group. 
 
1. A solution of thiol-modified aptamers was extracted three times with 2 volumes of ethyl 
acetate, at 15 000xg, for 5 min each.   
2. Meanwhile, a DNA grade NAP-5 column was washed and equilibrated with 3 volumes of 
phosphate buffer 10 mM (pH 8.0). 
3. After three extractions complete, the aqueous phase was loaded into the column for the 
aptamer to adsorb to the resin. 
4. When adsorption was complete and the first fraction washed out, the adsorbed aptamer was 
eluted with 1 mL of phosphate buffer 10 mM (pH 8.0), collected and immediately placed into ice.  
5. The solution was analysed via UV-Vis spectrophotometry to assess OD260 and ensure no traces 
of DTT were still in solution.  
6. Using the OD260 value as a reference for quantification, a theoretical ration of 50 oligos per 
nanoparticles was calculated. 
7. According to this ratio, AuNPs and aptamers were added to react in phosphate buffer 10 mM 
(pH 8.0), with 0.01 % SDS (final concentration). 
8. After 20 minutes, the salt-aging procedure began. Phosphate buffer 10 mM (pH 8.0) containing 
NaCl was added, to reach a final NaCl concentration of 0.05 M. The solution was sonicated for 
10 s and incubated for an additional 20 min, at RT. 
9. After 20 minutes, final NaCl concentration was raised to 0.1 M. The solution was sonicated 
for 10 s and incubated for an additional 20 min, at RT. 
10. After 20 minutes, final NaCl concentration was raised to 0.2 M. The solution was sonicated 
for 10 s and incubated for an additional 20 min, at RT. 
11. After 20 minutes, final NaCl concentration was raised to 0.3 M. The solution was sonicated 
for 10 s and incubated for 16 hours, at RT 
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12. After incubation, the aptamer-gold nanoprobe solution was centrifuged for 20 min, at 
15000xg, at RT. 
13. The supernatant was discarded, the pellet resuspended in phosphate buffer 10 mM (pH 8.0) 
and solution was centrifuged for 20 min, at 15 000xg, at RT. 
14. Step 13 was repeated one more time. 
15. The supernatant was discarded, and the pellet resuspended in phosphate buffer 10 mM (pH 
8.0), with 0.1 M NaCl. The solution was centrifuged for 20 min, at 15 000xg, at RT. 
16. After the final washing step, the supernatant was discarded and the pellet was resuspended in 
a small volume of phosphate buffer 10 mM (pH 8.0), with 0.1 M NaCl. 
17. The nanoprobe solution was analysed via UV-Vis spectrophotometry to assess the redshift in 
the maximum absorption band and for quantification purposes. 
 
2.4.3.4 Stability of aptamer-gold nanoprobes 
All colorimetric tests with aptamer-gold nanoprobes were performed on 384-well microplates, 
in triplicate and spectra/absorbance values were recorded on an Infinite 2000 Microplate Reader 
from Tecan (Switzerland). Procedures for reaction mixtures and colorimetric assays follow those 
described in Baptista et al. (2005a), Doria et al. (2007), Conde et al. (2010) and Doria (2010), for 
instance.   
1. Reaction mixtures were performed in 150 µL tubes, to a final volume of 30 µL, containing 
phosphate buffer (pH 8.0) and the aptamer-gold nanoprobes, to final concentrations of 5 mM, and 
2.5 nM, respectively. Sterile water was used to adjust the final volumes, when necessary.  
2. The mixtures were heated at 95 ºC, for 10 min and let cool down to RT for 30 min. 
3. After cooling down, MgCl2 was added to each tube, to attain the desired final concentrations 
(0-120 mM). 
4. The microplates were stored for 15 minutes, to for allow colour developing. Afterwards, 
spectrophotometric behaviour of the nanoprobes was followed from 400 to 800 nm. 
5. The Areas Under the Curve ratio (AUC) between the disperse (from 500 to 550 nm) and the 
aggregated (from 580 to 630 nm) fractions of the nanoprobe was estimated and used as an 
analytical tool for evaluating stability. 
 
2.4.3.5 Colorimetric assays with aptamer-gold nanoprobes 
1. Reaction mixtures were performed in 150 µL tubes, to a final volume of 30 µL, containing 
phosphate buffer (pH 8.0) and the aptamer-gold nanoprobes to final concentrations of 5 mM, and 
2.5 nM, respectively.  
2. To the mixtures, the analyte was added to the desired final concentration. The analytes varied 
according to the test: i) dNTPs; ii) GA-alkylated and non-alkylated dGTP; iii) GA-alkylated and 
non-alkylated genomic DNA. Sterile water was used to adjust the final volumes, when necessary. 
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3. The mixtures were heated at 95 ºC, for 10 min and let cool down to RT for 30 min. 
4. After cooling down, MgCl2 was added to each tube, to the threshold concentration determined 
beforehand (60 mM for the XBA-nanoprobe and 100 mM for the His-945 nanoprobe). Sterile 
water was used to adjust the final volumes, if necessary. 
5. The microplates were stored for 15 minutes, to allow for colour developing. Afterwards, 
spectrophotometric behaviour of the nanoprobes was followed from 400 to 800 nm. 
6. The Areas Under the Curve ratio (AUC) between the disperse (from 500 to 550 nm) and the 
aggregated (from 580 to 630 nm) fractions of the nanoprobe was estimated and used as an 
analytical tool for discrimination. 
 
2.4.4 Mass spectrometry 
2.4.4.1 Characterisation of organic matrices 
1. Different commonly used matrices were prepared in 50:50 water:acetonitrile (by default) and 
consecutive dilutions were made to attain different concentrations. When necessary, organic 
solvent proportion was adjusted to increase solubility.  
2. UV-Vis characterisation of organic matrices was carried in a NanoDrop spectrophotometer 
using 2 µL of solution. The Hi-Abs mode was used, considering an optical path of 0.1 mm.    
3. UV-Vis spectra were analysed and a relation was established between matrix concentration 
and the absorbance value at 337 nm.  
4. For mass spectrometry, matrix solutions were diluted to reach 3 different final concentrations 
(5, 2.5 and 1.25 mg/mL), and spotted on a steel plate. 
5. Additional spots were prepared with matrix (same final concentrations) in the presence of 0.5 
mM dGTP. 
6. Analysis was carried out following the conditions described below. 
 
2.4.4.2 Sample deposition and MS-detection 
Samples were analysed as an external service at the C.A.C.T.I., Universidade de Vigo facilities 
in Vigo, Spain.  
 
1. For identification of nucleotides by MALDI, the final concentrations of analyte and matrix 
were 500 µM and 5 mg/mL, respectively. 
2. For identification of nucleotides by AuNP-SALDI, the final concentrations of analyte and 
AuNPs were 500 µM and 15 nM, respectively. The final concentrations of analyte and AuNPs 
were constant throughout the work, unless stated otherwise (e.g. variation of analyte 
concentration). 
3. For analysis of GA-Guanine adducts formed by in vitro alkylation, AuNP and analyte final 
concentrations were kept at 15 nM and 500 µM, respectively. 
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4. Each sample was mixed 1:1 with the chosen matrix or AuNP solution. Afterwards, 1 µL of 
that mixture was spotted onto an AnchorChip 600/384 Target plate (Bruker, Germany) and 
allowed to dry at RT, protected from light. All analyses were performed in triplicate. 
5. For analysis of DNA adducts in biological samples, solutions containing fragmented genomic 
DNA were evaporated and later resuspended in matrix or AuNP solution to attain final 
concentrations of 5 mg/mL or 15 nM, respectively. The volume was calculated so that each spot 
contained the equivalent to 1 µg of fragmented genomic DNA. All analyses were performed in 
triplicate.     
6. Samples were analysed using an Autoflex MALDI-TOF system from Bruker (Germany) 
equipped with a reflectron, according to the following conditions: 
 
 Conditions Positive-Ion 
mode 
Negative-
Ion mode 
Spectrometer Ion source voltage 1 (kV) 19 19 
Ion source voltage 1 (kV) 16.54 16.55 
Ion source lens voltage (kV) 8.65 8.70 
Operation mode Reflector Reflector 
Reflector 1 (kV) 21 21 
Reflector 2 (kV) 9.7 9.7 
Ion extraction delay (ns) 0 0 
Suppression mode Deflection Deflection 
Suppressed up to (Da) 30 30 
    
Detection Detection gain reflector 6.8x 7.1x 
Sample rate (GS/s) 1 1 
    
Laser setup Laser frequency (Hz) 200 200 
Number of added shots 600 1200 
Laser power 45 % 45 % 
    
7. Mass spectra were acquired using the FlexControl software from Bruker (Germany) and 
treated using the mMass open source Mass Spectrometry tool (Strohalm et al. 2008, 2010). 
 
 
 
 
 
 
62 
 
2.4.5 Toxicity assays 
2.4.5.1 Experimental design for acute toxicity assay on goldfish  
1. Goldfish (Carassius auratus L.), 6 cm standard length and 4 g average total wet weight, 
were obtained from national producers (Koi Park, Portugal).  
2. Prior to the beginning of the experiments, fish were acclimated in 400 L polystyrene tanks for 
two weeks, in a closed circuit system with filtered dechlorinated tap water at a pH of 7.4±0.2, at 
a temperature of 19±1 °C, under a 12 h light: 12 h dark photoperiod and with continuous aeration. 
3. Following the acclimation period, mature fish (n = 8 biological replicates per treatment) were 
randomly distributed into 10 L volume polystyrene tanks in groups of eight fish per tank. 
4. Static exposure of fish to different concentrations of acrylamide (50 to 200 mg/L) in each tank 
was conducted at high density (32 g fish per 10 L water) and a feeding condition of 96 hours, 
using an additional tank with clean tap water as control. During the experiment, fish were fed ad 
libitum with commercial feed. Exposure concentrations were chosen in accordance with the scant 
LC50 information for other freshwater teleosts, reporting the threshold in excess of 100 mg/L 
(Krautter et al. 1986, Walker 1991, Weston et al. 2009). 
5. Mortality and morbidity was recorded continuously to determine LC50, estimated using the US 
EPA Probit software v3.2. 
 
2.4.5.2 Experimental design for acute and chronic toxicity assays on mussels 
1. Mediterranean mussels, Mytilus galloprovincialis, (c.a. 36x20 mm shell size) were collected 
from the intertidal zone of a clean site in NW Portuguese coast (c.a. 250 individuals).  
2. Prior to the beginning of the experiments, mussels were acclimatised in 50 L polystyrene tanks 
for one week, arranged in a closed circuit system with clean seawater (pH 7.65 ± 0.2, temperature 
of 19 ± 1 °C, and salinity of 31 ± 1 ‰) under a 12 h light: 12 h dark photoperiod, with continuous 
aeration. The same water was used to in the bioassays.  
3. Following the acclimation period, mussel individuals (n = 15 biological replicates per 
treatment) were randomly distributed to a duplicate array of 15 L polystyrene tanks. The 
concentrations of acrylamide ranged between 100 and 2 000 mg/L, in face of the absent 
information on acrylamide LC50 for bivalves (all concentrations depicted in Table 5.3). 
4. Static exposure of mussels to different concentrations of acrylamide (100 to 2 000 mg/L) in 
each tank was carried for 96 hours, using an additional tank with seawater as control. During the 
experiment, mussels were fed ad libitum with Dunaliella salina.  
5. Mortality and morbidity was recorded continuously to determine LC50, estimated using the US 
EPA Probit software v3.2. 
6. Following acute exposure and information retrieved on LC50, a chronic exposure assay was 
conducted. This consisted of a semi-static disposition of 15 L tanks with 39 randomly-selected 
mussels (n = 13 biological replicates per test) exposed to 1 and 10 mg/L acrylamide, with an 
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additional tank with seawater as control.  
7. Exposure was performed during 21 days, with water changes (100 %) done every 48 hours to 
ensure constancy of water parameters. Feeding was provided as mentioned above. 
 
2.4.5.3 Genotoxicity assessment 
Genotoxic effects were assessed in freshly-collected whole peripheral blood cells for clastogenic 
and strand breakage levels through the erythrocyte nuclear abnormalities (ENA) and Comet 
assays, respectively.  
  
2.4.5.3.1 Erythrocyte nuclear abnormality (ENA) assessment 
ENA assessment was performed according to Costa and Costa (2007). 
 
1. Following the experimental period, fish were collected and blood sampled from the caudal 
peduncle with EDTA-treated syringes as anticoagulant.  
2. A drop of freshly-collected blood was smeared on a glass microscopy slide and left to dry at 
room temperature. 
3. After drying, preparations were fixed with methanol for 15 min and left to dry, protected from 
light and humidity. 
4. Preparations were stained with a 100 mg/L acridine orange solution for 45 min, protected from 
light. 
5. Excess staining solution was by rinsing slides in ENA washing solution, subsequent washing 
in ethanol for 1 minute and dried at room temperature, protected from light. 
6. After drying, preparations were mounted with DPX resin and xylene. 
 
The frequency of cells exhibiting nuclear abnormalities was determined by observing at least 
1000 mature erythrocytes per preparation. Abnormalities such as micronuclei, nuclear buds, 
polynucleated cells and fragmenting nuclei were considered for this analysis. 
 
2.4.5.3.2 Single-cell gel electrophoresis (comet-assay) 
The Comet assay (alkaline) was performed according to Singh et al. (1988) and adapted by 
Costa et al. (2008) for fish blood. 
 
1. To ensure a successful experiment, glass microscope slides were coated beforehand with 1.5 
% (w/v) agarose in 1xTAE, and left to dry in a kiln for 48 hours. 
2. After sampling, blood aliquots were diluted 1:200 in cold PBS and diluted in 1 % (w/v) liquid 
low melting-point agarose (LMPA) in PBS. 
3. 100 µL of the dilutions was dropped on previously coated microscopy slides, covered with a 
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glass coverslip and immediately placed at 4 °C, for 30 min. 
4. After agarose solidification, coverslips were removed and the slides were dipped into the 
comet Lysis solution (CS1) during 1 h, at 4 °C, protected from light. 
5. Following lysis, slides were placed for 40 min into cold CS2 buffer. 
6. Electrophoresis was then carried out in CS2 buffer, at 4 °C, for 30 min, at 25 V, using a Sub-
Cell model 96 apparatus (Bio-Rad). 
7. Slides were neutralised in CS3 solution during 15 min. 
8. Staining with 20 µg/mL of ethidium bromide was performed for subsequent epifluorescence 
microscopy analysis. 
 
For the analysis, approximately 100 intact comets per slide were scored, using the CometScore 
software (TriTek, USA). The average value of DNA percentage in tail per individual was used as 
direct indicator of total DNA strand breakage. 
 
2.4.5.4 Sampling and preparation of goldfish PMS and microsomal fractions 
Goldfish hepatopancreas tissue was prepared as described by Nilsen et al. (1998).  
 
1. Following the experimental period and collection of blood samples for genotoxicity, goldfish 
were euthanised by cervical sectioning and hepatopancreas samples were excised and stored for 
further analysis (at -80 ºC). 
2. Previously stored samples were thawed on ice and homogenised in PMS buffer using 4 mL 
per g of sample.  
3. Homogenates were centrifuged at 12 000xg for 20 min at 4 °C and the postmitochondrial 
supernatants (PMS) were collected. 
4. Collected PMS were further centrifuged for 60 min at 100 000xg at 4 °C and resulting pellets 
(microsomal fractions) were resuspended in MIC buffer and stored at -80 °C. 
5. Sub-samples of PMS fractions were collected to new tubes and also stored at -80 ºC. 
 
Total protein concentration of the samples was estimated by the Bradford assay, using BSA as 
standard (Bradford, 1976) and biochemical biomarker responses were normalised to total protein 
concentration (calibration curves are presented in Appendix II). 
 
2.4.5.5 Sampling and preparation of mussel whole-body homogenates 
1. Following the experimental period, mussel individuals were collected and dissected with the 
aid of a scalpel. Two similar soft-body sections were produced, one for histology, other for 
biochemical analysis.  
2. The soft-body halves for biochemical analysis were homogenised in 600 µL of 1xPBS 
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(phosphate buffered saline). 
3. Afterwards samples were centrifuged at 12 000xg, for 20 min, at 4 °C and the pellet discarded 
to obtain the cleared homogenates. All supernatants were stored at -80 ºC for subsequent 
biomarker analysis.  
 
Total protein in samples was determined by the Bradford assay, using BSA as standard 
(Bradford, 1976) and all biochemical biomarker responses were norrnalised to total protein 
concentration (calibration curves are presented in Appendix II). 
 
2.4.5.6 Analysis of CYP1A induction 
Cytochrome P4501A (CYP1A) was determined as described by Nilsen et al. (1998).  
 
1. Previously collected microsomal fractions were diluted in ice cold coating buffer. 
2. In each well of a 96-well ELISA microplate 50 µL of the sample were immobilised, with 3 
replicas per sample. Microplates were incubated overnight at 4 °C. 
3. Each well was washed three times with TPBS.  
4. After the washing step, 100 µL of blocking solution was added to each well and microplates 
were incubated for two hours, at room temperature. 
5. Each well was washed three times with TPBS. 
6. After washing, 50 µL of the anti-CYP1A polyclonal antibody solution (diluted 1:100 in PBS) 
were added, with subsequent incubation at 37 °C for 1 hour. 
7. Each well was washed three times with TPBS 
8. After washing, 50 µL of the alkaline phosphatase (AP)-labelled secondary antibody (diluted 
1:1000 in PBS) were added to each well and the microplates incubated at room temperature for 1 
h.  
9. Each well was washed five times with TPBS. 
10. After washing, 50 µL of p-nitrophenylphosphate (pNPP) developing solution was added to 
each well, followed by 30 min incubation at room temperature.  
11. To stop the reaction, 50 µL of 5 M NaOH were added to each well.  
12. The absorbance was measured at 492 nm using a microplate reader and obtained results were 
normalised to the total protein concentration, previously estimated by the Bradford assay. Due to 
the absence of a commercial CYP1A standard as a reference, results were expressed as fold 
change relatively to the control group.  
 
2.4.5.7 Discontinuous ethoxyresorufin-O-deetylase (EROD) spectrophotometric assay  
EROD activity was measured through the discontinuous method, adapted from De Almeida et 
al. (2011).  
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1. A reaction mixture was prepared in Tris-HCl 50 mM (pH 7.4), containing 1.0 mg/mL of BSA, 
5 µM of 7-ethoxyresorufin and 0.5 mM of NADPH (final concentrations).  
2. On a 96-well microplate, 20 µL of the sample and 150 µL of the reaction mixture were 
incubated for 20 min, at 37 °C, in the dark, with 3 replicas per sample.  
3. Afterwards, reaction was stopped by adding 100 µL of 2 M glycine (pH 10.4).  
4. Absorbance at 572 nm was recorded, and data analysed according to a resorufin calibration 
curve, within the 0.78125 - 50 µg/mL linear range (calibration curves are presented in Appendix 
II). 
 
2.4.5.8 Activity of acetylcholinesterase (AChE) 
Determination of AChE activity was performed via quantification of thiocholine, following 
Ellman et al. (1961). 
 
1. A DTNB solution of 270 µM in 50 mM sodium phosphate (pH 7.4) was prepared beforehand.  
2. On a 96-well microplate, 50 µL of the sample were added, with 3 replicas per sample.  
3. Different wells for the positive (standard AChE from electric eel) and negative control were 
included, also with 3 replicas. 
4. Subsequently, 150 µL of DTNB solution were added to all wells. 
5. Afterwards, 50 µL of 3 mM ACTI were added to all wells.  
6. Absorbance at 412 nm was recorded for 15 min. 
 
2.4.5.9 Analysis of glutathione-S-transferase (GST) activity 
GST activity was determined following the procedure described by Habig et al. (1974) and 
optimised for 96-well microplates.  
 
1. On a 96-well microplate, 20 µL of the PMS fraction was added, with 3 replicas per sample.  
2. Different wells for the positive and negative control were included, also with 3 replicas.  
3. To each well (either containing sample or control), 180 µL of GST mix were added. 
4. Mixtures were incubated for 1 minute and afterwards, the absorbance at 340 nm was measured 
at every minute during 10 minutes. Equine liver GST (Sigma-Aldrich) was used as positive 
control. The results were normalised to total protein concentration determined by the Bradford 
assay. 
 
2.4.5.10 Analysis of catalase (CAT) activity 
Catalase activity was assessed by measuring the concentration of formaldehyde produced from 
methanol in the presence of hydrogen peroxide using a spectrophotometric method described by 
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Johansson and Borg (1988), adapted to the microplate reader.  
 
1. On a 96-well microplate, 20 µL of the sample were added, with 3 replicas per sample. 
2. In different wells, 20 µL of bovine liver catalase were added, as a standard.  
3. Subsequently, 30 µL of 100 % methanol were added to all wells. 
4. Afterwards, 100 µL of 50 mM phosphate buffer (pH 7.4) were added to all wells.  
5. To each well, 20 µL of hydrogen peroxide were added, to reach a final concentration of 0.035 
M, and mixtures were allowed to react for 20 min. 
6. The reaction was stopped by adding 30 µL of 10 M potassium hydroxide. 
7. Afterwards, 30 µL of 35 mM Purpald were added to the mixture and samples allowed to 
incubate for 10 min. 
8. Finally, 10 µL of 65.2 mM Potassium periodate were added as colour developer. 
9. Absorbance was measured at 540 nm and results were quantified using a formaldehyde 
standard curve within the 0-75 µM range (calibration curves are presented in Appendix II). 
 
2.4.5.11 Analysis of total antioxidant capacity (TAC) 
Total antioxidant capacity of the samples was determined using a modified protocol according 
to the Trolox equivalent antioxidant capacity (TEAC) principle (Miller et al. 1993).   
 
1. On a 96-well microplate, 10 µL of the sample were added, with 3 replicas per sample. 
2. To each well 10 µL of myoglobin and 150 µL of ABTS were added (final concentrations of 
4.5 µM and 300 µM, respectively). 
3. Afterwards, 40 µL of hydrogen peroxide (final concentration of 250 µM) were added to initiate 
the reaction and the microplate was incubated for 5 min, RT. 
4. Absorbance at 405 nm was recorded and results were analysed according to a Trolox standard 
curve, in the 0-1.5 mM linear range (calibration curves are presented in Appendix II). 
 
2.4.5.12 Analysis of lipid peroxidation (LPO) 
Lipid peroxidation was assessed via thiobarbituric acid-reactive species (TBARS) assay 
described by Uchiyama and Mihara (1978) and adapted to microplate reader by Costa et al. 
(2011). 
 
1. Samples were incubated with two volumes of ice cold 10 % (m/v) trichloroacetic acid (TCA) 
for 15 min at 4 ºC. 
2. Samples were then centrifuged at 12 000xg, for 15 min. 
3. Supernatants were mixed with an equal volume of 1% (m/v) thiobarbituric acid (TBA) and 
incubated for 15 min in a boiling water bath.  
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4. Samples were cooled on ice for 5 min to stop the reaction and then loaded onto a 96-well 
microplate. 
5. Absorbance of the reddish pigment was measured at 530 nm. A malondialdehyde (MDA) 
standard curve was used for quantification, in the 0-0.1 µM linear range (calibration curves are 
presented in Appendix II). 
 
2.4.5.13 Histological preparations and analysis 
Histological preparations were obtained following essentially Martoja and Martoja (1967). 
Different procedures were employed for goldfish and mussels. Alterations are explained below. 
 
1. Goldfish tissue samples were placed into a tube and fixed in Bouin-Hollande´s solution over 
48 h, at RT (c.a. 1 mL per 50-100 mg of tissue). As for mussels, half of an individual’s soft body 
was fixed in Carnoy’s solution over 5 h, at RT (c.a. 5 mL per g of tissue). 
2. Samples were washed with distilled water (24 h for goldfish and 2 h for mussels), at RT.  
3. Samples were placed into 70 % ethanol, until paraffination. 
4. Paraffin pellets left in a kiln for c.a. 8 hours, at 62 °C to melt.  
5. Meanwhile, samples were progressively dehydrated as follows: 2x15 min in 95% ethanol; 
3x30 min in absolute ethanol. 
6. Afterwards, 3x15 min in xylene was employed for intermediate impregnation. 
7. After drying completely, samples were placed into liquid paraffin O/N (enough volume to 
cover all the sample tissue). 
8. The following day, paraffin molds were cast and left to harden 15-20 min, at RT. 
9. Paraffin-embedded sections were cut with a microtome (5-7 µm thick) and placed on 
microscopy glass slides. 
10. Once preparations dried completely, deparaffination was carried out in xylene for 2x30 s. 
11. Afterwards, preparations were rehydrated as follows: 30 s in absolute ethanol; 2x30 s in 95 % 
ethanol; 3 min in 70 % ethanol; 6 min in bidistilled water.  
12. Preparations were stained with haematoxylin solution for 4 min and subsequently washed in 
distilled water for 2x2 min. 
13. Preparations were placed 3 min in 70 % ethanol and subsequently stained with eosin for 2 min. 
14. Afterwards, preparations were progressively dehydrated as follows: 30 s in 70 % ethanol; 2x30 
s in 95 % ethanol; 2x30 s in absolute ethanol.  
15. A final 30 s step in xylene was carried out. Preparations were let to dry O/N. 
16. The following day, all slides were mounted with DPX resin and left to dry for at least 6 h. 
17. Observations were carried out using a DMLB model microscope equipped with a DFC480 
digital camera (Leica microsystems), on about 8 sections per slide, with at least 3 slides being 
prepared per specimen. 
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2.4.6 Statistical analysis 
All statistics were performed using the Statistica10 software from Statsoft Inc. (Tulsa, USA) 
considering a significance value of 95 % (α = 0.05), following Zar (1998) and Sheskin (2000). 
The Kolmogorov-Smirnoff and Liliefors tests were employed to verify normality of data, and the 
Levene’s test to evaluate homogeneity of variances.  
 
2.4.6.1 Colorimetric assays with aptamer-gold nanoprobes 
1. Colorimetric assays involving Au-nanoprobes were analysed using parametric methods: 
ANOVA and Tukey’s honest significant difference (HSD) for multiple comparisons. 
 
2.4.6.2 Estimation of effect concentrations 
1. Effect concentrations (LC50) were estimated via Probit model analysis, using the EPA Probit 
software v3.2 (EPA, USA).  
 
2.4.6.3 Analysis of biomarker data 
Analysis of all biomarker-related data was performed using non-parametric methods, following 
invalidation of at least one of the assumptions needed for parametric analysis.  
 
1. The Kruskal-Wallis H test was used for multiple comparisons and to assess significant 
differences within all data. 
2. Subsequently, the Mann-Whitney U test was employed to assess pairwise significant 
differences between treatments. 
3. For the goldfish data, the Spearman rank-order R with Bonferroni correction was used to 
establish correlations between biomarker responses and exposure concentrations.  
4. For the mussel data, a correlation-based principal component analysis (PCA) was employed 
to integrate data on all tested biomarkers. 
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CHAPTER 3. OPTIMISATION OF SAMPLE PREPARATION 
 
Some of the results presented in this chapter have been published in Larguinho M, 
Santos HM, Doria G, Scholz H, Baptista PV, Capelo JL. 2010. Development of a fast and 
efficient ultrasonic-based strategy for DNA fragmentation. Talanta 81:881-886, where 
Miguel Larguinho was responsible for most of the experimental work (all experiments 
with ultrasonic energy and DNA) and writing part of the manuscript. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
It is not enough to have a good mind; the main thing is to use it well. 
René Descartes 
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3.1 Introduction 
 
The main objective of the work portrayed in this chapter has always been the achievement of a 
suitable procedure for sample treatment, beginning with DNA isolation from a biological source, 
up to when the sample is spotted on the MALDI plate. This chapter includes all data obtained 
from experiments regarding sample preparation for subsequent detection.  
The first section addresses ultrasonic fragmentation of DNA as a means to attain poly-, oligo- 
and, ultimately, free nucleotides from heavier and more complexed DNA molecules. At the same 
time, several ultrasonic platforms are evaluated in terms of efficiency, to ascertain the optimal 
and most economic method to achieve ideal fragments for downstream applications, such as 
biomolecular detection, via mass spectrometry (MS) for instance. The last part of this first section 
evaluates the feasibility of ultrasonic platforms when compared or combined to nuclease 
digestion. These results have not been discussed solely in the interest of MS-based detection, but 
also in the context of cellular and molecular biology techniques in general (e.g. PCR amplification 
or enzymatic treatments). However, throughout this chapter these methods will be integrated into 
a more complete protocol, ending with MS-based detection, and a comprehensive discussion 
provided on the advantages and drawbacks of these methodologies for sample treatment. 
The second section of this chapter addresses liquid chromatography, mainly high performance 
liquid chromatography (HPLC) of nucleotide mixtures. This section evaluates the pros and cons 
of including a HPLC step in the overall protocol, for additional purification/separation and 
discusses the decisions made regarding this technique. 
The final section presents the overall protocol for sample preparation before MS detection, from 
the moment of DNA isolation, up to when it is spotted in the MALDI plate.  
Despite these techniques being very different, all have been included in the same chapter due to 
the common purpose, the development and optimisation of an ideal protocol for nucleotide sample 
preparation for MS-based detection. With this in mind, a brief introduction is in order where the 
basic concepts of each technique will be explained, before heading on to the Results and 
Discussion section. 
 
3.1.1 Ultrasonic energy and DNA fragmentation 
The use of ultrasonic energy as fragmentation procedure for DNA samples has been gradually 
gathering momentum as a robust approach to attain DNA fragments susceptible of use in 
downstream detection protocols with minimum additional purification. The growing development 
of biomolecular assays (e.g. diagnostics) for biomarker analysis or nucleic acid recognition 
increases the concern for optimal sample preparation. This is particularly relevant when the 
detection depends on the specific hybridisation of oligonucleotide probes (Mehlmann et al. 2005, 
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Liu et al. 2007, Vinogradova et al. 2007, Baptista et al. 2008) or the decomplexation and 
breakdown of high molecular weight DNA, where small DNA fragments with known molecular 
weight and concentration are required.  
Ultrasounds are described as high frequency acoustic waves (20 kHz or higher) requiring a 
medium in order to propagate (Luque de Castro and Capote 2007, Mason and Lorimer 2002). 
When passing through an aqueous solution, acoustic waves cause the formation of microbubbles 
filled with gas (cavities), a process known as cavitation. Two types of cavitation have been 
described: stable cavitation (gas body activation) and inertial cavitation (transient or vaporous). 
Stable cavitation occurs during low intensities of ultrasound, but inertial cavitation requires high 
intensities of ultrasound. The latter is responsible for high energy events, considered to be 
extremely destructive to biological molecules (Miller et al. 1996). During inertial sonication, the 
size of microbubbles varies through several cycles of compression and rarefaction: first, there is 
a rapid increase in size, followed by a decrease, and this cycle continues until it implodes (see 
Figure 3.1). The high temperatures and high pressures inside the bubble are sufficient to cause 
hydrolysis, sonoluminescence phenomena (Suslick et al. 1999) and shearing of biological 
molecules in its vicinity (Miller and Thomas 1996). Besides cavitation, two additional phenomena 
may lead to the damage of biological molecules: mechanical and thermal degradation; and 
reaction with radicals generated from water (Pritchard et al. 1966, Peacocke and Pritchard 1968, 
Makino et al. 1983, O’Brien Jr. 2007). Also, the use of ultrasonic waves directly in cells was 
shown to induce DNA fragmentation and damage (Miller et al. 1995, Miller and Thomas 1996). 
 
 
Figure 3.1. Generation and collapse of an acoustic cavitation microbubble. Adapted from Luque de Castro 
and Capote (2007), Mason and Lorimer (2002). 
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The study of the influence of acoustic shear waves in the behaviour of oligonucleotides (Cavic 
and Thompson 2002) has prompted the development of methodologies for DNA sample treatment 
relying on the use of ultrasonic probes resulting in efficient in vitro fragmentation of purified 
DNA, which can then be used in a multitude of biosensing applications (Mann and Krull 2004, 
Grokhovsky 2006). Several ultrasound platforms can be used towards DNA sample preparation, 
such as probes, sonoreactors, baths, etc., but previous studies describe only ultrasonic probes as 
a practical tool for DNA fragmentation (Mann and Krull 2004). Besides this, no data has yet been 
produced comparing these systems in terms of optimisation for ideal conditions towards DNA 
sample preparation. 
 
3.1.2 Enzymatic hydrolysis of DNA molecules 
In molecular biology and genetic engineering, nucleic acid cleavage is a most utilised and 
valuable tool by specialised enzymes, the nucleases. In terms of Enzyme Commission number, 
nucleases are classified as hydrolases (EC-number 3) for they catalyse the hydrolysis of a 
phosphodiester bond between two nucleotides in a polymeric chain (see Figure 3.2A). Nucleases 
may be classified into exonucleases and endonucleases. Exonucleases cleave the terminal 
nucleotide off the nucleic acid chain, yielding a monophosphate nucleoside and a polynucleotide, 
whereas endonucleases cleave the nucleic acid chain in different positions, yielding 
polynucleotides, oligonucleotides and free nucleotides. Considering the recognition sequence, 
different types of endonucleases may be distinguished. Restriction endonucleases for instance are 
enzymes that cleave DNA in specific recognition sequences, which vary depending on the enzyme 
(see Figure 3.2B for some examples).  
The activity of these enzymes has firstly been verified in bacteria by Luria and Human (1952), 
and by Bertani and Weigle (1953), by observing differential growth of bacteriophages, depending 
on the host genotype. However, Arber and Linn (1969) were the first ones to propose that bacteria 
could protect themselves from bacteriophages by an enzymatically-mediated genetic defense 
mechanism. Bacteria methylate their genome in order to protect it, and these enzymes recognise 
and cleave a specific non-methylated DNA sequence, working as an intracellular defense 
mechanism against viral intrusions (Wilson and Murray 1991). The different names given to 
restriction enzymes are directly related to the species and strain from where they have firstly been 
identified (e.g. EcoRI from E. coli, R - strain RY13, I - first to be identified). In contrast to 
restriction enzymes, other endonucleases such as DNAse I for instance, possess no recognition 
sequence, and cleave DNA molecules in a relatively nonspecific way. Digestion with nucleases 
is a powerful tool for sample preparation, as a means to de-complex and fragment DNA samples 
in a more specific, controlled way. Despite this, it is a time-consuming technique that requires 
optimal conditions such as pH, ionic strength and temperature in order to benefit from its full 
potential.  
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Figure 3.2. A) Mechanism of hydrolysis of a phophodiester bond between two nucleotides in a nucleic acid 
molecule. B) Examples of recognition sequence and restriction sites for three different restriction 
endonucleases. 
 
 
Figure 3.3. Classification of chromatography modes (highlighted both ion-exchange and size-exclusion). 
CEC – Capillary electrochromatography. Adapted from Kazakevich and LoBrutto (2007).  
 
 
77 
 
3.1.3 A word on liquid chromatography 
Chromatography may be defined as a physicochemical method for separation of different 
components in a mixture, by selective adsorption to a specific substrate, or surface. In order to 
occur, this separation requires two phases: a mobile phase and a stationary phase. 
Chromatographic methods may be divided into liquid and gas, according to the physical state of 
the mobile phase (Kazakevich and LoBrutto 2007) and liquid chromatography into several 
different categories, according to the principle of transport through the column (see schematics in 
Figure 3.2). Separation by liquid chromatography is achieved by forcing the sample through a 
column packed with a stationary phase. The motive force is generated by the flow of mobile phase 
passing through the column. Depending on the separation principle, different stationary and 
mobile phases are selected to achieve maximum efficiency. 
 
 
Figure 3.4. Schematics of different principles of separation in liquid chromatography. A) ion-exchange 
chromatography; B) size-exclusion chromatography. 
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In this chapter, two different principles of chromatographic separation will be addressed: ion-
exchange and size-exclusion (highlighted in Figure 3.3). Separation by ion-exchange is based on 
the retention of differently charged analytes by a charged stationary phase (may be cationic or 
anionic, depending on the analytes) (Randerath and Randerath 1964, Kopaciewicz et al. 1983). 
This type of chromatography requires a column loaded with charged functional groups (as 
stationary phase) and a solvent gradient including the addition of a counter-ion to the mobile 
phase, in order to elute the retained compounds (see Figure 3.4A for more details). Ion-exchange 
columns usually attain a very good separation of components in a mixture, but require addition 
of salt to the mobile phase, which in some cases bring the need for desalting procedures 
afterwards. Besides this, ion-exchange columns are particularly sensitive to conditions such as 
organic solvents, pH and temperature.  
In contrast to this method, size-exclusion chromatography (SEC) separates analytes by their 
differences in size. The SEC relies on a column packed with a porous gel, with a specific pore 
size, in order to slow down the elution of compound smaller than the pore (Barth et al. 1994. Sun 
et al. 2004). Particles larger than the pore size do not enter the gel and are excluded, eluting sooner 
than smaller particles (see schematics in Figure 3.4A). This kind of chromatographic separation 
is extremely useful for separation procedures during polymer synthesis (Moore 1964, Podzimek 
et al. 2001) or desalting procedures during sample preparation, for instance (Mori and Barth 
1999). Despite its usefulness, this method bears a major drawback, the possibility of interaction 
between the mobile and stationary phases, affecting both elution and separation of components. 
        
3.2 Results and Discussion  
 
3.2.1 Development of a fast and efficient ultrasonic-based strategy for DNA 
fragmentation 
3.2.1.1 Ultrasonic devices 
The outcome and efficiency of ultrasonication depends on the ultrasonic device. Parameters such 
as frequency and intensity of ultrasonication must be carefully analysed in the implementation of 
this type of energy in any sample treatment workflow. To assess the differences between three 
ultrasonic devices, 1 mL of water was submitted to ultrasonication at different times, using 50 % 
of the nominal amplitude and every 5 s the temperature was measured. Figure 3.5 plots the 
increment in time versus the increment in Q (heat). The slope of the linear relation obtained 
increases according to the following: sonoreator (0.626) > UP100 probe (0.311) > Ultrasonic 
Bath. Since the increment in Q can be associated to cavitation effects, especially for short 
operation times, one may speculate that the best performance is obtained with the sonoreactor. 
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This was subsequentely confirmed with experimental data (see below). The VialTweeter was not 
included in this study. 
 
 
Figure 3.5. ∆Q [J] versus time of sonication for three of the four ultrasonic devices assessed in this work. 
The slopes of the lines (J/s) are as follows: sonoreactor, 0.453; ultrasonic probe UP100, 0.319; ultrasonic 
bath 0.013. The VialTweeter was not analysed in this study due to its low performance. 
 
3.2.1.2 Finding out the best device for DNA ultrasonic fragmentation 
For effective hybridisation and detection protocols, the average length of target DNA fragments 
should be reduced to decrease secondary structure formation (Mehlmann et al. 2005, Liu et al. 
2007, Vinogradova et al. 2007). The efficiency of four different ultrasonic-based platforms to 
yield suitable DNA fragments was initially assessed by setting the amplitude of ultrasonication at 
its maximum value (100 %) and the time of treatment at 2 min. Figure 3.6 shows the 
electrophoretic profile of fragments originated from plasmid and genomic DNA submitted to 
ultrasonication. Results show that the ultrasonic bath and the VialTweeter have little effect in 
DNA integrity, causing only a slight disruption of some plasmid conformations - see lanes 4 and 
5 for ultrasonic bath and lanes 6 and 7 for the VialTweeter. Other native conformations of the 
plasmid are still present after the ultrasonic treatment (red arrows in Fig. 3.6 showing the intact 
conformations). This can easily be explained since both systems have low intensity of sonication, 
and therefore cavitation efficiency is not enough to promote considerable DNA fragmentation. 
Conversely, the ultrasonic probe and the sonoreactor originated smaller fragments in short 
operation times, yielding low molecular weight fragments with total disruption of native DNA 
conformations (see Fig. 3.6, lanes 8–11).  
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Figure 3.6. DNA fragmentation potential for different sonication setups. 1% Agarose gel (in 1x TBE) 
electrophoresis of plasmid and genomic DNA, respectively: lanes 2 and 3: non-sonicated; lanes 4 and 5: 
ultrasonic bath; lanes 6 and 7: VialTweeter; lanes 8 and 9: sonoreactor; lanes 10 and 11: UP100H probe (1 
mm diameter tip). All samples were sonicated for 2 min at maximum amplitude. Lanes 1 and 12: GeneRuler 
DNA Mix Ladder (Fermentas). Red arrows show intact plasmid DNA conformations.  
 
The best performance was obtained for the ultrasonic probe, where 2 min ultrasonic time and 
100% ultrasonic amplitude yielded a DNA fragment distribution comprised between 600 and 100 
bp – see Table 3.1. The sonoreactor also provided good results for the same experimental 
conditions as no native DNA conformations were observed and DNA fragments’ size dispersion 
within the 1 500–100 bp range - see Table 3.1 and lanes 8 and 9 in Fig. 3.6. What is more, when 
the time of ultrasonication was increased to 8 min, the DNA fragments’ size homogeneity was 
better, being comprised between 1 000 and 100 bp. These results are in agreement with previously 
reported data by Fukudome et al. (1986) and by Bankier (1993), which observed that the 
molecular weights of DNA fragments after ultrasound exposure were remarkably decreased when 
ultrasonic power was increased from 25 to 105 W. The use of an UP to fragment DNA and the 
evaluation of the influence of ultrasonic power and ionic strength on DNA fragmentation has 
already been reported (Mann and Krull 2004). More recently, it was observed that the plasmid 
DNA condensation affects its resistance to fragmentation caused by ultrasonic waves (Wu et al. 
2009b). Despite the UP probe’s potential for DNA fragmentation, this device presents two major 
disadvantages: aerosol formation when ultrasonication is applied to the sample, which causes loss 
of sample; and risk of carry over contamination, as the tip of the probe is inserted into the sample. 
Also, as the tip vibrates to generate ultrasonic waves, it is subjected to micro-degradation (Freitas 
et al. 2006), potentially leading to sample contamination with metal fragments that may hamper 
downstream applications (e.g. enzymatic amplification or digestion). On the other hand, the 
sonoreactor allows to apply indirect sonication on a sealed sample, i.e. does not enter in direct 
contact with the sample. Therefore, it presents the advantage of reducing the contamination risk 
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and possible sample losses. In addition, the formation of an aerosol is not observed. Also, the 
sonoreactor has been desceibed to input 50 times less energy into the sample than the ultrasonic 
probe (Santos and Capelo 2007, Rial-Otero et al. 2007), reducing the risk of thermal degradation. 
In addition, although 2 min was enough to complete the treatment with the UP (1 sample), 4 
samples can be treated at once using the sonoreactor. Therefore sample throughput is equivalent. 
Last but not least, the minimum sample volume that can be treated with a regular UP is 100 µL, 
whilst with the sonoreactor it can be as low as 1 μL. Based on these data, the sonoreactor-based 
ultrasonic treatment was selected for further studies and optimisation. 
 
Table 3.1. Comparison of DNA fragmentation potential for different sonication setups 
 Conditions Plasmid DNA Genomic DNA 
Devices Time 
(min) 
Ampl 
(%) 
Vol 
(µl) 
[DNA] 
(µg/mL) 
Peak Homogeneity Peak Homogeneity 
Non- 
-sonicated 
2 Max. 100 100 8 500 bp 13 000, 8 500 
bp 
12 000 
bp 
12 000-500 
bp 
Bath 8 500 bp 13 000, 8 500 
bp 
12 000 
bp 
12 000-500 
bp 
VialTweeter 8 500 bp 8 500 bp 12 000 
bp 
12 000-500 
bp 
Sonoreactor 800 bp 1 500-200 bp 700 bp 1 200-100 bp 
Probe 500 bp 600-100 bp 400 bp 600-100 bp 
 
3.2.1.3 Influence of ultrasonication time  
The effect of time in ultrasonication was evaluated by applying ultrasonic energy to DNA 
samples at different time intervals comprised between 2 and 6 min - see Table 3.2. The 
ultrasonication amplitude was set at 100 %, since previous data had shown that lower amplitudes 
(<80 %) led to lower efficiency in the fragmentation of DNA. As may be seen in Table 3.2, the 
sample treatment is clearly time-dependent. For plasmid DNA, 4 min of sample treatment was 
enough to reach a fragment distribution comprised between 1 000 and 100 bp, whilst for genomic 
DNA a distribution comprised between 800 and 100 bp was obtained with 6 or 8 min of sample 
treatment. To guarantee the robustness of the procedure, the duration of treatment in further 
experiments was set to 8 min. 
 
3.2.1.4 Influence of sample denaturation 
To study the influence of the DNA conformation in the efficiency of the ultrasonic induced 
fragmentation, previously denatured and non-denatured DNA were submitted to the same 
conditions of ultrasonication. Fig. 3.3 shows that there was no improvement in the efficiency of 
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the treatment due to previous denaturation. This suggests that the fragmentation process caused 
by cavitation is mainly a physical process and not chemical, i.e. caused by the creation of radicals 
during the cavitation process. Ultrasonication may also cause denaturation of proteins and DNA, 
and therefore previous DNA denaturation maybe of little help in the fragmentation process. These 
findings suggest that the main contribution to DNA strands’ fragmentation is due to 
hydrodynamic shearing forces as consequence of cavitation bubble collapse. This has been 
proposed by Grokhovsky (2006) to explain the influence of temperature in the breaking of DNA, 
where hydrodynamic forces are the main causes of ultrasonic DNA fragmentation, and that 
chemical processes generating radicals during cavitation play only a minor role, if any (Table 
3.2).  
 
Table 3.2. Comparison of different conditions using the sonoreactor system and its influence on DNA 
fragmentation potential.  
 Conditions Plasmid DNA Genomic DNA 
Devices Time 
(min) 
Ampl 
(%) 
Vol 
(µL) 
[DNA] 
(µg/mL) 
Peak Homogeneity Peak Homogeneity 
Non-sonicated - - 100 100 8 500 
bp 
13 000, 8 500 
bp 
12 000 
bp 
12 000-500 
bp 
Sonoreactor 
(SR) 
2 100% 100 100 800 
bp 
1 500-200 bp 700 bp 1 200-100 bp 
4 450 
bp 
1 000-100 bp 500 bp 1 100-100 bp 
6 420 
bp 
1 000-100 bp 380 bp 800-100 bp 
8 420 
bp 
1 000-100 bp 380 bp 800-100 bp 
      
8 300 700 
bp 
1 500-100 bp 500 bp 1 200-100 bp 
500 900 
bp 
2 100-100 bp 550 bp 1 200-100 bp 
      
100 200 500 1 200-100 bp 480 bp 1 000-100 bp 
500 500 1 500-100 bp 480 bp 1 000-100 bp 
      
SR (sample 
denatured 
beforehand) 
100 420 
bp 
1 000-100 bp 380 bp 800-100 bp 
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3.2.1.5 Influence of sample volume  
For equal conditions of time and amplitude of ultrasonication, as the sample volume increases, 
the ultrasonication density (i.e. efficiency of treatment) is expected to decrease. This was 
confirmed in a set of experiments in which the ultrasonic conditions and DNA concentration were 
maintained, but the sample final volume was incremented from 100 to 500 μL. As shown in Fig. 
3.3, the average size of the plasmid DNA fragments was 900, 700 and 420 bp whilst for genomic 
DNA was 550, 500 and 380 bp for sample volumes of 500, 300 and 100 μL, respectively. A 
volume of 100 μL was chosen as optimal for further experiments. 
 
3.2.1.6 Influence of DNA concentration  
The influence of DNA concentration was also assessed. Results suggest that for the same 
ultrasonication time and amplitude, the fragmentation efficiency is slightly diminished as the 
DNA concentration increases (Table 3.2). The size distribution of DNA fragments obtained 
incremented from 1 000–100 to 1 500–100 bp for plasmid DNA and from 800–100 to 1 000–100 
bp for genomic DNA. However, if the time of treatment is increased, the average size of the 
fragments and the size distribution can be the same, regardless of the DNA concentration (range 
100–500 μg/mL). After exhaustive analysis of all different conditions and setups, an optimised 
protocol for DNA fragmentation was set out in which the sample was sonicated by means of a 
sonoreactor for 6 min at 100% ultrasonication amplitude in a volume of 100 μL. 
 
3.2.1.7 Ultrasonic fragmentation versus restriction enzyme digestion  
The optimised ultrasonic protocol was compared to restriction enzyme digestion for 
fragmentation of DNA samples. To assure digestion, a double restriction was performed with two 
frequent cutters - Eco47I and MvaI. Figure 3.7 displays the electrophoretic patterns for sonicated 
and digested DNA samples (plasmid and total genomic DNA). The patterns corresponding to 
plasmid DNA samples sonicated (lane 3) and digested (lane 4) show considerable differences. 
The ultrasonicated sample exhibits a fragment distribution (100–500 bp), whilst the digested 
sample consists of numerous DNA fragments with discrete molecular weight (100–3 000 bp). 
This is not observed for the genomic DNA samples, where both the sonicated and digested 
samples (Fig. 3.7 - lanes 6 and 7, respectively) exhibit a smear corresponding to extensive 
fragmentation. It should be noted that, whilst ultrasonication yields fragments with low size 
dispersion (<500 bp), the digested sample shows a wider range of fragment distribution from high 
to low molecular weight fragments (from 10 000 to <100 bp). 
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Figure 3.7. Comparison between the sonoreactor system and restriction enzyme digestion in generating 
DNA fragments. 1% Agarose gel (in 1x TBE) electrophoresis of plasmid DNA samples, respectively: lane 
2: non-sonicated; lane 3: sonicated with the sonoreactor; lane 4: digested with restriction enzymes; and 
genomic DNA samples, respectively: lane 5: non-sonicated; lane 6: sonicated with the sonoreactor; lane 7: 
digested with restriction enzymes. Lanes 1 and 8: GeneRulerDNAMix Ladder (Fermentas). Conditions of 
ultrasonication: ultrasonication time 8 min, ultrasonication amplitude 100%. 
 
The restriction enzyme treatment of genomic DNA results in a fragment profile which can be 
compared to that attained by simple mechanic fragmentation occurring during DNA extraction 
and purification (untreated sample). When compared to the untreated sample, the restriction 
enzyme treatment can be considered negligible as it shows a much lower capability of 
fragmentation than that of ultrasonication. Restriction enzyme digestion, due to the specific 
sequence recognition, may allow a more discrete cleavage but it is time consuming, relies on 
expensive reagents (e.g. enzymes, buffers) for the reaction to occur at optimum activity 
conditions, and requires subsequent sample purification. Contrary to what it might seem, DNA 
fragmentation through ultrasounds does not occur totally at random, as 5’-CpG-3’ dinucleotides 
have been shown to be primary hotspots for double-strand breaks (Grokhovsky 2006). What is 
more, the ultra-sonication approach here proposed avoids any purification step, is significantly 
faster and less expensive than restriction enzyme methods, generating fragments of equivalent 
molecular weight and suitable for downstream detection applications. 
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3.2.1.8 Ultrasonic acceleration of nuclease-mediated DNA hydrolysis 
Both ultrasonic fragmentation and nuclease digestion have been shown valuable as a means to 
produce DNA fragments suitable for downstream applications. However, DNA fragments may 
prove difficult to analyse with time-of-flight (TOF) analysers, due to its elevated molecular 
weight and structure. So, the ultimate objective would be a complete breakdown of the DNA 
molecule into free nucleotides using a rapid, inexpensive protocol. For this purpose, an 
experiment was performed to assess how ultrasonication would influence DNAse I digestion.  
The acceleration of enzymatic digestion by sonication has previously been described for trypsin 
proteolytic digestion in different occasions (Lopéz-Ferrer et al. 2005, Rial-Otero et al. 2007) but, 
no data has ever been published on ultrasonic acceleration of DNA digestion. Consequently, a 
simple experiment to attain whether ultrasonic energy would influence DNAse I-mediated DNA 
hydrolysis was carried out. Contrastingly to MvaI and Eco471 (previously used), DNase I does 
not possess a specific recognition sequence, as it cleaves the DNA molecule preferentially next 
to pyrimidines, generating both oligonucleotides and free nucleotides. Results in Figure 3.8 depict 
electrophoretic patterns for DNase I digestions of 1 µg of plasmid DNA, for 10 minutes, with and 
without sonication. In both cases, down to a concentration of 0.1 units enzyme per reaction, most 
substrate is degraded (Figure 3.8, wells 1 to 3). A smear-like pattern is denoted in wells 4, 
indicating that the respective enzyme concentration (0.05 units per reaction) is not sufficient to 
breakdown most substrate in solution. Lower concentrations than this produce similar patterns to 
the non-digested DNA (Figure 3.8, wells 5 to 7).  
 
 
Figure 3.8. Electrophoretic patterns obtained for DNAse I digestion of plasmid DNA with and without 
ultrasonication. Conditions: 1% agarose gel in 1xTBE; 50 V; 120 min. Lane 1: 1U DNase I; lane 2: 0.5U 
DNase I; lane 3: 0.1U DNase I; lane 4: 0.05U DNase I; lane 5: 0.01U DNase I; lane 6: 0.005U DNase I; 
lane 7: without DNase I; lane 8: without plasmid DNA.  
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Figure 3.9. Electrophoretic patterns obtained for DNAse I digestion of plasmid DNA with incrasing 
ultrasonic amplitude. Conditions: 1% agarose gel in 1xTBE; 50 V; 120 min. Lane 1: GeneRulerDNAMix 
Ladder (Fermentas). Lane 2: 0% amplitude; lane 3: 10% amplitude; lane 4: 25% amplitude; lane 5: 50% 
amplitude; lane 6: 70% amplitude; lane  7: 80% amplitude; lane 8: without DNase I. All reactions were 
performed with 0.01U DNaseI, during 10 min.  
 
Whether the digestion occurred at 37 °C in a thermo cycler, or in a sonoreactor with 50% 
amplitude, very similar results are observed in Figure 3.8. A slight difference in wells 3 is denoted, 
where ultrasonic treatment seems to have produced a seemingly longer smear, which would mean 
that the digestion suffered some sort of impairment, perhaps due to premature increased enzyme 
denaturation via acoustic cavitation. Results in Figure 3.8 seem to indict that 10 minutes of 
ultrasonic treatment at 50% amplitude did not accelerate DNAse I digestion. In comparison to 
proteins, the DNA molecule presents a higher resistance to unfolding and denaturation. This may 
be why treatment of DNA samples proves more of a challenge. Nevertheless, an additional 
experiment was performed, to assess whether ultrasonic amplitude would produce differences. 
Data in Figure 3.9 depicts electrophoretic patterns of plasmid DNA reacted with DNase I, for 10 
min, at different ultrasonic amplitudes. A remarkable resemblance can be observed in 
electrophoretic patterns in lanes 2 to 8, from 0 to 80% amplitude, primarily indicating that, at the 
tested conditions, ultrasonic energy did not effectively accelerated DNase I digestion of plasmid 
DNA. The maximum established amplitude for this experiment was 80% because previous 
knowledge on fragmentation of DNA showed that above this amplitude, plasmid DNA may 
fragment due to action of ultrasonic energy alone, and if that occurred, results would be rendered 
inconclusive. Also, the period of sonication/digestion was kept constant at 10 minutes in all 
digestion-related experiments with a specific purpose. Based on previous experiments, this 
sonication period may be considered a long time for continuous sonication of a DNA/protein 
solution. However, if an ultrasonic acceleration of digestion would have been denoted at 2, 5 or 
7 minutes, it would be seen in the electrophoretic pattern. Thus, considering there is no 
spontaneous re-ligation of DNA fragments in solution (phosphodiester bond), by action of 
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ultrasonic energy or DNase I, a maximum time limit was set at 10 minutes. As both experiments 
carried out showed no significant influence of ultrasonic energy on DNA-mediated hydrolysis, 
the variation of sonication period (reaction time) was found of little relevance and was therefore 
not investigated.      
Considering all data discussed beforehand, to improve DNA breakdown to free nucleotides the 
most successful option would be a combined protocol involving a first, rapid DNA fragmentation 
step with ultrasonic energy and a subsequent digestion step with DNAse I.   
 
3.2.2 Chromatography for nucleotide separation and purification 
Liquid chromatography (LC) was procured to achieve efficient separation of nucleotides from 
the remainder molecules in a solution. This technique would be preceded by DNA fragmentation 
and breakdown to nucleotides, which would mean that enzymatic components and saline buffers 
might still remain in solution. To rid the solution of these contaminants, the first suggestions 
would be to perform a phenol:chlorophorm extraction for protein removal, followed by a desalting 
step using a DNA-grade size-exclusion column (NAP-5). This protocol possesses some 
advantages, such as low cost, easiness and time-effeciency, however it presents a major 
disadvantage: it pools together all nucleotides in a given mixture and cannot effectively separate 
each one from the next. Since this separation may be important, the incorporation of a high 
performance liquid chromatography (HPLC) step in the protocol was evaluated. It would present 
a considerable increase in time and cost, however, depending on the results, it could prove 
extremely valuable for subsequent analysis. For better results, a DNA-grade anion exchange 
column was tested, which would efficiently retain the nucleotides, separating them from other 
components. 
 
3.2.2.1 Profiling different nucleotides 
Preliminary results indicated that reverse-phase and normal-phase chromatography were not 
adequate for elution of phosphate nucleotides. The similar affinity of all nucleotides towards the 
stationary phase rendered these methodologies unable to efficiently resolve its separation. After 
some experimenting with ion-exchange chromatography (using a HPLC system), the best 
conditions for nucleotide elution were found (described in Methods section 2.4.2.5). The first step 
would be the identification each nucleotide’s elution peak, as well as its characteristic retention 
time, according to the experimental chromatography conditions. In order to accomplish this, 
different mixtures of 3 nucleotides were analysed by ion-exchange HPLC (Figure 3.10). The 
retention times vary according to the nucleotide in question. Pyrimidine nucleotides present lower 
retention times than purines with thymine being the nucleotide which elutes sooner (retention 
time ≈ 7.54 min).  Also, guanine seems to be the nucleotide more effectively retained by the 
column, possibly due to lower affinity towards the mobile phase (retention time ≈ 9.36 min). As 
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the used principle was ion-exchange, when a nucleotide passes through the column, it would 
mainly be retained by trapping the phosphate groups, and the observed shifts in retention times 
are possibly due to the chemistry of the nucleobase and its interaction with the mobile phase. 
After acquiring the retention times and chromatographic profile of all 4 nucleotides, the next step 
included the analysis of modified nucleotides and the alkylating agent, glycidamide. 
 
Figure 3.10. Chromatograms of different nucleotide mixtures, for identification of different 
deoxynucleotides by ion-exchange HPLC. Lines of different colours highlight different nucleotide elution 
peaks. Measured retention times, thymine ≈ 7.54 min; cytosine ≈ 7.87 min; adenine ≈ 8.51 min; guanine ≈ 
9.36 min.  
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3.2.2.2 Separation of modified nucleotides via HPLC 
When inserted in a more complete protocol, the separation of modified nucleotides would not 
be performed in treated, contaminant-free samples, but rather in mixtures containing the 
remainder of nuclease digestions (saline buffers, enzymatic fractions, etc.) and possibly molecular 
radicals generated during the ultrasonication step (Milowska and Gabryelak 2007). So, to simulate 
such conditions and contaminants, a mixture containing these components was made (see 
Methods section 2.4.2.4), and spiked with i) glycidamide (GA), ii) dGTP, and iii) GA-modified 
dGTP (GA-guanine adduct). Mixtures were desalted, filtered and analysed by ion-exchange 
HPLC, employing previously described conditions. 
 
 
Figure 3.11. Chromatograms for mixtures spiked with A) glycidamide (GA); B) dGTP; C) GA-modified 
dGTP. Insets represent an overview of the chromatogram, with a broader scale.on the YY axis. Different 
numbers correspond to different chromatographic signals. 
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Considering all chromatograms in Figure 3.11, immediate differences are denoted amongst 
them. The signal marked with 1 (Fig. 3.11 A and C) appears only in samples containing GA, at 
relatively low retention times, which may be related to the elevated hydrophilic nature of GA, as 
well as low interactions with positively charged groups (in the column). The chromatographic 
signal of dGTP appears later in the chromatograms and can easily be identified as 3, in Fig. 
3.11B,C. Its intensity appears lower in 3.11C, possibly due to the consumption of guanines, during 
the previous alkylation reaction with GA. The visible signal of dGTP in Fig. 3.11C (marked with 
3) indicates a reaction yield below 100%, so unreacted (non-alkylated) guanine molecules still 
remained in solution. Other than this, a sharp negative peak is also denoted in Fig. 3.11B,C 
(marked with 2), which can possibly be linked to differences in absorbance between the mobile 
phase and saline components in the sample. The chromatogram in Fig. 3.11 C presents no visible 
chromatographic signals that can be attributed to a GA-guanine adduct. Considering the chemistry 
of both guanine and GA, a signal corresponding to the GA-Gua adduct might appear at low 
retention times, in case the alkylated guanine would be released from the pentose and phosphate 
groups. Otherwise, it would be trapped in the column and should elute in close proximity to the 
dGTP signal. The fact that a GA-Gua adduct elution peak is not visible in the chromatogram may 
indicate that either GA greatly increased its hydrophilicity and lowered retention, or its 
concentration is too little to be analysed by a UV-Vis diode-array detector, at 254 nm. Both these 
hypotheses are regarded as a disadvantage of this method for separation of modified nucleotides. 
Nevertheless, fractions corresponding to low retention times were collected and subsequently 
analysed by MALDI-TOF, using CHCA as a matrix. The analysis revealed no mass signals 
corresponding to GA-guanine adducts. 
 
3.2.2.3 Brief considerations on liquid chromatography for sample preparation 
The incorporation of an ion-exchange HPLC step in the protocol for sample preparation and 
detection of DNA adducts possessed the main advantage of isolating the desired analyte (GA-
Guanine adduct) removing additional contaminations and possibly increasing sensitivity and 
resolution. However, this protocol required the addition of two desalting steps, before and after 
HPLC separation. Besides this, the HPLC technique is time-consuming and did not bring a 
significant advantage to the protocol. Considering this scenario, it was decided to employ a 
phenol:chlorophorm microextraction, followed by a size-exclusion chromatography step by using 
a NAP-5 DNA-grade column and subsequent sample concentration. Phenol:chlorophorm 
microextractions are commonly used in DNA isolation protocols and effectively remove 
contaminant proteins from solution. By using this combined approach, a contaminant-free 
solution of nucleotides may be attained, without additional treatment. The elution step was 
performed using sterile water, in order to prevent an elevated content in salt when concentrating 
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the sample. Previous experience within the research group with microextraction procedures and 
NAP-5 columns for DNA and oligonucleotide purification contributed greatly for this decision.    
 
3.3 Conclusions 
 
This chapter firstly described a simple, fast, high-throughput and inexpensive sonoreator-based 
method for DNA fragmentation. Four ultrasonic devices were compared in terms of fragmentation 
efficiency, and only the sonoreactor and the ultrasonic probe were found suitable for efficient 
DNA fragmentation. Despite this, the sonoreactor (cup horn) shows several advantages when 
compared to an ultrasonic probe: (i) allows for processing of smaller sample volumes, down to 1 
µL; (ii) prevents extensive sample overheating, reducing the degradation of analytes in solution; 
and (iii) avoids cross-contamination between samples and contamination with metal fragments 
resulting from vibration of immersed ultrasonic probes. When comparing methodologies for DNA 
fragmentation, the proposed sonoreactor approach shows some advantages when compared to 
restriction enzyme digestion, namely a larger extent of DNA fragmentation with smaller size 
dispersion is attained in less time at smaller costs.  This data was published in Larguinho et al. 
2010 (Talanta 81:881-886). 
Restriction enzyme digestion exhibits a greater control on DNA fragmentation, as it is entirely 
sequence-dependent. However, both methodologies are valuable and noteworthy tools to consider 
when preparing DNA samples. For this reason, an attempt to accelerate nuclease digestion via 
ultrasonic energy was further presented and discussed. No major differences were denoted 
between electrophoretic patterns from DNA solutions digested in the same conditions, with and 
without sonication. Also, ultrasonic amplitude did not seem to considerably affect nuclease 
digestion of DNA samples. 
The second part of this chapter consisted on an assessment of chromatographic methods for 
nucleotide separation, prior to the detection step. An ion-exchange HPLC method was evaluated 
for nucleotide profiling and separation, showing that the desired analyte (GA-modified guanine 
nucleotides) cannot be efficiently isolated, under the tested conditions. An alternative was 
presented, consisting on a microextraction and size-exclusion chromatography for contaminant 
and salt removal, followed by sample concentration The final result would be a clean, 
contaminant-free mixture of nucleotides (both modified and unmodified) ready for detection. 
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Figure 3.12. Schematic representation of the complete protocol for sample preparation. 
 
The main objective pertaining the work presented in this chapter is represented in Figure 3.12. 
The devised protocol considers all steps between the initial preparation of tissues or cell lysates, 
down to the detection. Figure 3.12 highlights the main phases of the protocol for sample 
preparation. The procedure initiates with genomic DNA isolation and purification from the target 
tissue or cell lysate. Afterwards, DNA breakdown to free nucleotides is achieved by a 2-step 
method: ultrasonic fragmentation of DNA followed by a DNase I treatment of DNA fragments in 
solution. Subsequently, a micro-extraction with phenol and chlorophorm is carried out, before the 
desalting and concentration steps. In summary, the proposed procedure for sample treatment is 
rather fast, simple and inexpensive, and generates contaminant-free free nucleotide solutions, 
suitable for subsequent MS-detection.  
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CHAPTER 4. GOLD NANOPARTICLES FOR IDENTIFICATION 
OF MODIFIED NUCLEOTIDES THROUGH MASS 
SPECTROMETRY AND COLORIMETRY 
 
Some of the results presented in this chapter have been published in Larguinho M, 
Capelo JL, Baptista PV. 2013. Fast nucleotide identification through fingerprinting using 
gold nanoparticle-based surface-assisted laser desorption/ionisation. Talanta 105:417-
421, where Miguel Larguinho was responsible for the experimental work and writing part 
of the manuscript. 
 
Some of the results presented in this chapter have been published in Larguinho M, 
Santos S, Almeida J, Baptista PV. 2014. DNA adduct identification using gold-aptamer 
nanoprobes. IET Nanobiotechnology, where Miguel Larguinho was responsible for part 
of the experimental work (choosing the probe, synthesis and characterisation of 
nanoparticles and nanoprobes, and statistics), and writing part of the manuscript. 
 
 
 
 
 
 
 
 
 
Success is a science: if you have the conditions, you get the result. 
Oscar Wilde 
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4.1 Introduction 
 
Research on biomolecular detection has greatly benefitted from the advances on 
nanotechnology, namely synthesis, characterisation and conjugation of nanomaterials, such as 
gold nanoparticles (Baptista et al. 2008). Gold nanoparticles (AuNPs) exhibit remarkable 
physico-chemical and optical properties, which allow for procedures of derivatisation with 
biomolecules (Mirkin et al. 1996) and colorimetric strategies of detection (Baptista et al. 2005a, 
2005b, Thaxton et al. 2006, Veigas et al. 2012). Different studies have described the incorporation 
of AuNPs in already existing techniques, improving sensitivity and specificity (Zhang et al. 
2011a,b, Ambrosi et al. 2010), with strong impact in diagnostics, biomedicine and other related 
fields (Jain et al. 2006, Baptista et al. 2008). In addition, AuNPs have been proposed as 
substituents of organic matrices for SALDI-MS analysis of biomolecules, and these 
methodologies using have been effectively employed for the analysis of peptides and proteins 
(McLean et al. 2005, Huang and Chang 2006, Chiang et al. 2010). SALDI-TOF analysis of 
nucleic acid molecules and nucleotides has also been proposed (Huang and Chang 2007), 
overcoming issues related to the difficulty of detection of DNA molecules using time-of-flight 
(TOF) analysers due to the high molecular weight, while allowing identification of nucleotides 
and nucleosides. Furthermore, synthesis and application of AuNP bioconjugates has been 
described for different biomolecules, such as proteins, fluorophores (Rosa et al. 2011) or aptamers 
(Chen et al. 2008, Zhang et al. 2013). 
Aptamers are short polymeric molecules (e.g. nucleic acid, peptides) that adopt a particular 
secondary structure depending on their sequence and possess the capability of binding different 
ligands, according to sequence specificity and particular chemical interactions amongst them 
(Mairal et al. 2008). Aptamer molecules are usually generated by Systematic Evolution of Ligands 
by EXponential enrichment (SELEX), a combinatorial chemistry technique which has evolved to 
select specific aptamers by affinity (Ellington and Szostak 1990, Tuerk and Gold 1990) and 
consists in the synthesis of an oligonucleotide library, subsequent mixture with the target ligand 
and separation by affinity. Production of new, specific aptamer sequences and its compilation into 
a database allows for a subsequent search and utilisation of aptamer molecules already 
characterised and described. Due to their elevated affinity towards specific ligands, aptamers have 
been widely used in biosensing protocols, either for recognition and detection (Chen et al. 2008, 
Wang and Liu 2008) or in affinity probes for ligand enrichment. Thrombin-binding aptamers 
(TBA) for instance, have been combined with different nanoparticles and widely used towards 
detection of thrombin in biological fluids (Wang et al. 2008, Zhang et al. 2012). A distinct 
aptamer, specific for ATP binding, has been functionalised to AuNPs, creating ATP-binding 
probes used both for colorimetric detection (Chen et al. 2008) and ligand enrichment (Huang and 
Chang 2007). Still on nucleotide-binding aptamers, a different ATP-binding sequence has been 
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successfully employed on a label-free fluorescence assay for ATP detection (Wang and Liu 2008) 
and, on a different study, an RNA aptamer selective for both guanine and xanthine binding has 
been characterised (Kiga et al. 1998). Despite the described aptamer-based approaches for 
nucleotide binding, so far no attempts have been made for detection of modified nucleotides, e.g. 
DNA adducts derived from nucleobase alkylation.    
One of the major objectives of this thesis is the AuNP-based detection of DNA adducts 
(modified nucleotides) as biomarkers of exposure to an alkylating agent. Perhaps the main 
complication of using DNA adducts as biomarkers of DNA damage is their low abundance in 
tissues/fluids, after exposure. This situation leads to the use of radiolabelled isotopes (Gupta 1985, 
Coldwell et al. 2008) and cumbersome, expensive protocols when detecting DNA adducts, to 
guarantee suitable and sensitive approaches. Therefore, simple, sensitive and safer novel 
approaches for detection of DNA adducts as toxicological biomarkers are necessary, to prevent 
the use of procedures that present in itself, a considerable toxicological risk (e.g. radiolabeled 
isotopes).  
With this in mind, the following chapter emphasises the use of AuNPs in two distinct based 
approaches for nucleotide identification. Firstly, matrix- and surface- assisted laser 
desorption/ionisation (MALDI/SALDI) using gold nanoparticles (AuNPs) will be evaluated as an 
approach for identification of modified and unmodified nucleotides. Subsequently, a second 
section in this chapter will describe an alternative method, based on aptamer-gold nanoprobes, 
for colorimetric identification of modified nucleotides in solution. The chosen analyte of study 
will be the DNA adduct resulting from alkylation of guanines by glycidamide (GA-Gua), upon 
biotransformation of acrylamide by the CYP monooxygenase pathway (Settels et al. 2008, 
Watzek et al. 2012), which is regarded as a biomarker of exposure to acrylamide (Carere 2006). 
These methods may be viewed as relevant contributions towards identification of DNA adducts 
in solution in a rather fast and straightforward way, allowing for a quick biomarker screening and 
subsequent correlation to other biomarkers, in the context of genetic toxicology studies. 
 
4.2 Results and discussion 
 
4.2.1 Matrix- and surface-assisted laser desorption/ionisation mass spectrometry for 
nucleotide identification 
4.2.1.1 Characterisation and selection of organic matrices 
The main advantage of MALDI is the use of an organic matrix, which aids in ionisation and 
prevents extensive fragmentation of the analyte, however for optimal analysis of different 
analytes, a suitable matrix should be chosen in each case. With this in mind, some commercially 
available matrices, namely α-cyano-4-hydroxycinnamic acid (CHCA), ferulic acid, 2’,4’,6’-
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trihydroxyacetophenone (THAP), 3-hydroxypicolinic acid (3-HPA), super-dihydroxybenzoic 
acid (Super DHB), sinapinic acid (SA), 3-(4-chloro-phenyl)-2-cyano acrylic acid (Cl-Ph-AA) and 
2-(4’-hydroxybenzeneazo) benzoic acid (HABA), were characterised via UV-Vis 
spectrophotometry and tested for its efficiency in nucleotide ionisation. Nucleotide analysis with 
MALDI-TOF is usually carried out in negative-ion mode due to the analyte affinity towards the 
formation of negative molecular ions in the gas-phase (Huang and Chang 2006). In addition, and 
despite MALDI being classified as a soft ionisation technique, there is still the risk of fragmenting 
the nucleotide during ionisation, due to its molecular structure. Results are summarised in Table 
4.1 (for more information and mass spectra, see Appendix III) and show that m/z signals 
corresponding to dGTP molecular structure, i.e. identification of dGTP molecular ion peaks, 
appeared only when CHCA or ferulic acid were mixed with the sample, whereas the remaining 
organic matrices failed to yield conclusive identification signals. Moreover, when CHCA was 
employed, more intense (relative) m/z signals were denoted in positive and negative-ion mode 
(Table 4.1). Thus, CHCA was chosen as a matrix for subsequent experimentation. 
 
 
Figure 4.1. Characterisation of the synthesised gold nanoparticles: A) Transmission electron microscopy 
(TEM) imaging - inset presenting the size distribution from counting 250 particles; B) UV-Vis spectrum of 
the dispersed gold nanoparticle solution, with a maximum absorption centred at 519 nm (grey line), and the 
same solution, in the presence of 0.1 M NaCl (black line). C) Dynamic light scattering (DLS) measurements 
to determine the hydrodynamic radius of the AuNPs (PI = 0.37±0.02; z-average = 17.7±0.1 nm), including 
the zeta-potential (ζ-potential) measurement as an indicator of colloid. D) Correlation curves obtained for 
three independent measurements of a AuNP solution by DLS. 
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Table 4.1. Summary on organic matrix characterisation 
Name Chemical structure Max Absorption dGTP mass signal 
Positive Negative 
CHCA 
 
337 nm YES YES 
Ferulic 
acid 
 
325 nm NO YES 
THAP 
 
286 nm NO NO 
3-HPA 
 
304 nm NO NO 
Super 
DHB 
 
328 nm NO NO 
Sinapinic 
acid 
 
325 nm NO NO 
Cl-Ph-
AA 
 
304 nm NO NO 
HABA 
 
361 nm NO NO 
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4.2.1.2 Characterisation of gold nanoparticles 
Synthesised AuNPs were characterised by TEM, DLS, ζ-potential and UV-Vis spectroscopy. 
TEM imaging revealed a spherical NP population following a roughly normal distribution, with 
an average diameter of 14±1.6 nm (see Figure 4.1A). The attained AuNP dispersion exhibited a 
bright red colour and a maximum plasmon band around 519 nm, which shifts to higher 
wavelengths (≈650 nm) in the presence of NaCl (Figure 4.1B).  DLS measurements showed a 
higher frequency of NPs with diameter values around 15-17 nm, with a z-average of 17.7±0.1 nm 
and a polydispersion index (PI) of 0.37±0.025 (Figure 4.1C,D). Measurement of ζ-potential 
showed a value of -66.33±2.35 mV indicated a very stable colloidal solution.  
 
 
Figure 4.2. MALDI-TOF spectra of dNTPs, using CHCA as a matrix. A-D) acquisition in positive-ion 
mode: A) matrix+dGTP; B) matrix+dATP; C) matrix+TTP; D) matrix+dCTP. E-H) acquisition in negative-
ion mode:  E) matrix+dGTP; F) matrix+dATP; G) matrix+TTP; H) matrix+dCTP; Mass signals of 
nucleobases marked with a black star (A-D). Molecular ion peaks highlighted in the mass spectra (E-H). 
Structural information on nucleobases and nucleotides is included on each spectrum. Final concentrations: 
analyte = 500 µM; matrix = 5 mg/mL. 
 
4.2.1.3 Profiling different nucleotides via MALDI and SALDI 
Profiling of diverse deoxynucleotides with CHCA matrix in both positive and negative-ion 
mode showed different ionisation patterns, revealing a variety of possible molecular 
rearrangements in the ion plume (Knochenmuss and Zenobi 2003, Knochenmuss and Zhigilei 
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2012). In positive-ion mode, m/z signals that could be attributed to different nucleobases appeared 
in lower mass regions of the spectrum (100-200 Da), and molecular ion signals from the whole 
structure were not detected (Figure 4.2A-D). However, in negative-ion mode m/z signals 
corresponding to the complete, intact structure of the nucleotides were denoted in the 450-550 Da 
range (see Figure 4.2E-H), depending on the nucleotide: 505.94 Da for dGTP; 489.89 Da for 
dATP; 480.87 Da for dTTP; 465.88 Da for dCTP. These results suggest that the analytes fragment 
during the MALDI process, i.e. the presence of a matrix is not sufficient in protecting this 
particular type of analytes from fragmentation. Furthermore, mass signals were obtained at 
relatively close m/z values to those resulting from fragmentation and rearrangement of matrix 
ions. Therefore, matrix ions constitute an important source in the analysis. 
 
 
Figure 4.3. SALDI-TOF-MS spectrum for AuNP:nucleotide mixture, acquired in negative-ion 
mode: m/z signals for gold clusters are visible, as well as an unknown intense signal at 74.21 Da. 
 
In contrast to CHCA, using AuNPs to assist in ionisation do not allow to unequivocally attribute 
an existing m/z signal to a given nucleotide when acquiring in negative-ion mode. The resulting 
spectra for any of the different dNTPs are very similar, presenting characteristic signals attributed 
to gold clusters and a high intensity peak at 74.21 Da, which cannot be associated to the 
mass/charge (m/z) ratio of any known structures that might have been present in the sample (see 
Figure 4.3). Conversely, when acquiring in positive-ion mode, specific patterns are observed for 
each of the analysed nucleotides. Figure 4.4 shows the mass spectra for different 
deoxynucleotides, when using AuNPs to assist in the ionisation process. Fig. 4.4A presents the 
mass spectrum for the AuNP solution, where the characteristic signals at 196.96 Da, 236.44 Da, 
393.93 Da and 590.89 Da attributed to gold clusters may be observed (McLean et al. 2005). When 
AuNPs are mixed with the deoxynucleotide sample, the intensity of these characteristic peaks 
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often plummets, resulting in clearer spectra, allowing identification of specific nucleobase signals 
with low background noise. This way, identification of deoxynucleotides in positive-ion mode is 
accomplished in a rather straightforward and rapid manner, as signature peaks that may mask the 
nucleotide fingerprint are removed from the spectrum. Further analysis of Fig. 4.4B–E reveals 
common m/z signals in all spectra (337.54 Da, 365.55 Da, 377.55 Da, 421.40 Da, 603.36 Da, 
631.30 Da - highlighted with a black asterisk) with variable relative intensities, which may be 
related to structural similarities between all analytes, i.e. the pentose (deoxyribose) and the 
phosphate groups. In addition to these signals, some specific signature peaks for each nucleobase 
can also be easily attributed as the related peak differs according to the analysed nucleotide (Fig. 
4.4B: 157.66 Da for guanine; C: 141.65 Da for adenine; D: 132.64 Da for thymine; E: 117.24 Da 
for cytosine). 
In the previous chapter, it was discussed how it was not possible to efficiently separate modified 
nucleotides from unmodified ones, via chromatography, during sample preparation. For this 
reason, a final, contaminant-free mixture of nucleotides was obtained, for subsequent MS 
analysis. With this in mind, and to evaluate specific nucleotide identification via fingerprinting 
using AuNP-assisted desorption/ionisation, different nucleotides were mixed in equimolar 
proportions and ionised using AuNPs - see Fig. 4.5. For each case, the specific patterns can be 
visualised (highlighted in Fig. 4.5 with black asterisks), depending on the presence of distinct 
nucleobases in the mixture (Fig. 4.5A–D). Regarding ion formation, guanine and cytosine bases 
are clearly favoured (Fig. 4.5C), as they present a considerably more intense signal. Thymine 
shows the lowest relative intensity of the analysed nucleotides (see Fig. 4.5B and D). These results 
support the association between m/z signals in the mass spectra and the presence of different 
nucleobases in the sample. Despite this association, these signals present a deviation, when in 
comparison to the molecular weights of different nucleobases. These differences are too great to 
be explained by calibration errors of the apparatus, but are too low to be considered as cation 
adducts. At present there is no data in the literature that could help clarifying the underlying reason 
for this deviation, but this might be somehow related to the AuNPs used for assisting ionisation, 
whose energy transfer to the sample may induce different ion combinations that have, thus far, 
not been characterised. 
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Figure 4.4. Gold nanoparticle based ionisation of dNTPs. The SALDI-TOF spectra of dNTPs obtained 
using AuNPs for ionisation. A) AuNPs with a final concentration of 15 nM; B) mass spectrum for dGTP; 
C) mass spectrum for dATP; D) mass spectrum for TTP; E) mass spectrum for dCTP. Black asterisks 
highlight signature peaks common to all nucleotides. Specific peaks for each nucleotide indicated with the 
mass value (Da) and structural information displayed next to the label. Final concentration of dNTPs = 500 
µM; AuNPs = 15 nM. 
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Figure 4.5. AuNP-based SALDI-TOF spectra of equimolar mixtures of dNTPs. A) dATP and dGTP; B) 
TTP and dGTP; C) dCTP and dGTP; D) dCTP and TTP; Specific peaks for each nucleotide are highlighted 
in the mass spectra with black stars and chemical information of the various nucleotides displayed next to 
it. Final concentration of dNTPs = 500 µM; AuNPs = 15 nM. 
 
4.2.1.4 Influence of concentration and pH for nucleotide detection 
Because laser desorption/ionisation is a destructive ionisation technique with some instrumental 
variability, the influence of analyte and matrix/AuNP concentration on the signal intensity was 
assessed, together with spot-to-spot variability. All MALDI-TOF and SALDI-TOF analyses were 
performed considering the most intense m/z signal in the spectrum as 100%, and the relative 
intensities of the desired signals calculated accordingly. This would provide an analysis of the 
variation of relative intensity in m/z signals corresponding to the analyte, without however 
providing any kind of information on quantification. Varying the matrix concentration has not 
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produced major alterations in relative intensity of dGTP signal, in negative-ion mode (see Figure 
4.6A), apart from variability. As for the relation between analyte concentration and relative 
intensity, it follows a hyperbolic tendency, with an initial increase and subsequent stabilisation, 
from a dGTP concentration of 100 µM on (Figure 4.6B).  
 
 
Figure 4.6. Variation of analyte and matrix concentration. A) The relative intensity of the dGTP peak is 
plotted against the dGTP concentration from data attained for the observed mass peak at 507.9 Da, in 
negative-ion mode. B) Variation of relative intensity with concentration of CHCA in the mixture. All data 
was collected from 5 independent replicates. 
 
Regarding SALDI-TOF analysis, the analyte (dGTP) concentration was varied from 0 to 250 
µM in the presence of AuNPs, and the relative intensities of the identified peak (157.66 Da) have 
been analysed. Data depicted in Figure 4.7A shows an increase in the intensity of m/z signals for 
an increasing analyte concentration up to 50 µM, where the signal intensity starts to stabilise up 
to the maximum concentration of analyte used (250 µM). The inset shows a closer look into the 
first concentrations, until 50 µM, where there appears to be a linear relation between the signal 
relative intensity and analyte concentration. This relation between relative intensity and analyte 
concentration shows that, after optimisation of the procedure and calibration of the detection set-
up, an actual quantification assay might be possible (using a standard with different isotopes). 
The 0–50 µM concentration range was chosen to further analyse glycidamide–guanine adducts. 
The influence of AuNP concentration was also evaluated. Figure 4.7B shows that 15 nM appears 
to favour both relative intensity and little variability of the mass signal. Other authors have also 
reported this concentration as being suitable for analysis of other small organic molecules via 
AuNP-based SALDI-TOF (Chiang et al. 2010). All in all, this concentration also seems to be 
suitable for nucleotide analysis. Subsequently, a rapid evaluation of the influence of pH was 
performed, as well as the differences when using buffer or water as a solvent (Figure 4.7C). Data 
in Figure 4.7C indicates that, if standard deviations are considered, there is no considerable 
variation in relative intensity according to the pH of the sample. Using water as a solvent promotes 
both elevated intensity in the analyte signals, as well as low spot-to-spot variability, similarly to 
ammonium citrate at a pH close to neutral (6 or 7). 
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Figure 4.7. Variation of different parameters and its influence on the relative intensity of the guanine m/z 
signal. A) Semi-quantification of dGTP via AuNP-SALDI: relative intensity of the signal is plotted against 
the dGTP concentration from data attained for the observed mass peak at 157.66 Da, as an indicator to the 
presence of guanine (inset highlights a linear tendency between 0 and 50 µM). B) Influence of AuNP 
concentration on spot-to-spot variability and relative intensity. C) Alterations in relative intensity according 
to variations in the pH of the mixture.  
 
4.2.1.5 Identification of DNA adducts generated in vitro 
Upon a successful identification of deoxynucleotides in positive-ion mode using AuNPs for 
ionisation, the described AuNP-SALDI approach was applied to enhance detection of a most 
relevant analyte that can be used as exposure biomarker. Glycidamide (GA) is a well-known 
alkylating agent capable of generating guanine derived DNA adducts. GA is an epoxide derived 
from acrylamide (AA) biotransformation via cytochrome P450 monoxygenase pathway. 
Genotoxicity induced by AA has been reported that has been frequently associated to the N7–
GA–Gua adduct resulting from a nucleophilic attack of GA to the guanine nitrogen centres on 
DNA molecule (Segerbäck et al. 1995, Gamboa da Costa et al. 2003, Besaratinia and Pfeifer 2004, 
Martins et al. 2007). 
In vitro alkylation reaction and sample spotting on the MALDI plate were performed as 
described in chapter 2, sections 2.4.1.3 and 2.4.4.2, respectively. Based on the GA molecular 
weight (87 Da) and previously described structures for GA–DNA adducts (Gamboa da Costa et 
al. 2003, Backman et al. 2004), the GA-Gua adduct ought to present a specific peak in the 244–
245 Da mass range (considering the guanine’s characteristic signature of 157.66 Da attained 
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beforehand plus 87 Da). Fig. 4.8 shows the obtained AuNP-based SALDI spectra for GA, in Fig. 
4.8A; dGTP, in Fig. 4.8B; and dGTP+GA, in Fig. 4.8C All spectra present a considerably intense 
mass peak at 236.44 Da, associated to AuNPs. Fig. 4.8C shows a mass peak at 244.62 Da, which 
is not present in any other sample and can be attributed to the presence of guanine adducts. A 
similar mass deviation is denoted, such as the one discussed for nucleotide identification, as GA-
Gua adducts have been analysed via MALDI-TOF with CHCA, and found to possess a m/z signal 
of 239.97 Da (see Figure 4.6). No formation of sodium cationic species was observed when 
AuNPs were used, in contrast to what happened with CHCA (Figure 4.9). Fig. 4.8D reveals a 
linear trend within the 0–50 mM concentration range for dGTP+GA. The proposed AuNP-based 
SALDI approach allows identification of GA-Gua adducts through fingerprinting down to 5 µM, 
which corresponds to 5 pmol on the MALDI plate. However, this concentration may not 
correspond to the actual GA–Gua adduct final concentration as this is directly related to the 
alkylation reaction yield. 
 
 
Figure 4.8. AuNP-SALDI-TOF for identification nucleotide adducts. AuNPs based SALDI approach was 
used to identify a glycidamide-guanine DNA adduct. Mass spectra attained within the considered mass 
range for A) AuNPs and glycidamide; B) AuNPs and dGTP; C) AuNPs and dGTP, previously reacted with 
glycidamide. A specific signature peak only observed in spectrum C, at 244.62 Da associated to the 
presence of GA-Gua DNA adduct. D) Plot of relative intensity vs. analyte concentration for the observed 
mass peak at 244.62 Da. 
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Figure 4.9. MALDI-TOF analysis of a previously reacted mixture of GA and dGTP, using CHCA as a 
matrix. A specific signal corresponding to a GA-guanine adduct can be denoted. Structural information on 
the GA-Gua adduct is also depicted on the spectrum.   
 
4.2.1.6 Identification of DNA adducts as biomarkers in biological samples 
The proposed AuNP-SALDI approach was applied to detection of glycidamide-DNA adducts 
in biological samples from goldfish hepatopancreas. Carassius auratus (goldfish) individuals 
were exposed to 150 mg/L of acrylamide in water during 96 hours, then euthanised and the organs 
removed for further testing, as indicated in chapter 2, section 2.4.5.4. Hepatopancreas samples 
were treated as previously described in chapter 3 and subsequently spotted in a stainless steel 
plate with CHCA (for MALDI) or AuNPs (for SALDI). MALDI-TOF with CHCA allowed the 
identification of a m/z signal at 239.97 Da, with a S/N of 103, which may correspond to a GA-
guanine DNA adduct (marked with a black star in Figure 4.10A). No combinations with cations 
or other molecular rearrangements that may have occurred after ionisation were observed. The 
identified m/z signal does not appear in mass spectra from control samples (Figure 4.10B), i.e. 
individuals not exposed to acrylamide, so it must identify a by-product from acrylamide 
metabolisation or cellular damage. In contrast, no similar m/z signals have been observed when 
AuNPs were employed for SALDI-TOF analysis (Figure 4.10C). These results seem to indicate 
that the AuNP-based SALDI-TOF approach for analysis of modified nucleotides does not yield 
comparable results to MALDI-TOF, when employing an adequate organic matrix, e.g. CHCA.    
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Figure 4.10. MS analysis of a previously treated DNA sample: A) MALDI-TOF analysis of a sample from 
goldfish, previously exposed to 150 mg/L acrylamide; B) MALDI-TOF analysis of a sample from control 
goldfish, not exposed to acrylamide; C) AuNP-SALDI-TOF analysis of a sample from goldfish, previously 
exposed to 150 mg/L acrylamide. Black star marks the molecular ion signal for a DNA adduct (structural 
information included). 
 
4.2.2 Colorimetric detection of modified nucleotides using aptamer-gold nanoprobes 
 
4.2.2.1 Characterisation of gold nanoparticles 
Characterisation of synthesised gold nanoparticles is equivalent to that depicted in Figure 4.1. 
Synthesis yielded spherical AuNPs with an average diameter of 14 nm. The NP population 
followed a normal distribution, with a maximum absorption band centred at 519 nm. For 
additional information, please refer to section 4.2.1.2 and Figure 4.1 in this chapter. 
 
4.2.2.2 Stability of synthesised nanoprobes  
Functionalisation with the DNA aptamers causes the plasmon band to shift 6 nm to the right 
(maximum absorption at 525 nm) – see spectral profiles of disperse and aggregated nanoprobes 
in Figure 4.11A,B. Au-aptamer nanoprobe stability against increasing MgCl2 concentrations was 
assessed and the areas under the curve (AUC500-550/AUC580-630) were used as an analytical tool to 
evaluate nanoprobe stability (see progressive de-stabilisation in Figure 4.11C,D). XBA-
nanoprobe de-stabilisation is observed for MgCl2 concentrations above 50 mM (Figure 4.11A,C). 
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Contrastingly, His-945 nanoprobe shows a more elevated stability, up to a concentration on 90 
mM of MgCl2 (Figure 4.11B,D). To ensure maximum efficiency and discrimination in the 
subsequent detection assays, the chosen MgCl2 concentrations for the XBA and His-945 
nanoprobes were 60 and 100 mM, respectively. 
Afterwards, the Au-aptamer nanoprobe behaviour in the presence of dNTPs was assessed. The 
presence of dNTPs appears to differently influence nanoprobe stabilisation as different tendencies 
can be denoted for both nanoprobes. In the presence of different dNTPs, the AUC ratio of XBA-
nanoprobe increases progressively with purine nucleotide (dATP and dGTP) concentration, 
whereas pyrimidines do not appear to efficiently stabilise the nanoprobe (Figure 4.12A). On the 
other hand, His-945 nanoprobe does not appear to efficiently stabilise with increasing dNTP 
concentration, regardless of the nucleotide (Figure 4.12B), and exhibits increased variability than 
XBA nanoprobe. From this test, the different specificity from each aptamer towards nucleotides 
can clearly be denoted. The XBA-aptamer has been described for specific binding of guanine and 
xanthine (Kiga et al. 1998), and according to this result, purine nucleotides better succeed in 
stabilising the XBA-nanoprobe, so it would appear that a ligand with a higher affinity stabilises 
the Au-nanoprobe against salt-induced aggregation. 
 
 
Figure 4.11. Gold-aptamer nanoprobe stability against salt-induced aggregation. Spectral profiles of 
disperse and aggregated nanoprobes for A) XBA-nanoprobe, and B) His-945 nanoprobe. Progressive de-
stabilisation with increasing MgCl2 concentration for C) XBA-nanoprobe, threshold set at 60 mM MgCl2; 
and D) His-945 nanoprobe, threshold set at 100 mM MgCl2. 
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Figure 4.12. Detection assay for different dNTPs with: A) the XBA-nanoprobe, with a final MgCl2 
concentration of 60 mM; B) His-945 nanoprobe, with a final MgCl2 concentration of 100 mM. Presented 
values and error bars correspond to average ± SD. 
 
4.2.2.3 Colorimetric detection of glycidamide-guanine adducts 
Both nanoprobes were evaluated for its capability to efficiently discriminate GA-alkylated 
guanines from GA and dGTP. A discrimination assay between dGTP, GA and modified guanine 
(GA-Gua adduct) is highlighted in Figure 4.13A, where both the AUC ratio and the spectral 
behaviour are shown. Regarding the spectra, in both dGTP and GA assays a plasmon shift occurs 
to higher wavelengths (~600 nm) which translates into Au-nanoprobe de-stabilisation and 
subsequent aggregation, whereas in the presence of GA-Gua adduct, the maximum plasmon band 
remains at 525 nm indicating higher stabilisation against ionic strength. The presence of an 
analyte with affinity is believed to bind the aptamer, inducing the formation of a secondary 
structure that increases Au-nanoprobe stabilisation against salt-induced aggregation. Rising 
concentrations of these analytes were tested and verified both spectral behaviour and AUC ratio.  
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Figure 4.13. Detection of glycidamide-guanine adducts using gold-aptamer nanoprobes. A) Discrimination 
of glycidamide-guanine adducts by AUC analysis (left) and spectral behaviour (right) in a final nucleotide 
concentration of 67 µM. Areas under the curve (AUC) for B) the XBA-nanoprobe and C) the His-945 
nanoprobe, in the presence of the three different analytes. AUC values and error bars correspond to average 
± SD. *** highlight statistical significant differences (p < 0.001). Square brackets indicate comparisons 
between the three different conditions (GA, dGTP and GA-Gua adduct). Curly brackets indicate 
comparison between two conditions. 
 
Results in Figure 4.13B present similar AUC ratios for increasing concentration of GA, which 
means the nanoprobe stability is not altered, for the tested concentrations. Rising concentration 
of guanine nucleotides however, both unmodified and alkylated, progressively stabilise the XBA-
nanoprobe against salt-induced aggregation. Nevertheless, for all tested concentrations, the AUC 
ratio is considerably higher in the case of the latter, which allows the identification of modified 
guanines in a dGTP:adduct mixture, for guanine concentrations higher than 33 µM. Multiple 
comparisons using the Tukey’s HSD test found significant differences (p < 0.001) between all 
AUC ratio mean values, at concentrations of 33 and 100 µM (square brackets and asterisks in 
Figure 4.13B). At a superior concentration, no significant differences were found between dGTP 
and GA-Gua adduct (p > 0.05), however both significantly differ from GA (p < 0.001) – curly 
brackets in Figure 4.13B. Regarding the His-945 nanoprobe, throughout the studied 
concentrations, the AUC ratio is slightly more elevated than both dGTP and GA, however with 
similar values, none of them reaching the threshold value of 1 (Figure 4.13C). For the His-945 
probe, no significant differences were found between the obtained values of AUC (p > 0.05). This 
indicates that the His-945 nanoprobe is not efficiently stabilised against salt-induced aggregation, 
which may indicate this sequence possesses reduced affinity for the tested analytes. 
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4.2.2.4 Identification of DNA adducts in solution 
Considering the previously obtained results where the XBA-nanoprobe seems to efficiently 
identify alkylated guanines, this nanoprobe was tested with rising concentrations of both alkylated 
and unmodified genomic DNA. Both samples were heated to 95 °C to ensure complete release of 
the alkylated guanines from the DNA chain. Increasing concentrations of genomic DNA increase 
the AUC ratio i.e. progressively stabilise the nanoprobe against aggregation. The values for AUC 
ratio are very similar and only from 150 µg/mL differences can be denoted, although both values 
remain above the threshold (Figure 4.14), and a clear discrimination between treated and untreated 
genomic DNA is more troublesome to attain. This is in accordance with statistical analysis, which 
found no significant differences (p > 0.05) between the mean values of AUC ratios, for 
colorimetric detection in genomic DNA. These differences are possibly related to fewer DNA 
adducts being generated in vitro when GA is reacted with genomic DNA, rather than dGTP alone. 
Moreover, the sample complexity is considerably higher than before, when only dGTP was 
present as a monomer, instead of all four nucleotides as a polymer chain. 
 
Figure 4.14. DNA adduct detection assay with XBA-nanoprobe. Below 150 µg/mL genomic DNA, no 
differences are denoted; final MgCl2 concentration = 60 mM. AC values and error bars correspond to 
average ± SD. 
 
4.3 Conclusions 
 
The first section of this chapter described a rapid and easy methodology for identification of 
deoxynucleotides through specific nucleotide fingerprint by using gold nanoparticles for SALDI-
TOF-MS. The use of gold nanoparticles greatly contributes to lower background noise generally 
associated with fragmentation of organic matrices used in MALDI-TOF analysis of molecules in 
the low mass range (<600 Da). However, MALDI-TOF using CHCA as a matrix has proved more 
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flexible, as it can identify nucleotides in both positive and negative-ion mode. The AuNP-SALDI 
approach was subsequently applied to the successful identification of a biologically relevant DNA 
adduct resulting from glycidamide alkylation of guanine. In vivo formation of glycidamide-
alkylated guanines may be regarded as a biomarker of acrylamide-induced genotoxicity, and its 
detection is therefore of paramount importance for toxicity studies. However, the proposed 
concept was not enough to ensure an efficient detection of DNA adducts in biological samples 
from individuals exposed to acrylamide possibly due to a low abundance of DNA adducts being 
generated in vivo. To increase the probability of a successful identification, further work before 
detection is required, namely the development of optimal preparation strategies including 
isolation of the DNA adduct in study. MALDI-TOF with CHCA, on the other hand produced a 
low intensity signal, albeit with very good S/N, accounting for identification of glycidamide-
guanine DNA adducts in biological samples. All data considered it would appear that, in terms of 
sensitivity, AuNP-SALDI-TOF still does not yield comparable results to MALDI-TOF with a 
suitable organic matrix. This data was published in Larguinho et al. 2013 (Talanta 105:417-421).    
In the second section of this chapter, a colorimetric detection assay using Au-aptamer 
nanoprobes for the detection of modified nucleotides was shown. This approach was inspired on 
the non-cross-linking hybridisation system developed by Baptista et al. (2005) and optimised for 
discrimination of nucleotide sequences and point mutations (Doria et al. 2007, Doria 2010; Conde 
et al. 2010). The reported concept was employed to identify glycidamide-alkylated guanines, 
firstly in a nucleotide solution, with statistical significance (p < 0.001), and afterwards in a 
genomic DNA sample. This methodology may reveal itself very valuable for its capability to 
detect DNA adducts in solution in a rather fast, simple and inexpensive way, with results as 
rewarding as currently used techniques. However, there is still the need for future studies on 
quantification capability together with characterisation of the limit of detection when using real 
biological samples. This data was published in Larguinho et al. 2014 (IET Nanobiotechnology). 
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CHAPTER 5. ALTERATIONS TO AQUATIC ORGANISMS 
INDUCED BY ACUTE AND CHRONIC EXPOSURE TO 
ACRYLAMIDE 
 
Some of the results presented in this chapter have been published in Larguinho M, Costa PM, 
Sousa G, Costa MH, Diniz MS, Baptista PV. 2014. Histopathological findings on Carassius 
auratus hepatopancreas upon exposure to acrylamide: correlation with genotoxicity and 
metabolic alterations. Journal of Applied Toxicology, 34:1293-302, where Miguel Larguinho was 
responsible for the part of the experimental work (exposure assay, effect concentrations, comet-
assay and phase I/phase II biomarkers), and writing part of the manuscript. 
 
Some of the results presented in this chapter have been published in Larguinho M, Cordeiro A, 
Diniz MS, Costa PM, Baptista PV. 2014. Metabolic and histopathological alterations in the 
marine bivalve Mytilus galloprovincialis induced by chronic exposure to acrylamide, 
Environmental Research, 135:55-62, where Miguel Larguinho was responsible for part of the 
experimental work (exposure assays, effect concentrations, oxidative stress biomarkers and part 
of the histology), and writing part of the manuscript. 
 
 
 
 
 
 
 
 
If you only read the books that everyone else is reading, you can only think what 
everyone else is thinking. 
Haruki Murakami 
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5.1 Introduction 
 
In order to fully understand the toxicological challenge pertaining a specific toxicant, it is 
paramount to possess a well characterised biological model of exposure. The previous chapter 
addressed the detection of DNA adducts as biomarkers of exposure to acrylamide. Apart from 
adducts generated in vitro, it was necessary to test the AuNP-based methods in biological samples 
from individuals previously exposed to acrylamide. With this in mind, this chapter describes 
toxicity studies in biological organisms, to establish a model of exposure to acrylamide in water. 
Exposure assays will be carried out to evaluate molecular and cellular consequences in aquatic 
organisms, triggered after acute or chronic exposure to waterborne acrylamide, to mimetise a “real 
exposure” and its consequences. 
Acrylamide is widely used for the production of polyacrylamide (co)polymers for agricultural 
applications (Myagchenkov and Kurenkov 1991) and water treatment processes (Bajdur 2008). 
The presence of acrylamide in water courses, mainly freshwater, is somewhat inevitable, in part 
due to the degradation chemistry of polyacrylamide polymers to acrylamide monomers, but also 
due the proximity of agricultural crop fields or manufacturing plants to freshwater systems. In 
brackish or seawater, however it is more ecologically relevant to assess the prolonged effects of 
exposure to low acrylamide concentrations, since it is very difficult to reach elevated toxic 
concentrations in marine ecosystems due to its wide surface area and depth. The environmental 
risk associated with the presence of acrylamide in water ecosystems has led to the work here 
presented.  
Due to their ecological and biological relevance, two different models of study will be used. The 
first section addresses the effects of acrylamide to a teleost freshwater fish (Carassius auratus), 
commonly known as goldfish. The second section will address the putative chronic effects of 
acrylamide in aquatic wildlife, using a marine bivalve (Mytilus galloprovincialis), commonly 
known as Mediterranean mussel, as a model. For a more clear comprehension and cohesive 
discussion integrating all obtained data, each of the sections in the following chapter is divided 
into separate Results and Discussion sections.  
 
5.2 Acute toxicity of waterborne acrylamide to goldfish 
 
Teleosts constitute almost 50% of the subphylum Vertebrata, comprising an immense variety of 
habitats and possess several advantages towards the research of toxicological issues such as 
relatively short life cycles, high reproduction rate, rather easy manipulation and low cost 
maintenance, which renders these organisms as appealing surrogates for higher-order vertebrates, 
such as mammals (reviewed in Bolis et al. 2001). In addition, these fish present biological 
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similarity with higher vertebrates, including the ability to metabolise xenobiotics and 
bioaccumulate toxicants and their by-products (Bolis et al. 2001, van der Oost et al. 2003). 
Carassius sp. in particular have been used for a multitude of studies concerning toxicity effects 
(Diniz et al. 2009, Cavas 2011, Kubrak et al. 2012) including exposure to different pollutants in 
water, e.g. heavy metal ions. This first section shall evaluate the effects of acrylamide at several 
levels of biological organisation and try to establish a vertebrate biological model of study for 
acrylamide deleterious effects. Particularly, the extent of genotoxic and mutagenic effects of 
acrylamide will be evaluated, and its correlation to deployment of biochemical defences that are 
recognised mechanisms for other organic toxicants (c.a. CYP1A and glutathione S-transferases). 
In addition, a qualitative histopathological analysis in liver and pancreatic tissues will also be 
subject of study. 
 
5.2.1 Results 
5.2.1.1 Mortality 
The determined LC50 for acrylamide in water was estimated as 119.5 mg/L as shown in Figure 
5.1. The highest tested concentration of acrylamide (200 mg/L) resulted in a mortality index of 
100 % (see Table 5.1).  
 
Table 5.1. Mortality rate for the control group and each tested acrylamide concentration (Conc.). 
Conc. (mg/L) Control 50 100 150 200 
Individuals 8 8 8 8 8 
Total Dead 0 1 1 5 8 
Mortality (%) 0 12.5 12.5 62.5 100 
 
 
Figure 5.1. Fitted dose-response curve obtained for goldfish 96-hour exposure to acrylamide. Estimated 
LC50 = 119.5 mg/L.  
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5.2.1.2 Genotoxicity assessment  
Fig. 5.2 illustrates representative examples of erythrocytic nuclei, from normal-shaped (Fig. 
5.2A) to distinct classes of ENAs (Figs. 5.2B to 5.2I). Lobed nuclei (Fig. 5.2B) and nuclear buds 
(Fig. 5.2E) were the most frequently observed abnormalities. Fig. 5.3A summarises the average 
frequency of ENA-exhibiting cells observed for each acrylamide test. The control group shows 
an ENA frequency of 4.09±0.39%, which tends to increase significantly - Mann-Whitney U (p < 
0.05) - with acrylamide concentration, reaching a value of 17.14±0.93% for the highest tested 
concentration (150 mg/L).  
 
 
Figure 5.2. Reference images for the observed erythrocytes and alterations. A) mature goldfish 
erythrocytes; B) bilobed (fragmenting) nucleus; C,D) budding nuclei; E-G) nuclear buds, towards formation 
of a micronucleus; H) erythrocyte exhibiting evidenced micronuclei (highlighted with a white arrow); I) 
polynucleated cell (full fragmentation) exhibiting micronuclei. 
 
Peripheral blood cell comets were assigned to five different classes, according to the % of DNA 
in tail: class I - 0 to 20% DNA, class II - 20 to 40%, class III - 40 to 60%, class IV - 60 to 80% 
and class V - 80 to 100% (Fig. 5.4). No comets were found belonging to class V in any 
experimental condition. The control group shows an average 32.35±10.68% of DNA in tail (Fig. 
5.3B) that tends to increase with acrylamide concentration. The most significant increase, 
comparative to control, was observed in fish exposed to 150 mg/L, where the average value of 
DNA percentage in tail reached 59.61±9.23% (Fig. 5.3B). Significant positive correlations (p < 
0.01) were found between acrylamide concentration and both ENA frequency and DNA-strand 
breakage (R = 0.961 and 0.636 respectively), and between individual ENA frequencies and total 
DNA-strand breakage (R = 0.676) – see Table 5.2, extrapolated from the % of DNA in the 
nucleoids’ tail.  
 
5.2.1.3 CYP1A induction 
Figure 5.3C shows a progressive increase in hepatic CYP1A according to the different 
acrylamide concentrations. Data show a similar behaviour to that of the Comet assay, i.e. a dose-
dependent increase is observed, steeper towards exposure to 150 mg/L acrylamide, where the 
 
 
122 
 
induction of CYP1A reached 1.67-fold in comparison to control (Fig. 5.3C). CYP1A induction 
yielded significant, positive correlations (p < 0.01) with ENA frequency, total DNA strand 
breakage and acrylamide concentrations (R = 0.745, 0.670 and 0.678, respectively) – Table 5.2. 
 
 
Figure 5.3. Average biomarker responses and effects (±SE). A) Observed ENA frequencies (Kruskal-
Wallis H = 22.15, p < 0.01); B) DNA strand-breakage assessed from the % DNA in tail (Kruskal-Wallis H 
= 10.44, p < 0.02); C) Induction of CYP 1A [-fold increase, relatively to the control group] (Kruskal-Wallis 
H = 11.21, p < 0.02); D) Assessment of GST activity (Kruskall-Wallis H = 13.75, p < 0.01). Different 
letters indicate pairwise significant differences detected using the Mann-Whitney U test for post-hoc 
comparisons (p < 0.05). 
 
5.2.1.4 Glutathione S-transferase activity 
A significant increase in hepatic GST activity when comparing acrylamide exposed and controls 
was detected [Mann-Whitney U test (p < 0.05)], even though no differences were detected 
between different concentrations of exposure (Fig. 5.3D). Significant differences were only 
denoted when comparing the control group with different exposure concentrations. Significant 
positive correlations (p < 0.01) were found between GST activity and acrylamide concentration 
(R = 0.859), ENA frequency (R = 0.791) and DNA-strand breakage (R = 0.739) – Table 5.2. 
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Figure 5.4. Representative images observed for each class in comet-assay, scored after exposure to 150 
mg/L of acrylamide in water. I) <20% DNA in tail; II) 21-40% DNA in tail; III) 41-60% DNA in tail; IV) 
61-80% DNA in tail. 
 
Table 5.2. Values for the correlation established between biomarker response and acrylamide 
concentrations, using Spearman rank-order correlation R with Bonferroni correction. (Conc: Acrylamide 
concentration; DNA-SB: DNA strand-breakage; ENA: erythrocytic nuclear abnormalities; CYP: Induction 
of CYP 1A; GST: glutathione S-transferase activity). Bold values denote significant correlations (p < 0.01). 
 Conc DNA-SB ENA CYP GST 
Conc 1.000 0.636 0.961 0.678 0.859 
DNA-SB 0.636 1.000 0.676 0.670 0.739 
ENA 0.961 0.676 1.000 0.745 0.791 
CYP 0.678 0.670 0.745 1.000 0.528 
GST 0.859 0.739 0.791 0.528 1.000 
 
5.2.1.5 Liver histopathology 
Control animals presented the typical/normal structure of the hepatic parenchyma (Fig. 5.5A), 
consisting of polygonal regular-sized hepatocytes containing a central spherical nucleus, densely 
packed around sinusoids, with pancreatic tissue intrusions thus forming a hepatopancreas 
(Takashima and Hibya 1995, Akiyoshi and Inoue 2004).  
Fish exposed to 50 mg/L acrylamide yielded no distinctive lesions and alterations to tissue, 
however, the pancreatic acini were considerably affected, consistent with chronic pancreatitis, 
exhibiting acinar cell necrosis and diffuse intrusion of macrophages containing irregular-sized 
bodies of lipofuscin-like pigments, which should indicate a response to increased cell death likely 
apoptosis (Fig. 5.5B). Affected acinar cells also revealed pronounced decolouration, likely due to 
a reduction in zymogen granules and endoplasmic reticula.  
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The same degree of pancreatic alterations occurred in animals exposed to 100 and 150 mg/L 
acrylamide. Additionally, significant hepatic tissue alterations occurred from 100 mg/L onwards, 
mostly comprising of diffuse eosinophilic hepatocellular alteration, a histopathological trait often 
regarded as pre-neoplastic (e.g. Vethaak and Wester 1996), with evidence of focal cell death and 
intrusion of macrophages but scant or absent hyperaemia (Fig. 5.5C). Nuclear morphological 
alterations (pleomorphisms) like pyknosis were observed focally, albeit infrequently. Evidence 
of pancreatic disease persisted at higher concentrations of exposure, still with an unclear dose-
effect relationship (Fig. 5.5D). Animals exposed to the highest concentration of acrylamide (150 
mg/L) also endured diffuse eosinophilic hepatocellular alteration but the inflammatory response 
was more evident than in the previous treatments, even though not diffuse (Fig. 5.5E). 
Additionally, hepatocytes revealed degeneration, either lipidic or eosinophilic, the latter 
consisting of intraplasmatic reddish inclusions, presumably caused by an accumulation of actin 
or its degradation products, similar in aspect (but not size) to the Mallory-Denk bodies found in 
mammalian hepatocytes (Strnad et al. 2008, Costa et al. 2009, 2011). Pancreatic intrusions into 
the hepatic parenchyma were seemingly reduced in size and number and the remaining acini were 
severely altered, as previous, evidencing also considerable intrusion by macrophages and focal 
cell death (Fig. 5.5F). 
 
5.2.2 Discussion 
The present study showed that a freshwater fish, although able to deploy biochemical defences 
towards waterborne acrylamide-induced challenge (namely boosting CYP1A biosynthesis and 
GST activity), is still susceptible to severe deleterious effects in the liver and, moreover, in 
pancreatic acini. Still, the histopathological appraisal failed to reveal endpoints consistent with a 
general systemic failure (e.g. acute inflammation in the hepatopancreas), indicating that the 
substance is in fact primarily toxic to pancreatic cells and that the organ failure may be the critical 
factor involved in acrylamide-induced mortality.  
In order to ensure that acrylamide degradation in water would not condition this study, existing 
reports on the subject were analysed. The biotic and abiotic degradation of the acrylamide 
monomer in aquatic environments has previously been addressed: Brown et al. (1980a) have 
studied this subject and concluded that abiotic factors such as hydrolysis or photolysis are 
negligible, upon verifying the absence of acrylamide degradation in sterilised water after 2000 
hours. Microorganism-derived degradation however was verified after 15 days in non-sterilised 
river water, up to an acrylamide concentration of 2 mg/L, according to the OECD 301D “Ready 
Biodegradability Closed Bottle Test” (United States Testing Company Inc. 1991). Concentrations 
above this threshold (comparable to the ones used in our work) were deemed too toxic for 
microorganisms, thus leading to the assumption that biodegradation should not be a confounding 
factor for this study.  
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Acrylamide lethality thresholds have been surveyed in several freshwater vertebrates and 
invertebrates. The LC50 (96 h) determined for freshwater fish ranged between 100 mg/L (bluegill), 
110 mg/L (rainbow trout) and 120 mg/L (fathead minnow) (Krautter et al. 1986; Walker 1991; 
Weston et al. 2009). 
 
 
Figure 5.5. Example micrographs of tested C. auratus liver (Bouin-Hollande’s, H&E). A) Normal liver 
architecture from control fish. Hepatocytes (hp) are regular in size, roughly polyhedric in shape and are 
arranged into a compact parenchyma with few sinusoids (sn). Pancreatic acini (an) intrude into the 
parenchyma, each comprised of reticulate, highly basophilic cells (i.e. with high affinity to haematoxylin), 
indicating a highly active cytoplasm with a dense rough endoplasmatic reticulum. Inset: detail of normal 
hepatic (hp) and acinar (an) cells. B) Severe atrophy of pancreatic acini in a fish exposed to 50 mg/L 
acrylamide. The acinus reveals focal necrosis (fn) and diffuse intrusion of macrophages containing 
lipofuscin-like material, brownish-yellow in colour (inset). Normal acinar cells are almost absent from the 
samples whereas the hepatic parenchyma appears to be essentially unaltered. C) Liver of a fish exposed to 
100 mg/L acrylamide, revealing alterations to pancreatic acini located in an area of hepatocellular alteration 
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consisting of enlarged, slightly eosinophilic cells that lost the common polyhedric shape (ah). Fact vacuoles 
(potentially) are also present (fv), as well as (melano)macrophages containing lipofuscin-like granules (lp) 
in small foci of necrotic tissue. Inset: a hepatocyte of the same specimen undergoing early-stage apoptosis 
aside a macrophage containing lipofuscin-like substances. The cell’s dense, highly basophilic nucleus 
reveals the typical “blebbing” of apoptosis (arrow). D) Same as previous, at high-power magnification, 
highlighting the altered pancreatic acini between altered hepatocytes (ah). Note the lipofuscin-containing 
bodies, likely inside macrophages (lp) and the vacuoles inside acinar cells containing undifferentiated 
cellular debris (vc). The blood vessel connecting the acini is engorged by erythrocytes (er), confirming 
local inflammatory processes, together with macrophage intrusion. E) Hepatocellular and inflammation-
related changes in the liver of a fish exposed to 150 mg/L acrylamide. The hepatic parenchyma is almost 
entirely formed by eosinophilic cells, occasionally presenting lipofuscin-containing bodies (lp) and 
eosinophilic bodies (eb). There are no evident signs of necrosis; however focal hyperaemia denounces 
inflammation (arrows). F) Same as previous, showing altered pancreatic acini (an) adjacent to a congested 
a branch of the hepatic portal vein (pv). Inset: detail of melanomacrophages containing pigment (melanin- 
or lipofuscin-like) vesicles (pg) near a bile duct (bd). Scale bars: 25 µm. 
 
Therefore, the 96-hour LC50 hereby estimated for C. auratus (119.5 mg/L) is consistent with 
previous findings. However, information regarding the lesions elicited by exposure to aquatic 
animals is essentially absent. The present study revealed that sub-lethal exposures to acrylamide 
in C. auratus are genotoxic and toxic to both liver and pancreas, in an apparent dose-dependent 
disposition, however clearly more severe to the pancreatic acini at all concentrations, which 
combined with the residual mortality occurring at the lowest concentration of exposure (50 mg/L), 
likely indicates a specific toxicological mechanism rather than a general physiological failure. 
Furthermore, both CYP1A and GST activity induction were correlated to acrylamide 
concentrations in water both the genotoxicity biomarkers. Altogether, these findings suggest that 
responses are triggered, albeit insufficient to avoid direct tissue- and organ-level damage to the 
surveyed organs.  
Genotoxicity analysis revealed a similar trend between clastogenesis (given by the frequency of 
ENA) and total DNA-strand breakage (derives from the Comet assay), meaning a dose-dependent 
increase with rising concentrations of waterborne acrylamide (Figs. 5.3A and 5.3B). Additionally, 
the two effects were linked, and correlated to CYP1A induction which should mean a similar 
pattern between in vivo metabolism of acrylamide and in vivo metabolism of other CYP-activated 
xenobiotics such as polycyclic aromatic hydrocarbons (PAHs) and dioxins. These xenobiotics, 
when bioactivated via CYP1A produce highly genotoxic compounds and reactive oxygen species 
(ROS) as by–products, equally genotoxic. Although both the Comet assay and ENA analysis have 
extensively been used in fish to assess genotoxicity of single or combined toxicants (Lee and 
Steinert 2003, Costa et al. 2008, Cavas 2011), few studies have been designed to understand the 
mechanisms of acrylamide-induced genotoxicity on these organisms. Much work made on 
acrylamide genotoxicity in vertebrates (i.e., rats, mice and humans) focuses on its 
biotransformation to glycidamide and establishes a comparison between effects caused by the two 
molecules at equivalent concentrations (e.g. Martins et al. 2007). For instance, El-Assouli (2009) 
demonstrated, through the Comet assay performed on rat leukocytes, that oral administration of 
acrylamide increased DNA damage. The same study also showed that in vitro incubation with 
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acrylamide does not result in increased DNA damage, which supports the fact that acrylamide per 
se has low reactivity to DNA, prior to CYP bioactivation. Several other Comet assay experiments 
have also revealed dose-dependent DNA damage in different tissues (e.g. liver, leukocytes, 
spleen) from mice and rats (Dobrzynśka 2007, El-Bohi et al. 2011), with more extensive damage 
in mice. According to Lee and Steinert (2003), chemicals associated with DNA damage in fish 
may be grouped in four classes: genotoxicants acting directly on DNA, chemicals whose 
metabolites alkylate DNA; substances that increase production of ROS; chemicals that inhibit 
DNA repair systems and substances that induce DNA damage by multiple mechanisms, which 
could be the case of acrylamide, as suspected from the occurrence of dose-dependent CYP1A 
induction. Additionally, the present findings show a significant increase in GST activity in liver 
cells at higher acrylamide concentrations (Fig. 5.3D) and a positive significant correlation 
between DNA strand breakage and GST activity. This enzyme, in fish inclusively, plays a major 
role as an antioxidant, involved in the detoxification of ROS and hydrophilic toxicants, e.g. CYP-
activated hydrophobic substances, by conjugating them with reduced glutathione (see Salinas and 
Wong 1999, Schlenk et al. 2008). In fact, different reports have suggested that acrylamide may 
potentiate intracellular ROS production (Yousef and El-Demerdash 2006) with genotoxic 
consequences, increased GST activity as response and with subsequent depletion of the free 
radical scavenger glutathione (Awad et al. 1998, Jiang et al. 2007). Studies with human 
lymphocytes have also shown that acrylamide-derived DNA damage may arise from increased 
free radicals in the cell and that, in addition, acrylamide may interfere with the DNA repair process 
(Blasiak et al. 2004). It is thus possible that acrylamide induces CYP1A, which in turn metabolises 
acrylamide to glycidamide (leading to the formation of DNA adducts, being directly genotoxic) 
with ROS as by-products. Ultimately it may boost GST, whose transcription is Keap1-mediated 
and therefore dependent of intracellular ROS (see Kobayashi and Yamamoto 2005) activity, 
impairing DNA repair. Research on this specific mechanism is still lacking. In addition, there is 
yet the need to provide conclusive evidence that (or which) CYP isoforms are able to metabolise 
acrylamide in fish. Still, caution is mandatory here, since CYP1A in fish is known to be induced 
by several classes of environmental toxicants (Haasch et al. 1992, Bucheli and Font 1995, Buhler 
and Wang-Buhler 1998, Oh et al. 2009), including non CYP-activatable (e.g. Diniz et al. 2009, 
Olsvik et al. 2011).  
Besides DNA-strand breakage, it has been verified that ENA frequencies increase with 
acrylamide concentrations, and a positive correlation has been found between the two effects, 
even though the two biomarkers reflect different levels of damage to the DNA molecule. 
Acrylamide has already been described to be clastogenic and mutagenic to animals (Friedman 
2003) and to arrest the mitotic cycle in human HT 1080 cells (Sickles et al. 1995). This is 
confirmed by evidence that acrylamide directly binds to neurofilaments and cytoskeletal proteins, 
namely microtubule-associated proteins (Lapadula et al. 1989) and inhibits kinesin proteins 
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preventing microtubule binding and disassembly (Sickles et al. 2007). These interactions may 
lead to deficiencies in the formation of the mitotic spindle, which would in turn result in increased 
nuclear abnormalities. In point of fact, it has been shown that acrylamide increases chromatid 
gaps and chromatid breaks in mammalian cells (Martins et al. 2007). Also, Jiang et al. (2007) 
verified increased micronuclei frequency in human HepG2 cells treated with acrylamide, which 
is in concordance with the current results. Given the similarity between phases I and II responses 
following exposure to acrylamide and potentially carcinogenic environmental toxicants (e.g. 
some PAHs), it is probable that pro-mutagenic effects of acrylamide in fish, as shown for murine 
models (see Besaratinia and Pfeifer 2007), are likely to occur.  
There is no information on hepatic or pancreatic histopathological lesions caused by acrylamide. 
However, both organs are well known to be involved in the storage and detoxification of 
xenobiotics. Although pancreatic toxicity is much less studied than the liver, in mammals chronic 
or acute pancreatitis (as observed in the present study) is long known to occur by action of 
pharmaceuticals and their metabolites (Scarpelli 1989). Still, there is some evidence from 
mammalian studies (including human epidemiology results) that acrylamide causes tumour and 
non-tumour alterations in several organs, including liver and pancreas, with some potential 
evidence of malignancies in the latter (Shipp et al. 2006). Interestingly, eosinophilic 
hepatocellular alteration, a recurrent alteration in the livers of fish exposed to 150 mg/L of 
acrylamide, has been considered pre-neoplastic in fish (Koehler et al. 2004), and has inclusively 
been associated (as in the present study) with the occurrences of eosinophilic bodies in the 
severely impacted livers of fish exposed to complex mixtures of environmental contaminants, 
especially by CYP-activatable PAHs (Costa et al. 2009). Lipofuscin on the other hand (the “age 
pigment”), is thought to result from the oxidation of lipids and proteins (Terman and Brunk 1998), 
which should indicate oxidative stress occurring in the tissues, especially in the pancreatic acini, 
leading to cell death and organ loss-of-function, thus another evidence of critical organ failure as 
a result from exposure to this substance. Moreover, since more severe lesions were verified in 
pancreatic acini than in hepatocytes, CYP1A induction in the liver may have not been 
considerably hampered at lower acrylamide concentrations of exposure. However, it is possible 
that the CYP1A response in fish exposed to concentrations higher than 100 mg/L acrylamide may 
have been directly influenced by occurring lesions in the hepatocytes, resulting in hindered 
production of CYP1A.  
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5.3. Acute toxicity of acrylamide to Mediterranean mussel and alterations induced 
by chronic exposure  
 
Bivalve molluscs, in particular mussels (Mytilus spp.) are widely surveyed within the field of 
environmental toxicology, whether to test the hazards of pollutants ex-situ or in biomonitoring 
(Fernandéz et al. 2010). Their ecological and economic importance, sensitivity to toxicants, 
relative simplicity of the mollusc body plan and easy handling render these organisms as key 
targets to address the effects of traditional and novel, so–called “emerging” pollutants, from 
endocrine disruptors to nanotoxicants (see for instance Aarab et al. 2006, Tedesco et al. 2010, 
Canesi et al. 2012). In terms of metabolic activity, the key organ to analyse is the bivalve digestive 
gland, which is the analogue of the vertebrate liver, in the sense that it is a major metabolic and 
excretion organ that plays an important role in bioaccumulation and detoxification. The second 
section of this chapter presents data obtained when determining the chronic and acute effects of 
waterborne acrylamide, at the cellular and subcellular levels, in the marine bivalve Mytilus 
galloprovincialis through a whole-organisms screening approach. 
 
5.3.1 Results 
5.3.1.1 Acute toxicity 
The LC50 (96 h) for acrylamide in water was estimated as 411 mg/L (95 % CI: 364.9 – 416.8 
mg/L) as shown in Fig. 5.6. The highest tested concentration of acrylamide (2000 mg/L) resulted 
in a mortality index of 87 %. The control test and exposure to 100 mg/L yielded no mortality 
(Table 5.3). Similarly, no mortality occurred during the chronic assay. 
 
5.3.1.2. Biochemical biomarkers after chronic exposure 
The biomarker results retrieved from the chronic assay are summarised in Fig. 5.7. The chronic 
bioassay yielded significant differences among treatments (Kruskall-Wallis H, p < 0.05) only for 
EROD activity, lipid peroxidation and GST activity. Specifically, the most significant differences 
in EROD were observed between mussels exposed to 1 mg/L acrylamide and the controls (Mann-
Whitney U, p < 0.05). However, no significant differences were found between individuals 
exposed to 1 and 10 mg/L (Fig. 5.7A). Conversely, no significant differences were found in either 
AChE or catalase activities between any experimental group (Figs. 5.7B and 5.7C, respectively). 
Lipid peroxidation and GST activity depicted a similar trend, with significant differences to 
control being found in animals exposed to 10 mg/L, albeit not between the two acrylamide 
treatments (Figs. 5.7D and 5.7E). Similarly to the activities of AChE, and catalase, no significant 
differences were found between treatments regarding TAC (Fig. 5.7F). The highest increment in 
biomarker responses was observed for lipid peroxidation in animals exposed to the highest 
concentration of the substance (up to ≈2-fold). 
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Table 5.3. Mussel mortality rate (by 96 h) for the control group and tested acrylamide concentrations 
(mg/L). 
 Control 100 250 500 1000 2000 
Individuals 15 15 15 15 15 15 
Total dead 0 0 5 12 12 13 
Mortality (%) 0 0 33 80 80 87 
 
 
Figure 5.6. Fitted dose-response curve obtained for mussel 96-hour exposure to acrylamide. Estimated 
LC50 = 411 mg/L. Grey area represents the 95 % confidence interval: 364.9 – 416.8 mg/L. 
 
5.3.1.3 Histopathology after chronic exposure  
No significant lesions were observed in the digestive glands of mussels exposed to either 
concentration of acrylamide during the chronic bioassay. However, all animals exposed to 10 
mg/L of the toxicant, when compared to control animals, presented few, scattered foci of 
haemocytic infiltration in the connective tissue that have nonetheless retained the normal structure 
(Fig. 5.8A). Similarly, no significant alterations were observed in gills (Fig. 5.8B) or male gonads 
(Fig. 5.8C) in any of the tested animals. The most significant alterations were observed in female 
gonads of animals exposed to 1 and 10 mg/L acrylamide, in a seemingly dose–response 
disposition. While control animals retained the typical microanatomy of maturing bivalve ovaries 
(Fig. 5.8D), all female mussels exposed to 1 mg/L acrylamide consistently revealed increased 
numbers of oocytes with signs of atresia (degenerating oocytes evidencing autolytic process) with 
few necrotic oocytes (Fig. 5.8E). The most severe lesions were observed in mussels exposed to 
10 mg/L acrylamide (Fig. 5.8F), where necrotic oocytes became common, which resulted in fully 
atrophied follicles. Inflammation–related alterations (namely intrusion of haemocytes) within the 
adipogranular tissue were also common. 
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5.3.1.4 Statistical integration of biomarker results 
Correlation-based principal component analysis (PCA) comprising tested concentrations and 
the individual data of all surveyed biomarkers yielded two main factors that, when combined, 
explained over 70% of the total variance (71.56%). Acrylamide nominal concentration in water 
was included as supplementary variable. The PCA data revealed GST and lipid peroxidation 
yielded a similar trend to the concentration of acrylamide in water, when compared to remaining 
biomarker responses (Fig, 5.9). Acetylcholine esterase and antioxidant capacity (TAC) appeared 
strongly linked, however not directly to acrylamide concentration. Contrastingly, EROD and 
catalase were set apart from the other responses and not directly correlated to each other or other 
biomarkers, although, comparatively, EROD activity exhibited a more similar trend to acrylamide 
concentration in water. 
 
Figure 5.7. Average biomarker responses determined from whole soft-body samples of mussels exposed 
for 21 days to waterborne acrylamide (1 and 10 mg/L) plus controls. A) ethoxyresorufin-O-deethylase 
(EROD) activity; B) acetylcholine esterase (AChE) activity; C) catalase activity; D) lipid peroxidation; E) 
glutathione-s-transferase (GST) activity; F) total anti-oxidant capacity. Error bars denote 95 % confidence 
intervals. Multiple comparison statistics were obtained with the Kruskall-Wallis ANOVA by ranks H-test 
(N.S. means not significant). Different letters indicate significant differences between specific pairs of 
experimental treatments (Mann-Whitney U test, p < 0.05). 
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5.3.2 Discussion  
 
To date, most information on acrylamide toxicity and effector concentrations to aquatic 
organisms has been retrieved from freshwater species, particularly teleosts (Krautter et al. 1986, 
Walker 1991, Weston et al. 2009). As such, there is only scant information on bivalves and 
seawater species in general. The current results show rather elevated effect concentrations for 
acrylamide in mussels (LC50 = 411 mg/L). This relatively high LC50, indicating low acute toxicity, 
compared to (freshwater) fish, typically  100 mg/L (see section 5.2 in this chapter) indicates, a 
priori, that the substance is of little toxicity to marine bivalves. Considering that the highest 
concentrations of acrylamide found in aquatic (freshwater) ecosystems range within the μg scale 
up to few mg/L in sewage effluents, according to aged studies (Croll et al. 1974, Brown et al. 
1980a), this information appears to substantiate the common notion that acrylamide poses little 
risk to aquatic fauna. Nonetheless, the findings from the chronic exposure assay (1 - 10 mg/L) 
indicate that acrylamide is able to induce responses to exposure in mussels, with respect to EROD 
and GST activities. Nonetheless, where the increase in lipid peroxides indicates the formation of 
oxidative radicals, the unchanged levels of TAC indicate that the overall ability to cope with 
oxidative stress remained unaltered, suggesting, thus, low-moderate oxidative challenge 
occurring at the present conditions of exposure. Also, severe lesions to female gonads in mussels 
(according to the observed individuals) were observed, which may imply a very significant risk 
for populations following prolonged exposure. Moreover, Croll et al. (1974) noticed that 
microbial degradation of acrylamide, judged to be fast in freshwater systems (within few days to 
reach half-life), tends to become extended in marine and brackish waters. It must be noted, though, 
that predicting acrylamide dispersion using level I and level III fugacity models showed that ≈ 
99% of acrylamide in the environment partitions to aquatic systems (NICNAS, 2002). Due to its 
elevated water solubility it is highly probable that the substance is washed away from atmosphere 
in rain water. A main source of acrylamide to environment is the presence of acrylamide 
monomers (around 0.1 %) in polyacrylamide polymers used for e.g. grouting applications, 
drinking water, paper manufacture and flocculants in mineral processing. Degradation tests made 
on acrylamide in water showed that its half-life varies greatly and that concentrations above 2 
mg/L are not efficiently and quickly degraded by biotic or abiotic factors (Brown et al. 1980a). 
With this in mind, the possibility of acrylamide accumulation in aquatic niches or washing out to 
seawater/estuarine systems has to be considered, where it may contaminate the biota directly or 
become deposited in sediments (Brown et al. 1980b), hence the importance of understanding the 
effects of the substance in a wide array of organisms. On the other hand, if degradation of 
acrylamide may be relatively inefficient, it is possible that biomagnification events occur, as well 
as trapping in sediments, rendering concentrations of the substance higher than could be expected 
off pollution hotspots, a subject that needs yet further research. As such, the relatively high 
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concentrations tested in the present study (which resemble those near effluent discharge sites) 
may not be so far astray of what could be found in highly impacted coastal waterbodies such as 
lagoons, rias and estuaries. 
 
 
Figure 5.8. Representative histological sections of tested mussels, after the 21-day exposure assay (H&E). 
A) Digestive gland of a mussel exposed to 10 ppm acrylamide. The digestive tubules (dt) present normal 
structure, consisting of a single–cell layer epithelium. Moderate haemocytic infiltration (arrow) is found in 
intertubular tissue (it). Inset: Detail of a digestive tubule of an animal exposed to 10 ppm acrylamide, 
revealing highly vacuolised digestive cells (dc). B) Normal gills of a control mussel, showing well–defined 
cilliary plates (cl) between lamellae (lm), similarly to animals exposed to 1 or 10 ppm acrylamide. Notice 
the haemal space devoid of any significant presence of haemocytes. C) Testes of a mussel exposed to 10 
ppm acrylamide, revealing normal microanatomy of maturing seminiferous tubules (st) and adipogranular 
tissue (at). D–E) Progressive series of ovarian atrophy of mussels exposed to acrylamide, compared to 
control animals. Control mussels (D) exhibited normal ovarian follicles (fl) containing maturing oocytes 
(oc). E) Atrophied follicles of a female mussel exposed to 1 ppm acrylamide, revealing many atresic 
(degenerating) oocytes (ao) and a few necrotic oocytes (no) amidst normal oocytes. The overall structure 
of the ovary remains intact, with no evident signs of alterations in the adipogranular connective tissue (at). 
F) Highly affected ovarian follicles in a mussel exposed to 10 ppm acrylamide, with many necrotic oocytes 
(no) and fewer atresic oocytes. Haemocytic infiltration (hm) can be observed in the adipogranular tissue. 
Scale bars: 25 µm. 
 
Many authors report mussels to be particularly well adapted to respond to environmental 
stressors (including toxicological challenge) due to their natural ability to cope with extreme 
variations in temperature and anoxia (owing to the intertidal habitat) and ability to interrupt filter-
feeding in face of sub-optimal environmental parameters (e.g. Davenport and Manley 1978, Sloof 
et al. 1983, Kramer et al. 1989, Santovito et al. 2005, Braby and Somero 2009). However, if these 
defence mechanisms could, at least in part, explain low acute toxicity of acrylamide to these 
organisms (and moderate biochemical responses), they are not consistent with the severe 
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histopathological lesions encountered in ovaries but not in other organs, indicating a specific 
toxicological target of the substance (i.e. gonadotoxic) rather than general systemic failure.  
 
Figure 5.9. Correlation-based principal component analysis (PCA) between biomarkers and nominal 
acrylamide concentration in water (as supplementary variable). The percentage of explained variance per 
PCA factor is indicated. Factor 1 eigenvalue = 2.73 and Factor 2 eigenvalue = 1.56. EROD: 
ethoxyresorufin-O-deetylase (EROD) activity; AChE: actetylcholine esterase activity; TAC: total anti-
oxidant capacity; LPO: lipid peroxidation; CAT: catalase activity; GST: glutathione-s-transferase (GST) 
activity. 
 
Overall, results from the biochemical analyses show modest responses and effects to waterborne 
acrylamide, although the increase in lipid peroxidation, GST and EROD activities suggest some 
degree of metabolic activation of the xenobiotic, since EROD is Ahr–dependent (reviewed by 
Tompkins and Wallace 2007). In fact, similarly to other organic xenobiotics, acrylamide 
bioactivation by CYP mixed function oxidases (MFOs) produces reactive oxygen species as by–
products which explains, at least in part, an elevated lipid peroxidation, whereas GST mediates 
the conjugation of hazardous metabolites to glutathione in an attempt to inactivate them. 
However, to date, no research has been published regarding the role of MFOs in the detoxification 
of acrylamide monomers in molluscs. There is evidence that molluscan MFOs may be less 
efficient than their vertebrate counterparts (Peters et al. 202), which may partially explain the 
overall moderate, albeit accountable biochemical responses of mussels to the substance, as well 
as reduced acute toxicity in mussels, when compared to fish. In fact, mussels tend to yield reduced 
acute toxicity effects in face of Ahr–mediated toxicants (as some PAHs and dioxins), which is 
accordant with the high LC50 (96 h) threshold obtained in this work. In spite of the scarce research 
on the chronic effects and responses triggered by the substance, acrylamide has been found to 
induce GST and EROD in vitro in human HepG2 cells (Sen et al. 2012) and to increase CYP1A 
levels in goldfish liver, as previously discussed in section 5.2.  
The findings also indicate low or null neurotoxic effects of acrylamide via inhibition of AChE 
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activity in M. galloprovincialis. Although acrylamide is often linked to neurotoxic effects in 
humans and other mammals (Howland 1985, He et al. 1989, LoPachin and Gavin 2012, Pennisi 
et al. 2013), literature reporting its effects on esterase enzymes is essentially missing. Moreover, 
no previous information on invertebrates was found. From the current state-of-the art, it is clear 
that the neurotoxic effects of acrylamide to these organisms need further research. Conversely, 
the most significant adverse effects endured by mussels in the present study were detected in 
female gonads (Fig. 5.8). The results thus suggest that in mussels, acrylamide targets primarily 
female gonads, which indicates that the substance holds a more important ecological impact than 
it could be expected. In fact, there are indications that acrylamide is indeed gonadotoxic, e.g. to 
male rats, with alteration in epididymal sperm reserves and possible induction of Leydig cell 
hyperplasia (Wang 2010).  
Oxidative stress is one of the main consequences of toxicological challenge, with multiple 
causes, mechanisms and effects. Organisms typically possess a broad array of defences against 
the formation of ROS. The increase in lipid peroxidation following exposure to acrylamide 
without a significant change in total anti-oxidant capacity (as well as catalase activity) should 
indicate that antioxidant defences were not fully depleted. It must be noticed, however, that the 
TAC assay measures the global antioxidant potential of the cell, including enzymatic and non-
enzymatic anti-oxidants (e.g. glutathione, tocopherol, ascorbic acid, etc.), therefore providing a 
generalist perspective of the anti-oxidant machinery, since responses to oxidative stress are not 
equally triggered by acrylamide. Catalase and GST for instance, yielded contrasting results (Fig. 
5.7C and E) despite being part of the enzymatic antioxidant machinery and being regulated by the 
same pathway. Both catalase and GST expression is mediated by the Nrf2-Keap1 pathway 
through which, electrophiles such as ROS will cause the release of the transcription factor Nfr2 
from its repressor, Keap1 (see schematics in Figure 5.10). The transcription factor will then bind 
to the antioxidant response element (ARE) of specific genes (such as catalase and GST), 
promoting transcription (reviewed by Kobayashi and Yamamoto 2005). Still, there are very 
significant species- and organ-specific variations in the activities of anti-oxidant enzymes. The 
activity of catalase, for instance, a phase II peroxisomal enzyme chiefly involved in H2O2 
catabolism, has been found to be especially responsive in the digestive gland of wild M. 
galloprovincialis from impacted sites, whereas GST activity was more responsive in gills (Vidal-
Liñan and Bellas 2013). Although no significant histopathological lesions were found in either 
organ, this information additionally highlights the need for caution when interpreting data from 
anti–oxidant enzymes, as noted by many researchers in the field (van der Oost et al. 2003), 
especially when retrieving data from whole-organism samples. On its turn, the similar pattern 
between lipid peroxidation and GST (Fig. 5.7) is accordant with the function of the latter in 
conjugating lipid peroxides during phase II processes, and thus assisted in the reduction of 
intracellular ROS formed during acrylamide bioactivation. Altogether, the ability to deploy anti-
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oxidant defences most likely contributed to the low or null histopathological alterations observed 
in most mussel tissues, with emphasis to the digestive gland, which is the analogue to the 
vertebrate liver and, therefore, the primary organ for detoxification. The link between lipid 
peroxidation, GST activity and acrylamide concentration in water (Fig. 5.9) agree with the notion 
that exposure to acrylamide induces the formation of ROS and likely the deployment of 
glutathione-related responses to deal with these by-products, and eventual acrylamide 
metabolites.  
 
 
Figure 5.10. Schematic model of the Nrf2–Keap1 signaling pathway. Under basal conditions, Keap1 binds 
to the ETGE and DLG motifs on Nrf2 and brings Nrf2 into Keap1–Cul3–E3 ubiquitin ligase complex, 
leading to ubiquitination and subsequent degradation of Nrf2. Oxidative stress or electrophiles can cause a 
conformational change in the Keap1–Cul3–E3 ubiquitin ligase by acting on specific cysteine residues in 
Keap1. These changes disrupt Nrf2–Keap1 binding at the DLG domain. Nrf2 is stabilized, and free Nrf2 
translocates to the nucleus, where it dimerizes with members of the small Maf family and binds to AREs 
(5′-RTGABNNNGCR-3′) within regulatory regions of a wide variety of cell defense genes, including 
NQO1, GCLM, HO-1, and MRP1. (E) ETGE; (D) DLG. Reprinted with permission, from Jaramillo and 
Zhang (2013). Copyright 2013 Cold Spring Harbor Laboratory Press. 
 
There are only a few references on histopathological alterations elicited by acrylamide. Among 
the few studies, there is evidence for testicular alterations in mice (Wang et al. 2010) and 
hepatopancreas lesions in goldfish (section 5.2 in this chapter). The lack of histopathological 
approaches to acrylamide toxicity renders difficult to pinpoint specific alterations induced by the 
substance. Although the present study, which intended to be a ground-breaking screening 
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assessment on the effects of acrylamide in mussels, surveyed a reduced number of organisms, it 
shows that chronic exposure to acrylamide may cause severe deleterious effects to mussel female 
gonads. Specifically, a reduction in number of oocytes per ovarian follicle and caused oocyte 
atresia and necrosis in mussels exposed to acrylamide from 1 mg/L (Fig. 5.8). These findings, 
although seemingly preliminary, should point to a new direction in research. Interestingly, these 
alterations resemble those observed in mussels exposed to endocrine disruptors (Aarab et al. 
2006). However, despite similar histological alterations it is not clear that acrylamide actually 
impairs hormonal functions and ought to be regarded as a potential endocrine disruptor. In fact, 
acrylamide has been found to de-regulate basal cellular functions and structures, inclusively by 
inducing deficiencies in the formation of the mitotic spindle, either by binding neurofilaments 
and cytoskeletal proteins (Lapadula et al. 1989) or by inhibiting kinesin proteins, consequently 
preventing microtubule binding and disassembly (Sickles et al. 2007). Although this information 
should imply that virtually all cell types and tissues are susceptible to acrylamide-induced 
damage, the present findings suggest that reproductive tissue may be particularly sensitive to the 
substance, suggesting a specific toxicological pathway and indicate that further research is needed 
to fully disclose the potential gonadotoxic effects of acrylamide in marine molluscs. Still, 
acrylamide-induced reproductive toxicity has been also reported in mice, for both male and 
female gonads and gametes (Sakamoto and Hashimoto 1986, Zenick et al. 1986, Chapin et al. 
1995, Wang et al. 2010), even though most of the studies do not consider histopathology as an 
endpoint. Still, male mice exposed to acrylamide in drinking water yielded alterations in Sertoli 
cells and epididymis, ultimately influencing spermatogenesis and the normal reproductive 
function (Wang et al. 2010). Overall, the specific mechanisms why acrylamide was notoriously 
gonadotoxic in female gonads following chronic exposure, whereas the digestive gland and gills 
(the main organ of apical entry of the xenobiotic) were less affected, remain elusive. Nevertheless, 
it is likely that, in spite the moderate biochemical responses and effects (and low acute toxicity as 
well), chronic exposure to acrylamide may seriously compromise the reproductive effort of 
mussels. As such, caution is mandatory when interpreting biomarker data from animals exposed 
to this substance. It must also be noticed that the bivalve gonads, especially testis, are relatively 
undifferentiated, comparative to vertebrates and even other molluscs, which hinders 
histopathological appraisals focusing mostly on structural alterations. Thus, more detailed 
microscopic, biochemical and fertility studies ought to be conducted with this and other species 
of bivalves in order to ascertain the full extent of gonadotoxicity of this aquatic pollutant.  
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5.4 Conclusions 
 
In summary, acrylamide is genotoxic by promoting both chromosomal clastogenesis and DNA-
strand breakage. The results are in accordance with the expected alterations imposed by CYP-
activated organic toxicants, which could mean DNA damage via ROS and epoxide adducts 
(generating strand breakage) and spindle malformations (causing clastogenesis due to faulty 
mitosis). On the other hand, ROS and mutations may easily explain the acute damage endured by 
the hepatic parenchyma and moreover by the pancreatic acini, both involved in toxicant 
metabolism and bioaccumulation. It should be noted though that the mechanisms by which 
acrylamide is biotransformed to glycidamide in vivo are not yet fully known, neither is the 
pathway of CYP induction by the substance (for instance, if the aryl hydrocarbon receptor is 
involved, as for known CYP-inducers). Also, the present study showed that acrylamide, at least 
in freshwater fish, owes a significant part of its toxicity to severe pancreatic tissue lesions, 
regardless of biochemical defences being deployed, which sustains the inherent physiological 
hazard of the toxicant, to which is added a most probable effect as a genotoxicant and probable 
mutagenic agent in fish. This data was published in Larguinho et al. 2014 (Journal of Applied 
Toxicology 34:1293-302). 
In accordance with the general notion that acrylamide holds reduced environmental hazards, the 
verified acute toxicity to M. galloprovincialis is low, attaining LC50  4 fold higher than for 
freshwater fish. However, chronic exposure to the xenobiotic indicated some degree of metabolic 
activation by mussels, with subsequent formation of ROS and toxic metabolites but without 
overwhelming the organisms’ anti–oxidant capacity, which clearly indicates the substance is 
toxicological active to these marine bivalves. However, probably the most significant findings 
were retrieved from the whole–organism histopathological screening, which revealed female 
gonads to be the most affected organ. As such, although posing little threat with respect to 
mortality, the chronic effects of acrylamide may be underestimated by the current state–of–the–
art, especially concerning the deleterious effects to the species reproductive effort, therefore 
compromising populational equilibrium. This data was published in Larguinho et al. 2014 
(Environmental Research 135:55-62). 
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CHAPTER 6. GENERAL DISCUSSION AND CONCLUSIONS 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Believe you can and you're halfway there. 
Theodore Roosevelt 
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The biological problem concerning the formation of DNA adducts and their role as biomarkers 
of exposure to carcinogen agents is of great importance and it has been growing within the 
scientific community. Analysis and quantification of DNA adducts provide valuable information 
not only about specific toxicants and the associated risk, but also about the susceptibility of a 
genome to a particular kind of carcinogen. The central objective portrayed in this thesis is the 
development of a nanotechnology-based method for detection of DNA adducts. With the 
emergence of nanotechnology as a scientific field of study, new and improved methods and 
materials arose, with advantages in terms of biomolecular detection. With this in mind, gold 
nanoparticles were incorporated into different systems to try and enhance their capabilities and 
render the suitable for DNA adduct detection. To accomplish this objective, a simultaneous three-
way strategy was devised consisting of: 1. optimisation of sample preparation for analysis; 2. the 
use of AuNPs to improve existing techniques for DNA adduct detection: a robust MS-based laser 
desorption technique, and a simpler colorimetric test; 3. the development of a biological model 
of exposure to acrylamide, including a toxicity assessment to better grasp the biological 
consequences of the toxicant. A workflow and timeline were properly set in order to address these 
several aspects i.e. procedures for sample preparation preceding detection, development of a 
AuNP-based method for rapid detection of DNA adduct in solution, in vitro production of DNA 
adducts from reaction with an alkylating agent and in vivo production of DNA adducts by 
exposure of a model organism to the toxicant. 
Regarding sample preparation, ultrasonic energy was found extremely valuable to produce DNA 
fragments suitable for downstream applications, via fragmentation of a highly complex genomic 
DNA sample. Enzymatic hydrolysis of DNA samples was compared with ultrasonic energy for 
fragmentation of DNA samples, and both techniques were found adequate, each with its own 
advantages, depending on the final purpose. Data concerning these experiments was published in 
Larguinho et al. 2010 (Talanta 81:881-886). Additionally, an attempt was made to accelerate 
nuclease digestion with ultrasonic energy, similarly to what has been described for proteolytic 
enzymes (Lopéz-Ferrer et al. 2005, Rial-Otero et al. 2007). This was believed to be an interesting 
concept however no major differences were denoted from using ultrasonic energy during 
digestion, at the tested conditions of study. The attempt to use ion-exchange HPLC to profile 
nucleotides and separate DNA adducts from remainder sample constituents revealed no visible 
elution signals of the DNA adduct in the chromatograms. Detection by UV-Vis is possibly not 
sensitive enough to identify trace amounts of DNA adducts in solution. On the other hand, the 
continuous desalting and purification procedures before and after HPLC separation may have 
resulted in sample loss. All things considered, ion-exchange HPLC proved valuable information 
when profiling different nucleotides in solution, but proved inconclusive for DNA adduct 
separation. With this in mind, a NAP-5 DNA-grade column for desalting and purification was 
used. The setup was less elaborated, there was no DNA adduct separation from other nucleotides, 
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but prevented extensive sample loss. Ultimately, by putting together all experiments concerning 
sample preparation, a complete protocol was devised for DNA adduct analysis by mass 
spectrometry, since DNA extraction and isolation from a biological model, down to detection via 
AuNP-based SALDI-TOF. 
About the proposed methodology for detection of DNA adducts, an attempted was made to 
introduce AuNPs into an already existing MS technique, to assess its potential for nucleotide 
analysis. Citrate-capped 14 nm AuNPs proved noteworthy in nucleotide profiling by SALDI-
TOF-MS, although the specific mass signals generated present some deviations to the expected 
molecular ion signals. These differences are too little to be due to formation of cation-adducts (no 
relation to DNA adducts) during gas-phase rearrangements, and no literature has been found that 
described such discrepancies. The method of AuNP-SALDI for nucleotide profiling was 
published in Larguinho et al. 2013 (Talanta 105:417-421). AuNPs have also accounted for 
identification of DNA adducts generated in vitro (GA-guanine adducts), but when biological 
samples were analysed, no mass signal could be identified. This may be related to the low 
abundance of DNA adducts in vivo, which possibly calls for alternative and elaborate methods 
for sample preparation and more importantly, isolation of DNA adduct from the remainder 
components in the sample (as mentioned before). Nevertheless, MALDI-TOF analysis of the 
same biological samples with an adequate organic matrix (CHCA) produced a mass signal 
corresponding to the DNA adduct molecular ion, which means that CHCA as a MALDI matrix is 
still capable of more sensitive detection than AuNPs. Future work may involve nucleotides 
labelled with different isotopes, e.g. 15C, 18O, to allow for both nucleotide and DNA adduct 
quantification in samples. An alternative colorimetric method based on AuNP and inspired in the 
non-cross-linking assay developed by Baptista and co-workers (2005a) was also presented. This 
method accounted for a positive identification of modified nucleotides in solution with statistical 
significance. Moreover, differences were observed, albeit not significant, for detection of DNA 
adducts in samples generated by in vitro alkylation of high complexity genomic DNA, with 
minimal sample preparation. All data concerning the colorimetric tests was recently published in 
Larguinho et al. 2014 (IET Nanobiotechnology). The approach shows enormous potential for 
rapid, simple and cost-effective detection of DNA adducts in solution, however there is still the 
need for further testing, namely in real biological samples, from organisms exposed to the 
carcinogen. 
The exposure assays performed during this thesis have provided valuable information on 
mechanistic and descriptive toxicology of acrylamide to aquatic organisms. The first exposure 
assay targeted a freshwater fish, focusing mainly on genotoxicity and induction of phase I and 
phase II metabolism enzymes, to evaluate biotransformation of acrylamide to glycidamide and 
correlate that with DNA and chromosomal damage. In addition, it was intended to evaluate the 
goldfish as a biological model for acrylamide toxicity, as well as correlate the detection of DNA 
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adducts in tissues with the other biomarkers, but since DNA adducts have only been detected by 
MALDI at the highest tested concentration (150 mg/L), this was not possible. Nevertheless, 
evaluation of genotoxicity via Comet assay and ENA analysis in peripheral blood samples 
constitutes a relatively rapid and simple approach which may prove worthy when screening for 
biomarkers of induced DNA damage in superior vertebrates. All data concerning acrylamide 
toxicity to goldfish was published in Larguinho et al. 2014 (Journal of Applied Toxicology 
34:1293-302). The second assay consisted of acute and chronic toxicity of waterborne acrylamide 
to a bivalve, and targeted mainly histopathological lesions and cell biochemical defences 
deployed in response to acrylamide-induced damage, namely oxidative stress. This was intended 
to be a study about acrylamide itself, its consequences to the cell, e.g. Michael’s addition to bind 
proteins, conjugation with glutathione, triggered antioxidant response, because most studies on 
acrylamide turn out to be a comparison between its toxicity and glycidamide, usually in terms of 
genotoxicity. All data concerning acrylamide toxicity to mussels was recently published in 
Larguinho et al. 2014 (Environmental Research 135:55-62).      
In terms of acute toxicity, waterborne acrylamide is low or mildly toxic to the organisms tested, 
as they presented relatively high effect concentrations (from 100 to 500 mg/L). It is very unlikely 
for the aquatic niche to reach this order of concentrations, unless a chemical disaster occurs. 
Aquatic vertebrates were shown to be less tolerant than invertebrates to short exposures to 
elevated acrylamide concentrations. This could be related to the feeding strategies and metabolic 
adaptations of each organism, revealing different susceptibilities in terms of internal organs and 
defence mechanisms activated to counter the xenobiotic. Nevertheless, from all obtained data, it 
seems that acrylamide effects become notorious when a more prolonged exposure to 
environmentally relevant concentrations comes into play. 
The most surprising results in both vertebrates and invertebrates were the histopathological 
lesions induced by acrylamide in different tissues. In fish, it targeted mostly pancreatic intrusions 
in the hepatopancreas, whilst in mussels the gonads were the main affected organ. Acrylamide 
provoked histopathological lesions similar to other classes of chemical toxicants, in both fish and 
mussels. This may suggest that aquatic organisms possess non-specific defence mechanisms 
which are triggered in the presence of a wide array of toxicants, e.g. PAHs, dioxins. Importantly, 
prolonged exposure to acrylamide has revealed to be extensively damaging to gonads from female 
mussels, despite these organisms exhibit a certain resilience to environmental toxicants and 
stresses. As such, despite the seemingly low mortality index, the adverse effects this substance 
has on the biota should not be underestimated and, both in terms of biological consequences to 
the organism and ecotoxicology, there is still much to be unravelled. 
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APPENDICES 
 
Appendix I – Plasmid maps and sequences: pUC19 and p158 
 
pUC19 
 
 
    1 TCGCGCGTTT CGGTGATGAC GGTGAAAACC TCTGACACAT GCAGCTCCCG 
   51 GAGACGGTCA CAGCTTGTCT GTAAGCGGAT GCCGGGAGCA GACAAGCCCG 
  101 TCAGGGCGCG TCAGCGGGTG TTGGCGGGTG TCGGGGCTGG CTTAACTATG 
  151 CGGCATCAGA GCAGATTGTA CTGAGAGTGC ACCATATGCG GTGTGAAATA 
  201 CCGCACAGAT GCGTAAGGAG AAAATACCGC ATCAGGCGCC ATTCGCCATT 
  251 CAGGCTGCGC AACTGTTGGG AAGGGCGATC GGTGCGGGCC TCTTCGCTAT 
  301 TACGCCAGCT GGCGAAAGGG GGATGTGCTG CAAGGCGATT AAGTTGGGTA 
  351 ACGCCAGGGT TTTCCCAGTC ACGACGTTGT AAAACGACGG CCAGTGAATT 
  401 CGAGCTCGGT ACCCGGGGAT CCTCTAGAGT CGACCTGCAG GCATGCAAGC 
  451 TTGGCGTAAT CATGGTCATA GCTGTTTCCT GTGTGAAATT GTTATCCGCT 
  501 CACAATTCCA CACAACATAC GAGCCGGAAG CATAAAGTGT AAAGCCTGGG 
  551 GTGCCTAATG AGTGAGCTAA CTCACATTAA TTGCGTTGCG CTCACTGCCC 
  601 GCTTTCCAGT CGGGAAACCT GTCGTGCCAG CTGCATTAAT GAATCGGCCA 
  651 ACGCGCGGGG AGAGGCGGTT TGCGTATTGG GCGCTCTTCC GCTTCCTCGC 
  701 TCACTGACTC GCTGCGCTCG GTCGTTCGGC TGCGGCGAGC GGTATCAGCT 
  751 CACTCAAAGG CGGTAATACG GTTATCCACA GAATCAGGGG ATAACGCAGG 
  801 AAAGAACATG TGAGCAAAAG GCCAGCAAAA GGCCAGGAAC CGTAAAAAGG 
  851 CCGCGTTGCT GGCGTTTTTC CATAGGCTCC GCCCCCCTGA CGAGCATCAC 
  901 AAAAATCGAC GCTCAAGTCA GAGGTGGCGA AACCCGACAG GACTATAAAG 
  951 ATACCAGGCG TTTCCCCCTG GAAGCTCCCT CGTGCGCTCT CCTGTTCCGA 
 1001 CCCTGCCGCT TACCGGATAC CTGTCCGCCT TTCTCCCTTC GGGAAGCGTG 
 1051 GCGCTTTCTC ATAGCTCACG CTGTAGGTAT CTCAGTTCGG TGTAGGTCGT 
 1101 TCGCTCCAAG CTGGGCTGTG TGCACGAACC CCCCGTTCAG CCCGACCGCT 
 1151 GCGCCTTATC CGGTAACTAT CGTCTTGAGT CCAACCCGGT AAGACACGAC 
 1201 TTATCGCCAC TGGCAGCAGC CACTGGTAAC AGGATTAGCA GAGCGAGGTA 
 1251 TGTAGGCGGT GCTACAGAGT TCTTGAAGTG GTGGCCTAAC TACGGCTACA 
 1301 CTAGAAGAAC AGTATTTGGT ATCTGCGCTC TGCTGAAGCC AGTTACCTTC 
 1351 GGAAAAAGAG TTGGTAGCTC TTGATCCGGC AAACAAACCA CCGCTGGTAG 
 1401 CGGTGGTTTT TTTGTTTGCA AGCAGCAGAT TACGCGCAGA AAAAAAGGAT 
 1451 CTCAAGAAGA TCCTTTGATC TTTTCTACGG GGTCTGACGC TCAGTGGAAC 
 1501 GAAAACTCAC GTTAAGGGAT TTTGGTCATG AGATTATCAA AAAGGATCTT 
 1551 CACCTAGATC CTTTTAAATT AAAAATGAAG TTTTAAATCA ATCTAAAGTA 
 1601 TATATGAGTA AACTTGGTCT GACAGTTACC AATGCTTAAT CAGTGAGGCA 
 
 
170 
 
 1651 CCTATCTCAG CGATCTGTCT ATTTCGTTCA TCCATAGTTG CCTGACTCCC 
 1701 CGTCGTGTAG ATAACTACGA TACGGGAGGG CTTACCATCT GGCCCCAGTG 
 1751 CTGCAATGAT ACCGCGAGAC CCACGCTCAC CGGCTCCAGA TTTATCAGCA 
 1801 ATAAACCAGC CAGCCGGAAG GGCCGAGCGC AGAAGTGGTC CTGCAACTTT 
 1851 ATCCGCCTCC ATCCAGTCTA TTAATTGTTG CCGGGAAGCT AGAGTAAGTA 
 1901 GTTCGCCAGT TAATAGTTTG CGCAACGTTG TTGCCATTGC TACAGGCATC 
 1951 GTGGTGTCAC GCTCGTCGTT TGGTATGGCT TCATTCAGCT CCGGTTCCCA 
 2001 ACGATCAAGG CGAGTTACAT GATCCCCCAT GTTGTGCAAA AAAGCGGTTA 
 2051 GCTCCTTCGG TCCTCCGATC GTTGTCAGAA GTAAGTTGGC CGCAGTGTTA 
 2101 TCACTCATGG TTATGGCAGC ACTGCATAAT TCTCTTACTG TCATGCCATC 
 2151 CGTAAGATGC TTTTCTGTGA CTGGTGAGTA CTCAACCAAG TCATTCTGAG 
 2201 AATAGTGTAT GCGGCGACCG AGTTGCTCTT GCCCGGCGTC AATACGGGAT 
 2251 AATACCGCGC CACATAGCAG AACTTTAAAA GTGCTCATCA TTGGAAAACG 
 2301 TTCTTCGGGG CGAAAACTCT CAAGGATCTT ACCGCTGTTG AGATCCAGTT 
 2351 CGATGTAACC CACTCGTGCA CCCAACTGAT CTTCAGCATC TTTTACTTTC 
 2401 ACCAGCGTTT CTGGGTGAGC AAAAACAGGA AGGCAAAATG CCGCAAAAAA 
 2451 GGGAATAAGG GCGACACGGA AATGTTGAAT ACTCATACTC TTCCTTTTTC 
 2501 AATATTATTG AAGCATTTAT CAGGGTTATT GTCTCATGAG CGGATACATA 
 2551 TTTGAATGTA TTTAGAAAAA TAAACAAATA GGGGTTCCGC GCACATTTCC 
 2601 CCGAAAAGTG CCACCTGACG TCTAAGAAAC CATTATTATC ATGACATTAA 
 2651 CCTATAAAAA TAGGCGTATC ACGAGGCCCT TTCGTC 
 
 
p158 
 
 
    
    1 GTTAACCTCC TATTTGACAC CACTGATTAC CCCATTGATA GTCACACTTT 
   51 GGGTTGTAAG TGACTTTTTA TTTATTTGTA TTTTTGACTG CATTAAGAGG 
  101 TCTCTAGTTT TTTATCTCTT GTTTCCCAAA ACCTAATAAG TAACTAATGC 
  151 ACAGAGCACA TTGATTTGTA TTTATTCTAT TTTTAGACAT AATTTATTAG 
  201 CATGCATGAG CAAATTAAGA AAAACAACAA CAAATGAATG CATATATATG 
  251 TATATGTATG TGTGTATATA TACACACATA TATATATATA TTTTTTCTTT 
  301 TCTTACCAGA AGGTTTTAAT CCAAATAAGG AGAAGATATG CTTAGAACCG 
  351 AGGTAGAGTT TTCATCCATT CTGTCCTGTA AGTATTTTGC ATATTCTGGA 
  401 GACGCAGGAA GAGATCCATC TACATATCCC AAAGCTGAAT TATGGTAGAC 
  451 AAAACTCTTC CACTTTTAGT GCATCAACTT CTTATTTGTG TAATAAGAAA 
  501 ATTGGGAAAA CGATCTTCAA TATGCTTACC AAGCTGTGAT TCCAAATATT 
  551 ACGTAAATAC ACTTGCAAAG GAGGATGTTT TTAGTAGCAA TTTGTACTGA 
  601 TGGTATGGGG CCAAGAGATA TATCTTAGAG GGAGGGCTGA GGGTTTGAAG 
  651 TCCAACTCCT AAGCCAGTGC CAGAAGAGCC AAGGACAGGT ACGGCTGTCA 
171 
 
  701 TCACTTAGAC CTCACCCTGT GGAGCCACAC CCTAGGGTTG GCCAATCTAC 
  751 TCCCAGGAGC AGGGAGGGCA GGAGCCAGGG CTGGGCATAA AAGTCAGGGC 
  801 AGAGCCATCT ATTGCTTACA TTTGCTTCTG ACACAACTGT GTTCACTAGC 
  851 AACCTCAAAC AGACACCATG GTGCATCTGA CTCCTGAGGA GAAGTCTGCC 
  901 GTTACTGCCC TGTGGGGCAA GGTGAACGTG GATGAAGTTG GTGGTGAGGC 
  951 CCTGGGCAGG TTGGTATCAA GGTTACAAGA CAGGTTTAAG GAGACCAATA 
 1001 GAAACTGGGC ATGTGGAGAC AGAGAAGACT CTTGGGTTTC TGATAGGCAC 
 1051 TGACTCTCTC TGCCTATTGG TCTATTTTCC CACCCTTAGG CTGCTGGTGG 
 1101 TCTACCCTTG GACCCAGAGG TTCTTTGAGT CCTTTGGGGA TCTGTCCACT 
 1151 CCTGATGCTG TTATGGGCAA CCCTAAGGTG AAGGCTCATG GCAAGAAAGT 
 1201 GCTCGGTGCC TTTAGTGATG GCCTGGCTCA CCTGGACAAC CTCAAGGGCA 
 1251 CCTTTGCCAC ACTGAGTGAG CTGCACTGTG ACAAGCTGCA CGTGGATCCT 
 1301 GAGAACTTCA GGGTGAGTCT ATGGGACGCT TGATGTTTTC TTTCCCCTTC 
 1351 TTTTCTATGG TTAAGTTCAT GTCATAGGAA GGGGATAAGT AACAGGGTAC 
 1401 AGTTTAGAAT GGGAAACAGA CGAATGATTG CATCAGTGTG GAAGTCTCAG 
 1451 GATCGTTTTA GTTTCTTTTA TTTGCTGTTC ATAACAATTG TTTTCTTTTG 
 1501 TTTAATTCTT GCTTTCTTTT TTTTTCTTCT CCGCAATTTT TACTATTATA 
 1551 CTTAATGCCT TAACATTGTG TATAACAAAA GGAAATATCT CTGAGATACA 
 1601 TTAAGTAACT TAAAAAAAAA CTTTACACAG TCTGCCTAGT ACATTACTAT 
 1651 TTGGAATATA TGTGTGCTTA TTTGCATATT CATAATCTCC CTACTTTATT 
 1701 TTCTTTTATT TTTAATTGAT ACATAATCAT TATACATATT TATGGGTTAA 
 1751 AGTGTAATGT TTTAATATGT GTACACATAT TGACCAAATC AGGGTAATTT 
 1801 TGCATTTGTA ATTTTAAAAA ATGCTTTCTT CTTTTAATAT ACTTTTTTGT 
 1851 TTATCTTATT TCTAATACTT TCCCTAATCT CTTTCTTTCA GGGCAATAAT 
 1901 GATACAATGT ATCATGCCTC TTTGCACCAT TCTAAAGAAT AACAGTGATA 
 1951 ATTTCTGGGT TAAGGCAATA GCAATATCTC TGCATATAAA TATTTCTGCA 
 2001 TATAAATTGT AACTGATGTA AGAGGTTTCA TATTGCTAAT AGCAGCTACA 
 2051 ATCCAGCTAC CATTCTGCTT TTATTTTATG GTTGGGATAA GGCTGGATTA 
 2101 TTCTGAGTCC AAGCTAGGCC CTTTTGCTAA TCATGTTCAT ACCTCTTATC 
 2151 TTCCTCCCAC AGCTCCTGGG CAACGTGCTG GTCTGTGTGC TGGCCCATCA 
 2201 CTTTGGCAAA GAATTCACCC CACCAGTGCA GGCTGCCTAT CAGAAAGTGG 
 2251 TGGCTGGTGT GGCTAATGCC CTGGCCCACA AGTATCACTA AGCTCGCTTT 
 2301 CTTGCTGTCC AATTTCTATT AAAGGTTCCT TTGTTCCCTA AGTCCAACTA 
 2351 CTAAACTGGG GGATATTATG AAGGGCCTTG AGCATCTGGA TTCTGCCTAA 
 2401 TAAAAAACAT TTATTTTCAT TGCAATGATG TATTTAAATT ATTTCTGAAT 
 2451 ATTTTACTAA AAAGGGAATG TGGGAGGTCA GTGCATTTAA AACATAAAGA 
 2501 AATGAAGAGC TAGTTCAAAC CTTGGGAAAA TACACTATAT CTTAAACTCC 
 2551 ATGAAAGAAG GTGAGGCTGC AAACAGCTAA TGCACATTGG CAACAGCCCC 
 2601 TGATGCATAT GCCTTATTCA TCCCTCAGAA AAGGATTCAA GTAGAGGCTT 
 2651 GATTTGGAGG TTAAAGTTTT GCTATGCTGT ATTTTACATT ACTTATTGTT 
 2701 TTAGCTGTCC TCATGAATGT CTTTTCACTA CCCATTTGCT TATCCTGCAT 
 2751 CTCTCAGCCT TGACTCCACT CAGTTCTCTT GCTTAGAGAT ACCACCTTTC 
 2801 CCCTGAAGTG TTCCTTCCAT GTTTTACGGC GAGATGGTTT CTCCTCGCCT 
 2851 GGCCACTCAG CCTTAGTTGT CTCTGTTGTC TTATAGAGGT CTACTTGAAG 
 2901 AAGGAAAAAC AGGGGTCATG GTTTGACTGT CCTGTGAGCC CTTCTTCCCT 
 2951 GCCTCCCCCA CTCACAGTGA CCCGGAATCT GCAGTGCTAG TCTCCCGGAA 
 3001 CTATCACTCT TTCACAGTCT GCTTTGGAAG GACTGGGCTT AGTATGAAAA 
 3051 GTTAGGACTG AGAAGAATTT GAAAGGCGGC TTTTTGTAGC TTGATATTCA 
 3101 CTACTGTCTT ATTACCCTGT CATAGGCCCA CCCCAAATGG AAGTCCCATT 
 3151 CTTCCTCAGG ATGTTTAAGA TTAGCATTCA GGAAGAGATC AGAGGTCTGC 
 3201 TGGCTCCCTT ATCATGTCCC TTATGGTGCT TCTGGCTCTG CAGTTATTAG 
 3251 CATAGTGTTA CCATCAACCA CCTTAACTTC ATTTTTCTTA TTCAATACCT 
 3301 AGGTAGGTAG ATGCTAGATT CTGGAAATAA AATATGAGTC TCAAGTGGTC 
 3351 CTTGTCCTCT CTCCCAGTCA AATTCTGAAT CTAGTTGGCA AGATTCTGAA 
 3401 ATCAAGGCAT ATAATCAGTA ATAAGTGATG ATAGAAGGGT ATATAGAAGA 
 3451 ATTTTATTAT ATGAGAGGGT GAAACCCTCA AAATGAAATG AAATCAGACC 
 3501 CTTGTCTTAC ACCATAAACA AAAATAAATT TGAATGGGTT AAAGAATTAA 
 3551 ACTAAGACCT AAAACCATAA AAATTTTTAA AGAAATCAAA AGAAGAAAAT 
 3601 TCTAATATTC ACGTTGCAGC CGTTTTTGAA TTTGATATGA GAAGCAAAGG 
 3651 CAACAAAAGG AAAAATAAAG AAGTGAGGCT ACATCAAACT AAAAAATTTC 
 3701 CACACAAAAA AGAAAACAAT GAACAAATGA AAGGTGAACC ATGAAATGGC 
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 3751 ATATTTGCAA ACCAAATATT TCTTAAATAT TTTGGTTAAT ATCCAAAATA 
 3801 TATAAGAAAC ACAGATGATT CAATAACAAA CAAAAAATTA AAAATAGGAA 
 3851 AATAAAAAAA TTAAAAAGAA GAAAATCCTG CCATTTATGC GAGAATTGAT 
 3901 GAACCTGGAG GATGTAAAAC TAAGAAAAAT AAGCCTGACA CAAAAAGACA 
 3951 AATACTACAC AACCTTGCTC ATATGTGAAA CATAAAAAAG TCACTCTCAT 
 4001 GGAAACAGAC AGTAGAGGTA TGGTTTCCAG GGGTTGGGGG TGGGAGAATC 
 4051 AGGAAACTAT TACTCAAAGG GTATAAAATT TCAGTTATGT GGGATGAATA 
 4101 AATTCTAGAG TCGACCTGCA GGCATGCAAG CTTGGCGTAA TCATGGTCAT 
 4151 AGCTGTTTCC TGTGTGAAAT TGTTATCCGC TCACAATTCC ACACAACATA 
 4201 CGAGCCGGAA GCATAAAGTG TAAAGCCTGG GGTGCCTAAT GAGTGAGCTA 
 4251 ACTCACATTA ATTGCGTTGC GCTCACTGCC CGCTTTCCAG TCGGGAAACC 
 4301 TGTCGTGCCA GCTGCATTAA TGAATCGGCC AACGCGCGGG GAGAGGCGGT 
 4351 TTGCGTATTG GGCGCTCTTC CGCTTCCTCG CTCACTGACT CGCTGCGCTC 
 4401 GGTCGTTCGG CTGCGGCGAG CGGTATCAGC TCACTCAAAG GCGGTAATAC 
 4451 GGTTATCCAC AGAATCAGGG GATAACGCAG GAAAGAACAT GTGAGCAAAA 
 4501 GGCCAGCAAA AGGCCAGGAA CCGTAAAAAG GCCGCGTTGC TGGCGTTTTT 
 4551 CCATAGGCTC CGCCCCCCTG ACGAGCATCA CAAAAATCGA CGCTCAAGTC 
 4601 AGAGGTGGCG AAACCCGACA GGACTATAAA GATACCAGGC GTTTCCCCCT 
 4651 GGAAGCTCCC TCGTGCGCTC TCCTGTTCCG ACCCTGCCGC TTACCGGATA 
 4701 CCTGTCCGCC TTTCTCCCTT CGGGAAGCGT GGCGCTTTCT CATAGCTCAC 
 4751 GCTGTAGGTA TCTCAGTTCG GTGTAGGTCG TTCGCTCCAA GCTGGGCTGT 
 4801 GTGCACGAAC CCCCCGTTCA GCCCGACCGC TGCGCCTTAT CCGGTAACTA 
 4851 TCGTCTTGAG TCCAACCCGG TAAGACACGA CTTATCGCCA CTGGCAGCAG 
 4901 CCACTGGTAA CAGGATTAGC AGAGCGAGGT ATGTAGGCGG TGCTACAGAG 
 4951 TTCTTGAAGT GGTGGCCTAA CTACGGCTAC ACTAGAAGGA CAGTATTTGG 
 5001 TATCTGCGCT CTGCTGAAGC CAGTTACCTT CGGAAAAAGA GTTGGTAGCT 
 5051 CTTGATCCGG CAAACAAACC ACCGCTGGTA GCGGTGGTTT TTTTGTTTGC 
 5101 AAGCAGCAGA TTACGCGCAG AAAAAAAGGA TCTCAAGAAG ATCCTTTGAT 
 5151 CTTTTCTACG GGGTCTGACG CTCAGTGGAA CGAAAACTCA CGTTAAGGGA 
 5201 TTTTGGTCAT GAGATTATCA AAAAGGATCT TCACCTAGAT CCTTTTAAAT 
 5251 TAAAAATGAA GTTTTAAATC AATCTAAAGT ATATATGAGT AAACTTGGTC 
 5301 TGACAGTTAC CAATGCTTAA TCAGTGAGGC ACCTATCTCA GCGATCTGTC 
 5351 TATTTCGTTC ATCCATAGTT GCCTGACTCC CCGTCGTGTA GATAACTACG 
 5401 ATACGGGAGG GCTTACCATC TGGCCCCAGT GCTGCAATGA TACCGCGAGA 
 5451 CCCACGCTCA CCGGCTCCAG ATTTATCAGC AATAAACCAG CCAGCCGGAA 
 5501 GGGCCGAGCG CAGAAGTGGT CCTGCAACTT TATCCGCCTC CATCCAGTCT 
 5551 ATTAATTGTT GCCGGGAAGC TAGAGTAAGT AGTTCGCCAG TTAATAGTTT 
 5601 GCGCAACGTT GTTGCCATTG CTACAGGCAT CGTGGTGTCA CGCTCGTCGT 
 5651 TTGGTATGGC TTCATTCAGC TCCGGTTCCC AACGATCAAG GCGAGTTACA 
 5701 TGATCCCCCA TGTTGTGCAA AAAAGCGGTT AGCTCCTTCG GTCCTCCGAT 
 5751 CGTTGTCAGA AGTAAGTTGG CCGCAGTGTT ATCACTCATG GTTATGGCAG 
 5801 CACTGCATAA TTCTCTTACT GTCATGCCAT CCGTAAGATG CTTTTCTGTG 
 5851 ACTGGTGAGT ACTCAACCAA GTCATTCTGA GAATAGTGTA TGCGGCGACC 
 5901 GAGTTGCTCT TGCCCGGCGT CAATACGGGA TAATACCGCG CCACATAGCA 
 5951 GAACTTTAAA AGTGCTCATC ATTGGAAAAC GTTCTTCGGG GCGAAAACTC 
 6001 TCAAGGATCT TACCGCTGTT GAGATCCAGT TCGATGTAAC CCACTCGTGC 
 6051 ACCCAACTGA TCTTCAGCAT CTTTTACTTT CACCAGCGTT TCTGGGTGAG 
 6101 CAAAAACAGG AAGGCAAAAT GCCGCAAAAA AGGGAATAAG GGCGACACGG 
 6151 AAATGTTGAA TACTCATACT CTTCCTTTTT CAATATTATT GAAGCATTTA 
 6201 TCAGGGTTAT TGTCTCATGA GCGGATACAT ATTTGAATGT ATTTAGAAAA 
 6251 ATAAACAAAT AGGGGTTCCG CGCACATTTC CCCGAAAAGT GCCACCTGAC 
 6301 GTCTAAGAAA CCATTATTAT CATGACATTA ACCTATAAAA ATAGGCGTAT 
 6351 CACGAGGCCC TTTCGTCTCG CGCGTTTCGG TGATGACGGT GAAAACCTCT 
 6401 GACACATGCA GCTCCCGGAG ACGGTCACAG CTTGTCTGTA AGCGGATGCC 
 6451 GGGAGCAGAC AAGCCCGTCA GGGCGCGTCA GCGGGTGTTG GCGGGTGTCG 
 6501 GGGCTGGCTT AACTATGCGG CATCAGAGCA GATTGTACTG AGAGTGCACC 
 6551 ATATGCGGTG TGAAATACCG CACAGATGCG TAAGGAGAAA ATACCGCATC 
 6601 AGGCGCCATT CGCCATTCAG GCTGCGCAAC TGTTGGGAAG GGCGATCGGT 
 6651 GCGGGCCTCT TCGCTATTAC GCCAGCTGGC GAAAGGGGGA TGTGCTGCAA 
 6701 GGCGATTAAG TTGGGTAACG CCAGGGTTTT CCCAGTCACG ACGTTGTAAA 
 6751 ACGACGGCCA GTGAATTCGA GCTCGGTACG GTACCAGTGG GGCCTCTAAG 
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 6801 ACTAAGTCAC TCTGTCTCAC TGTGTCTTAG CCAGTTCCTT ACAGCTTGCC 
 6851 CTGATGGGAG ATAGAGAATG GGTATCCTCC AACAAAAAAA TAAATTTTCA 
 6901 TTTCTCAAGG TCCAACTTAT GTTTTCTTAA TTTTTAAAAA AATCTTGACC 
 6951 ATTCTCCACT CTCTAAAATA ATCCACAGTG AGAGAAACAT TCTTTTCCCC 
 7001 CATCCCATAA ATACCTCTAT TAAATATGGA AAATCTGGGC ATGGTGTCTC 
 7051 ACACCTGTAA TCCCAGCACT TTGGGAGGCT GAGGTGGGTG GACTGCTTGG 
 7101 AGCTCAGGAG TTCAAGACCA TCTTGGACAA CATGGTGATA CCCTGCCTCT 
 7151 ACAAAAAGTA CAAAAATTAG CCTGGCATGG TGGTGTGCAC CTGTAATCCC 
 7201 AGCTATTAGG GTGGCTGAGG CAGGAGAATT GCTTGAACCC GGGAGGCGGA 
 7251 GGTTGCAGTG AGCTGAGATC GTGCCACTGC ACTCCAGCCT GGGGGACAGA 
 7301 GCACATTATA ATTAACTGTT ATTTTTTACT TGGACTCTTG TGGGGAATAA 
 7351 GATACATGTT TTATTCTTAT TTATGATTCA AGCACTGAAA ATAGTGTTTA 
 7401 GCATCCAGCA GGTGCTTCAA AACCATTTGC TGAATGATTA CTATACTTTT 
 7451 TACAAGCTCA GCTCCCTCTA TCCCTTCCAG CATCCTCATC TCTGATTAAA 
 7501 TAAGCTTCAG TTTTTCCTTA GTTCCTGTTA CATTTCTGTG TGTCTCCATT 
 7551 AGTGACCTCC CATAGTCCAA GCATGAGCAG TTCTGGCCAG GCCCCTGTCG 
 7601 GGGTCAGTGC CCCACCCCCG CCTTCTGGTT CTGTGTAACC TTCTAAGCAA 
 7651 ACCTTCTGGC TCAAGCACAG CAATGCTGAG TCATGATGAG TCATGCTGAG 
 7701 GCTTAGGGTG TGTGCCCAGA TGTTCTCAGC CTAGAGTGAT GACTCCTATC 
 7751 TGGGTCCCCA GCAGGATGCT TACAGGGCAG ATGGCAAAAA AAAGGAGAAG 
 7801 CTGACCACCT GACTAAAACT CCACCTCAAA CGGCATCATA AAGAAAATGG 
 7851 ATGCCTGAGA CAGAATGTGA CATATTCTAG AATATATTAT TTCCTGAATA 
 7901 TATATATATA TATACACATA TACGTATATA TATATATATA TATATATTTG 
 7951 TTGTTATCAA TTGCCATAGA ATGATTAGTT ATTGTGAATC AAATATTTAT 
 8001 CTTGCAGGTG GCCTCTATAC CTAGAAGCGG CAGAATCAGG CTTTATTAAT 
 8051 ACATGTGTAT AGATTTTTAG GATCTATACA CATGTATTAA TATGAAACAA 
 8101 GGATATGGAA GAGGAAGGCA TGAAAACAGG AAAAGAAAAC AAACCTTGTT 
 8151 TGCCATTTTA AGGCACCCCT GGACAGCTAG GTGGCAAAAG GCCTGTGCTG 
 8201 TTAGAGGACA CATGCTCACA TACGGGGTCA GATCTGACTT GGGGTGCTAC 
 8251 TGGGAAGCTC TCATCTTAAG GATACATCTC AGGCCAGTCT TGGTGCATTA 
 8301 GGAAGATGTA GGCAACTCTG ATCCTGAGAG GAAAGAAACA TTCCTCCAGG 
 8351 AGAGCTAAAA GGGTTCACCT GTGTGGGTAA CTGTGAAGGA CTACAAGAGG 
 8401 ATGAAAAACA ATGACAGACA GACATAATGC TTGTGGGAGA AAAAACAGGA 
 8451 GGTCAAGGGG ATAGAGAAGG CTTCCAGAAG AATGGCTTTG AAGCTGGCTT 
 8501 CTGTAGGAGT TCACAGTGGC AAAGATGTTT CAGAAATGTG ACATGACTTA 
 8551 AGGAACTATA CAAAAAGGAA CAAATTTAAG GAGAGGCAGA TAAATTAGTT 
 8601 CAACAGACAT GCAAGGAATT TTCAGATGAA TGTTATGTCT CCACTGAGCT 
 8651 TCTTGAGGTT AGCAGCTG 
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Appendix II – Calibration curves used for total protein quantification via Bradford 
assay and for analysis of several biomarkers 
 
Figure A.1. BSA calibration curve used for quantification of total protein in goldfish samples. 
 
 
 
 
Figure A.2. BSA calibration curve used for quantification of total protein in mussel samples. 
 
 
 
 
Figure A.3. Resorufin calibration curve used for analysis of EROD in mussel samples. 
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Figure A.4. Formaldehyde calibration curve used for analysis of catalase (CAT) in mussel samples. 
 
 
 
 
Figure A.5. Trolox calibration curve used for analysis of total antioxidant capacity (TAC) in mussel 
samples. 
 
 
 
 
 
Figure A.6. Malondialdehyde calibration curve used for analysis of lipid peroxidation in mussel samples. 
  
 
 
176 
 
Appendix III – Characterisation of organic matrices: UV-Vis and MALDI-MS  
 
177 
 
Figure A.7. Characterisation of the utilised organic matrices: UV-Vis spectrum (on the foremost left), 
Absorbance at 337 nm (on the center) and MALDI spectrum with dGTP (on the right). A) CHCA; B) 
Ferulic acid; C) THAP; D) 3-HPA; E) Super DHB; F) Sinapinic acid (SA); G) chloro-phenyl-acrylic acid 
(Cl-Ph-AA); H) HABA. Black stars on the MALDI spectra identify dGTP molecular ion signals when using 
CHCA and ferulic acid. Other matrices did not allow the identification of the analyte. 
 
      
 
 
 
  
 
 
 
 
 
